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ABSTRACT 
 1 
ABSTRACT 
Faithful chromosome segregation is crucial for cells. To achieve it, large protein 
complexes called kinetochores form a link between chromosomes and the mitotic 
spindle. The mechanisms of the recruitment and regulation of kinetochore 
components leading to functional kinetochore-microtubule attachments are still 
poorly understood. The work described in this thesis takes a step towards 
understanding this complex process by analyzing the interactions of the spindle and 
kinetochore associated Astrin/SKAP complex that is essential for mitotic progression 
and chromosome biorientation. A combinatorial approach including biochemical, 
biophysical, cell biological and structural methods was used to elucidate the structure 
and the functional role of the Astrin/SKAP complex during mitosis. 
Studies on the intersubunit interaction of the Astrin/SKAP complex identified the 
domains encompassing amino acids 482 to 850 in Astrin and 159 to 316 in SKAP as 
minimal interaction domains. The microtubule-binding domain of SKAP was mapped 
to amino acids 135 to 225, while no microtubule-targeting domain could be identified 
in Astrin, suggesting that the Astrin/SKAP complex binds microtubules through 
SKAP. Microtubule binding of SKAP requires several conserved positively charged 
residues that interact with microtubules at both the inter- and intra-tubulin dimer 
interface. The microtubule-binding sites of SKAP at least partly overlap with those of 
the Ndc80 complex, the major microtubule binder of the kinetochore. SKAP binds 
tubulin in solution and bundles microtubules. This work suggests that SKAP is a 
microtubule-stabilizing factor that facilitates microtubule nucleation and growth, 
explaining the functions of the Astrin/SKAP complex in spindle organization and 
stabilization of kinetochore-microtubule attachments. Functional inactivation of the 
microtubule-binding domain of SKAP prevents rescuing the significant defects in 
spindle formation, chromosome congression and mitotic progression that are caused 
by depletion of SKAP. Furthermore, this study shows that the kinetochore localization 
of the Astrin/SKAP complex does not depend on the presence of microtubules. First 
insights into the structural organization of the Astrin/SKAP complex reveal a highly 
elongated and flexible structure. A promising step towards the crystal structure of 
SKAP could be achieved by successful crystallization of different SKAP constructs. 
In summary, this work provides a first thorough in vitro analysis of the structure and 
function of the Astrin/SKAP complex. The obtained results significantly advance our 
understanding of the functional role of the Astrin/SKAP complex during mitosis and 
the mechanisms leading to functional kinetochore-microtubule attachments. 
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ZUSAMMENFASSUNG 
Die ordnungsgemäße Trennung der Chromosomen ist entscheidend für Zellen. Um 
dies zu erreichen, bilden große Proteinkomplexe, sogenannte Kinetochore, eine 
Verbindung zwischen den Chromosomen und der mitotischen Spindel. Die 
Mechanismen der Rekrutierung und Regulation von Kinetochor-komponenten, 
welche zu funktionellen Kinetochor-Mikrotubuli-Anbindungen führen, sind nach wie 
vor unzureichend erforscht. Die in der vorliegenden Dissertation beschriebene Arbeit 
erweitert das Verständnis dieses komplexen Prozesses durch die Analyse der 
Interaktionen des Spindel- und Kinetochor-assoziierten Astrin/SKAP-Komplexes, 
welcher essenziell für den mitotischen Verlauf und die Biorientierung der 
Chromosomen ist. Ein kombinatorischer Ansatz aus biochemischen, bio-
physikalischen, zellbiologischen und strukturellen Methoden wurde angewendet, um 
die Struktur und die funktionelle Rolle des Astrin/SKAP-Komplexes während der 
Mitose aufzuklären.  
Untersuchungen der Interaktionen zwischen den Untereinheiten des Astrin/SKAP-
Komplexes identifizierten die Domänen, welche die Aminosäuren 482 bis 850 in 
Astrin sowie 159 bis 316 in SKAP umfassen, als minimale Interaktionsdomänen. Die 
Mikrotubuli-bindende Domäne von SKAP wurde auf die Region von Aminosäure 135 
bis 225 eingegrenzt, während keine Mikrotubuli-bindende Domäne in Astrin 
identifiziert werden konnte. Dies deutet darauf hin, dass der Astrin/SKAP-Komplex 
durch SKAP an Mikrotubuli bindet. Die Mikrotubulibindung von SKAP erfordert 
mehrere konservierte positiv geladene Reste, welche mit Mikrotubuli sowohl an der 
Inter- als auch der Intra-Tubulindimer-Oberfläche interagieren. Die Mikrotubuli-
bindestellen von SKAP überlappen sich zumindest teilweise mit denen des Ndc80-
Komplexes, welcher der Hauptbinder für Mikrotubuli ist. SKAP bindet Tubulin in 
Lösung und bündelt Mikrotubuli. Diese Arbeit deutet darauf hin, dass es sich bei 
SKAP um einen Mikrotubuli-stabilisierenden Faktor handelt, welcher die Nukleation 
und das Wachstum von Mikrotubuli erleichtert, wodurch die Funktionen des 
Astrin/SKAP-Komplexes in der Spindelorganisation und Stabilisierung von 
Mikrotubuli-Kinetochor-Anbindungen erklärt werden können. Die funktionelle 
Inaktivierung der Mikrotubuli-bindenden Domäne von SKAP unterbindet die 
„Rettung“ signifikanter Defekte in der Spindelausbildung, der Chromosomen-
kongression und dem mitotischen Verlauf, welche durch die Degradation von SKAP 
verursacht werden. Weiterhin zeigt diese Studie, dass die Kinetochorlokalisierung 
des Astrin/SKAP-Komplexes nicht von der Anwesenheit von Mikrotubuli abhängig ist. 
Erste Einblicke in die strukturelle Organisation des Astrin/SKAP-Komplexes lassen 
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eine stark elongierte und flexible Struktur erkennen. Ein vielversprechender Schritt 
zur Kristallstruktur von SKAP konnte durch die erfolgreiche Kristallisation 
verschiedener SKAP-Konstrukte erreicht werden.  
Zusammenfassend liefert diese Arbeit eine erste sorgfältige in vitro Analyse der 
Struktur und Funktion des Astrin/SKAP-Komplexes. Die erhaltenen Ergebnisse 
leisten einen signifikanten Beitrag zur Verbesserung unseres Verständnisses der 
funktionellen Rolle des Astrin/SKAP-Komplexes während der Mitose und der 
Mechanismen, welche zu funktionellen Kinetochor-Mikrotubuli-Anbindungen führen.  
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1 INTRODUCTION 
1.1 The cell cycle 
The cell cycle describes the fundamental and highly regulated series of events, 
including DNA duplication and cell division, by which all cells reproduce their genetic 
material in order to generate two identical daughter cells (Alberts et al., 2008; 
Morgan, 2007). The eukaryotic cell cycle is divided into four phases. In S phase - S 
stands for DNA synthesis - the replication of DNA and the duplication of 
chromosomes take place. The duplicated chromosomes are called sister chromatids. 
They are tightly linked by a protein complex called cohesin until the latter is cleaved 
by the protease separase during mitosis (Waizenegger et al., 2000). Mitosis is the 
process of nuclear division and together with the division of the cell itself, also known 
as cytokinesis, represents one of two major events of M phase, in which the 
segregation of chromosomes to two daughter cells occurs (Alberts et al., 2008; 
Morgan, 2007). Between the M and S phases most cells pass through two so-called 
gap phases, the G1 phase between M and S phase and the G2 phase between S 
and M phase. These additional phases provide enough time for cell growth and 
duplication of proteins and cell organelles. The phases G1, S and G2 are 
summarized as interphase.  
The term mitosis was coined by Walther Flemming in the early 1880s (Flemming, 
1882; Mitchison & Salmon, 2001). It summarizes all processes that are required to 
faithfully segregate the sister chromatids, so that both daughter cells contain an 
identical set of chromosomes (Alberts et al., 2008). This extremely complex process 
is tightly regulated, as it is crucial for the viability of cells to maintain the integrity of 
their genomes. Defects in the accuracy of mitotic events can result in aberrations of 
the chromosome number, so-called aneuploidy, and genetic instability often leading 
to cell death or cancer (Lengauer et al., 1998).  
Mitosis can be subdivided into five phases called pro-, prometa-, meta-, ana- and 
telophase (Alberts et al., 2008; Morgan, 2007). The processes that take place during 
these phases are schematically shown in figure 1.1. In prophase, chromosomes 
condense into a compact flexible form and the centrosomes, the starting points of the 
spindle, mature, so that the assembly of the spindle can be initialized. In 
prometaphase, the nuclear envelope breaks down and the chromosomes become 
attached to the spindle microtubules at their centromere regions via large protein 
complexes known as kinetochores. In metaphase, all chromosomes are aligned at 
the spindle midzone, the so-called metaphase plate, in a state called biorientation 
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with both sister chromatids connected to spindle microtubules emanating from 
opposite spindle poles. In anaphase, the sister chromatids are separated and pulled 
towards the opposite spindle poles. After these early events at the onset of 
anaphase, also known as anaphase A, the spindle poles themselves move apart 
from each other in anaphase B. In telophase, the two sets of chromosomes are 
repackaged into the daughter nuclei completing the process of mitosis.  
 
 
Figure 1.1: Overview of mitotic cell division. During prophase, replicated chromatin is condensed. 
During prometaphase, the nuclear envelope breaks down and chromosomes get attached to spindle 
microtubules via kinetochores. In metaphase, all chromosomes are bioriented and aligned at the 
metaphase plate. During anaphase, sister chromatids become separated and are pulled towards 
opposite spindle poles. During telophase, two daughter nuclei are generated. The cell cycle is 
completed by cytokinesis (not shown here). Figure adapted from Cheeseman & Desai, 2008. 
 
Because of the need for accuracy, cell cycle progression is strictly controlled by a 
series of so-called checkpoints that ensure initiation of specific cell cycle events in 
the correct order and only upon successful completion of the previous event 
(Coudreuse & Nurse, 2010; Morgan, 2007). This cell cycle control system is based 
on the oscillating activities of a family of enzymes called the cyclin dependent 
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kinases (Cdks) that regulate cell cycle progression at three major checkpoints. The 
first checkpoint, the G1/S checkpoint or Start, makes sure that DNA replication only 
starts if the conditions for cell proliferation are ideal. The G2/M checkpoint regulates 
the entry into mitosis. The third checkpoint is the metaphase-to-anaphase transition, 
which is regulated by the spindle assembly checkpoint (SAC) that stimulates the 
separation of sister chromatids only after biorientation of all chromosomes 
(Musacchio & Salmon, 2007).  
 
1.2 Microtubules and the mitotic spindle 
Besides the function of microtubules in forming the mitotic spindle during cell division, 
microtubules exert several functions in non-dividing cells including organization of the 
cytoplasm, positioning of the nucleus and organelles as well as forming flagella and 
cilia (Desai & Mitchison, 1997). In the 1960s, it was discovered that the mitotic 
spindle is an array of long microtubule fibers consisting of tubulin as building block 
(Kiefer et al., 1966). Microtubules are hollow cylindrical polymers, 25 nm in diameter, 
comprised of 12 to 15 protofilaments with a heterodimer of α- and β-tubulin as its 
building block (Desai & Mitchison, 1997). These α-/β-tubulin heterodimers associate 
in a head-to-tail conformation to form a polar lattice with a slowly growing minus end, 
exposing α-tubulin, and a fast growing plus end, exposing β-tubulin (Wittmann et al., 
2001). The assembly of microtubules proceeds in two phases, nucleation and growth 
or elongation (Johnson & Borisy, 1977). The barrier to initiate microtubule growth by 
formation of nuclei is much higher than to elongate an existing polymer, but this 
nucleation barrier can be overcome in the presence of certain proteins (Murphy & 
Borisy, 1975). Indeed, several microtubule-associated proteins (MAPs) are 
implicated in the active control of the polymerization state of microtubules by 
promoting either their polymerization or depolymerization (Cheeseman & Desai, 
2008), as further described below.  
As shown in figure 1.2, microtubules are highly dynamic structures exhibiting fast 
transitions from polymerization to depolymerization, so-called catastrophes, and 
reverse transitions from depolymerization to polymerization, also known as rescue. 
This non-equilibrium polymerization behavior is known as dynamic instability (Desai 
& Mitchison, 1997) and the hydrolysis of GTP at the exchangeable or E-site of 
β-tubulin serves as its energy source (Weisenberg et al., 1976; David-Pfeuty et al., 
1977). The GTP-binding site on α-tubulin, the so-called N-site, is nonexchangeable 
and constitutively bound to GTP, because it is buried within the tubulin dimer 
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interface. The E-site of β-tubulin is exposed at the surface of the microtubule plus 
end and contacted by a newly incorporated tubulin dimer, which completes the 
binding pocket and enables hydrolysis, thereby forming a link between microtubule 
polymerization and GTP hydrolysis (Nogales et al., 1999). The resulting GDP after 
GTP hydrolysis is locked in the polymer lattice, so that microtubules predominantly 
contain GDP-tubulin. The polymerizing microtubule end is stabilized by a ‘GTP cap’, 
which has been postulated because of the much slower off rate of GTP-tubulin from 
a GTP-lattice compared to the off rate of GDP-tubulin from a GDP-lattice during 
depolymerization (Mitchison & Kirschner, 1984). Upon loss of the ‘GTP cap’, 
depolymerization with very rapid loss of GDP-tubulin subunits takes place. The 
released GDP-tubulin is then reprimed for another polymerization cycle by nucleotide 
exchange from GDP to GTP.  
 
 
Figure 1.2: Microtubule dynamics. Microtubules form a polar lattice by head-to-tail association of α-/β-
tubulin dimers. Their dynamic structure shows fast transition from polymerization to depolymerization, 
called catastrophe, and reverse transition, called rescue. Figure adapted from Cheeseman & Desai, 
2008. 
 
Microtubule dynamics are crucial for chromosome movement, and chromosome 
separation is mainly driven by microtubule depolymerization (Desai & Mitchison, 
1997). Confirming the importance of microtubule dynamics in vivo, many successful 
anticancer drugs, such as taxol, bind to tubulin and suppress microtubule dynamics 
by either increasing or decreasing microtubule polymerization (Dumontet & Jordan, 
2010). Although several studies have revealed a connection between tubulin 
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conformation and its polymerization state - with a straight tubulin conformation within 
the microtubule lattice and a curved conformation at depolymerizing ends -, a 
correlation with its nucleotide state has been challenging. Recent high-resolution cryo 
electron microscopy studies on microtubules that are either dynamic or stabilized by 
taxol or the slowly hydrolyzable GTP analog GMPCPP provide further insight into the 
mechanism of dynamic instability (Alushin et al., 2014; Zhang et al, 2015). These 
experiments suggest that GTP hydrolysis leads to a compaction around the E-site 
nucleotide at the longitudinal interfaces as well as a rearrangement of α-tubulin, 
thereby generating a destabilizing strain within the microtubule lattice that is released 
by tubulin bending during depolymerization. Taxol inhibits these conformational 
changes, thereby allosterically inducing a GTP-like state, indicating that the structural 
transitions are responsible for destabilization upon nucleotide hydrolysis. Since 
lateral contacts are not significantly affected by the nucleotide state or drug binding, 
the stability of the microtubule lattice seems to be mainly modulated at longitudinal 
interfaces.  
As briefly mentioned above, several microtubule-associated proteins can actively 
control the polymerization state of microtubules, which is important for fast 
remodeling of the microtubule cytoskeleton in response to cellular signals (Desai & 
Mitchison, 1997). Some proteins influence microtubule dynamics by acting as 
microtubule-depolymerizing factors, such as the kinesin-13 familiy including the 
mitotic centromere-associated kinesin (MCAK) that induces catastrophes (Desai et 
al., 1999). Others act as microtubule-stabilizing factors, such as the cytoplasmic 
linker protein (CLIP)-associated protein (CLASP) (Mimori-Kiyosue et al., 2005) and 
XMAP215, which promotes microtubule growth (Brouhard et al., 2008). Several 
proteins that regulate microtubule dynamics are plus-end tracking proteins, so called 
+TIPs. The end binding (EB) protein family acts as central hub for these +TIPs 
(Akhmanova & Steinmetz, 2010). EB proteins possess an N-terminal calponin 
homology (CH) domain that is important for the direct interaction with microtubules 
and autonomous tracking of growing microtubule plus ends (Hayashi & Ikura, 2003). 
The C-terminal dimerization domain mediates the recruitment of several other +TIPs 
that do not track microtubule plus ends autonomously, but through binding of EB 
proteins (Honnappa et al., 2009; Akhmanova & Steinmetz, 2010). The recognized 
features within the EB C-terminal domain are the EB homology domain and the 
acidic tail comprising an EEY/F motif. The EB homology domain is recognized by 
+TIPs through a small four-residue motif containing the sequence serine-X-
isoleucine-proline (X stands for any amino acid), the so-called SXIP motif (Honnappa 
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et al., 2009). Other +TIPs possess a small globular cytoskeleton-associated protein 
glycine-rich (CAP-Gly) domain with a hydrophobic cavity to interact with the 
C-terminal EEY/F motif of EB proteins (Honnappa et al., 2006). Recent high-
resolution cryo electron microscopy analysis of EB-bound microtubules provides new 
insight into the modulation of structural transitions at the growing microtubule end by 
EB proteins (Zhang et al., 2015). These experiments reveal that EB proteins 
preferentially recognize and promote an intermediate GDP-Pi state upon GTP 
hydrolysis, explaining their end-tracking behavior and their effect on microtubule 
dynamics including stimulation of microtubule growth as well as increase of 
catastrophe frequency. EB-bound microtubules exhibit a compacted lattice with a 
unique rotation between adjacent tubulin dimers compared to the untwisted 
compacted GDP-microtubule lattice. By generating this lattice compaction, EB 
proteins presumably promote rapid GTP hydrolysis. The stimulation of microtubule 
growth by EB proteins may be explained by EB binding between adjacent 
protofilaments and generation of a specific curvature that facilitate the establishment 
of lateral contacts and thereby seam closure.  
Another group of microtubule-associated proteins are motor proteins, which move 
along the microtubules. There are two families of motor proteins: the dyneins, which 
move towards the minus end, and the kinesin superfamily, which mostly move 
towards the plus end (Morgan, 2007). These motor proteins are typically dimers with 
microtubule-binding head domains and additional domains that form a link to a cargo 
or other subcellular structures. The ATPase activity in their head domains allows the 
motor proteins to convert chemical energy contained in ATP into mechanical energy 
of movement along the microtubule lattice, so that they can transport a cargo along 
microtubules or move the microtubules past an anchor point. The polarity of 
microtubules, by which they can act as directional track for motor proteins, and their 
dynamic instability, which generates significant forces that carry out useful 
mechanical work in vivo, present the two major properties of microtubules that allow 
them to form the mitotic spindle (Wittmann et al., 2001). The mitotic spindle contains 
three distinct sub-populations of microtubules that have their minus ends focused at 
the spindle poles and the plus ends pointing towards the chromosomes (Morgan, 
2007; Wittmann et al., 2001). A schematic view of these three microtubule types of 
the mitotic spindle is shown in figure 1.3. First, astral microtubules extend away from 
the centrosomes into the cytoplasm and help orienting and positioning the spindle 
within the cell. Second, interpolar microtubules emanate from opposite spindle poles 
and interact in an antiparallel manner at the spindle midzone, thereby stabilizing the 
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bipolar spindle. Third, kinetochore microtubules connect chromosomes to spindle 
poles and are responsible for pulling the sister chromatids apart towards opposite 
spindle poles during anaphase.  
 
 
Figure 1.3: The mitotic spindle. Schematic overview of different microtubule types at the mitotic 
spindle in metaphase. Figure adapted from Morgan, 2007. 
 
Mitotic microtubules exhibit a rapid turnover driven primarily by an increased 
catastrophe rate, which allows them to efficiently search for binding sites on the 
chromosomes in the surrounding cytosol, a mechanism also known as search-and-
capture model (Kirschner & Mitchison, 1986; Holy & Leibler, 1994). Upon successful 
capture of a spindle microtubule by a kinetochore, the microtubules show increased 
half-lives and are thereby stabilized. Besides this stabilizing effect of kinetochores, 
their ability to keep the chromosomes attached to growing and shrinking microtubules 
is an essential feature for proper functioning of the spindle (Rieder & Salmon, 1998).  
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1.3 Organization and function of kinetochores 
Kinetochores are complex protein networks that consist of over 100 individual 
proteins (DeLuca & Musacchio, 2012). First insights into the organization of a 
vertebrate kinetochore were obtained by electron microscopy (EM) studies revealing 
a trilaminar structure with electron dense inner and outer layers separated by an 
electron lucent middle layer (McEwen et al., 2007) as shown in figure 1.4. In the 
absence of microtubules, a fibrous corona is visible as dense array of fibers that 
extend from the outer plate. 
 
Figure 1.4: Vertebrate kinetochore ultrastructure. Left, schematic view of a mitotic chromosome with 
the sister chromatid on the right attached to spindle microtubules and the chromatid on the left 
unattached. Right, electron micrograph of a human kinetochore representing a single slice from a 
tomographic volume of a high-pressure frozen mitotic cell. Scale bar: 100 nm. Figure adapted from 
Cheeseman & Desai, 2008. 
 
This organization of the centromere-kinetochore region reflects the main functions of 
kinetochores, which can be divided into four modules (Musacchio & Salmon, 2007; 
Welburn & Cheeseman, 2008; Santaguida & Musacchio, 2009). A schematic view of 
these modules within the kinetochore is shown in figure 1.5.  
The first module is the inner kinetochore, which forms the interface with centromeric 
chromatin and appears as the electron dense inner layer in the EM image (see 
figure 1.4). It consists of a large complex comprising 16 subunits called the 
constitutive centromere associated network (CCAN). The CCAN builds a robust 
interface at the centromere region and serves as structural core for the recruitment of 
outer kinetochore components (Perpelescu & Fukagawa, 2011). Its members are 
identified as CENP - for centromere protein - followed by a letter. The association of 
the CCAN with centromeric DNA is the first step in kinetochore assembly. Two 
distinct pathways for the recruitment of the kinetochore based on the CCAN subunits 
CENP-C and CENP-T/W have been proposed. CENP-C directly binds to 
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nucleosomes containing the histone H3 variant CENP-A (Carroll et al., 2010), which 
defines the centromeric region together with epigenetic modifications (Black & 
Bassett, 2008). The CENP-T/W complex was found to associate with H3, but not 
CENP-A containing nucleosomes (Hori et al., 2008). The histone-fold containing 
complexes CENP-T/W and CENP-S/X form a stable CENP-T/W/S/X heterotetramer 
that is able to bind and supercoil DNA to form a nucleosome-like structure as scaffold 
for kinetochore assembly (Nishino et al., 2012). Furthermore, the CCAN was shown 
to be important for the deposition of new CENP-A at centromeres after mitosis, thus 
making it not only essential for recognition of centromeric chromatin, but also for its 
maintenance (Hori et al., 2013). Some organisms, like Caenorhabditis elegans or 
Drosophila melanogaster, seem to have lost many CCAN components and only rely 
on CENP-A and CENP-C for inner kinetochore assembly (Westermann & Schleiffer, 
2013). Such simplified kinetochores retain the basic chromosome segregation 
function, but robust and high fidelity chromosome segregation requires the assembly 
of the entire protein network. 
The second module is the outer kinetochore, which acts as attachment site for the 
plus ends of spindle microtubules and corresponds to the electron dense outer layer 
in the EM image (see figure 1.4). The central component of this outer plate is the 
KMN network, which contains the Knl1 complex, the Mis12 complex and the Ndc80 
complex and is essential for the establishment of kinetochore-microtubule 
interactions. It is linked to the inner kinetochore through direct interactions with the 
two CCAN components CENP-C and CENP-T that bind to the Mis12 complex and 
the Ndc80 complex, respectively (Gascoigne et al., 2011; Screpanti et al., 2011). The 
outer kinetochore is discussed in more detail in section 1.4.  
The third module is the spindle assembly checkpoint (SAC), which is recruited to 
outer kinetochore components. The SAC is a feedback control mechanism that 
monitors the state of kinetochore-microtubule attachments and coordinates it with the 
progression of the cell cycle. It delays anaphase onset by generating a ‘wait-
anaphase’ signal until all sister chromatids are properly attached to opposite spindle 
poles. The SAC is further discussed in section 1.5. 
The forth module, which is located at the inner centromere region, contains the 
chromosomal passenger complex (CPC). The CPC is responsible for discriminating 
between correct and incorrect kinetochore-microtubule attachments. It is believed 
that the CPC acts as tension sensor and thereby selectively stabilizes correct 
attachments, whereas it favors the correction of incorrect attachments. The CPC is 
discussed in more detail in section 1.5.  
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Figure 1.5: Organization of the centromere-kinetochore region. The kinetochore can be divided into 
four building blocks: 1.) The constitutive centromere associated network (CCAN), which is located at the 
inner kinetochore, is responsible for chromatin binding. 2.) The outer kinetochore, which contains the 
KMN (Knl1 complex/Mis12 complex/Ndc80 complex) network, is required for the establishment of 
kinetochore-microtubule attachments. 3.) The spindle assembly checkpoint (SAC), which is recruited to 
outer kinetochore components, synchronizes kinetochore-microtubule attachments and cell cycle 
progression. 4.) The chromosomal passenger complex (CPC), which associates with the inner 
centromere region, is required for correction of improper kinetochore-microtubule attachments. Figure 
adapted from Musacchio & Salmon, 2007. 
 
The simplest kinetochore is found in the budding yeast Saccharomyces cerevisiae 
and binds a single microtubule (Westermann et al., 2007), whereas human 
kinetochores bind 15-20 microtubules (Cheeseman & Desai, 2008). With few 
exceptions, yeast kinetochore components have vertebrate homologs, suggesting 
that important features of kinetochore composition and organization are conserved 
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throughout evolution, despite some organism-specific differences (Kitagawa & Hieter, 
2001; Cheeseman & Desai, 2008; Welburn & Cheeseman, 2008).  
Although the overall network of kinetochore proteins is relatively well defined, the 
molecular details of the interactions between the different proteins and the dynamics 
of kinetochore-microtubule attachments during mitotic progression remain poorly 
understood.  
 
1.4 The outer kinetochore 
The outer kinetochore contains the 10-subunit KMN network consisting of the 
2-subunit Knl1 complex, the 4-subunit Mis12 complex and the 4-subunit Ndc80 
complex (Santaguida & Musacchio, 2009; Varma & Salmon, 2012). Whereas the 
CCAN components colocalize with CENP-A nucleosomes throughout the cell cycle, 
the KMN network is only recruited to kinetochores during late interphase-prophase 
and dissociates again during late anaphase-telophase (Cheeseman & Desai, 2008).  
The KMN network exhibits two main functions. First, it provides the main microtubule-
binding interface and therefore couples kinetochores to assembling and 
disassembling microtubules, which is crucial to align chromosomes at the metaphase 
plate and to pull them towards the spindle poles in anaphase (Maiato et al., 2004). 
Second, the KMN network is involved in the recruitment of all SAC components, with 
the possible exception of Aurora B, and thereby plays an important role in SAC 
control and the regulation of kinetochore dynamics (Martin-LLuesma et al., 2002; 
Kiyomitsu et al., 2007). 
Significant progress in the in vitro reconstitution of the KMN network and its 
interaction with the inner kinetochore has been achieved in recent years (Ciferri et 
al., 2005; Cheeseman et al., 2006; Petrovic et al., 2010; Screpanti et al., 2011; 
Petrovic et al., 2014). A schematic overview of the molecular architecture of the KMN 
network is shown in figure 1.6.  
The Mis12 complex comprises the four subunits Dsn1, Mis12, Nnf1 and Nsl1. It 
exhibits an elongated rod-shaped structure with a length of about 22 nm (Petrovic et 
al., 2010; Varma & Salmon, 2012). Its subunits are linearly aligned with Nnf1 at the 
inside, followed by Mis12 and Dsn1 and Nsl1 at the outside. The Mis12 complex 
forms a link to the inner kinetochore by binding directly to CENP-T and CENP-C 
(Gascoigne et al., 2011; Screpanti et al., 2011; DeLuca & Musacchio, 2012). It acts 
as a scaffold for the assembly of the outer kinetochore by binding both the Ndc80 
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and the Knl1 complex with the C-terminal tail of the Nsl1 subunit (Cheeseman & 
Desai, 2008; Petrovic et al., 2010). In agreement with the function of the Mis12 
complex as platform for outer kinetochore assembly, depletion of its subunits results 
in reduced kinetochore localization of Ndc80 and defects in chromosome 
biorientation and segregation (Kline et al., 2006).  
The Knl1 complex is a heterodimer formed by the two subunits Knl1 and Zwint 
(Varma & Salmon, 2012). The ~300 kD multidomain protein Knl1 has an elongated 
structure with its N-terminal region pointing outwards and binding to microtubules 
(Cheeseman et al., 2006), whereas its C-terminal region is associated with the Mis12  
 
 
Figure 1.6: Schematic view of the molecular architecture of the KMN network. With the exception 
of CENP-T, W and C all CCAN subunits have been omitted. CENP-T/W associates with H3 
nucleosomes (H3), whereas CENP-C associates with CENP-A nucleosomes (CA). The Mis12 complex 
forms a bridge between inner and outer kinetochore by binding CENP-T and C as well as the 
Spc24/Spc25 subcomplex of the Ndc80 complex. The Ndc80/Hec1 and Nuf2 subunits of the Ndc80 
complex interact with microtubules and the N-terminal region of Knl1 also possesses microtubule-
binding abilities. Figure adapted from DeLuca & Musacchio, 2012. 
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complex (Petrovic et al., 2010; Varma & Salmon, 2012). This interaction with the 
Mis12 complex recruits Knl1 to kinetochores. The N-terminal region of Knl1 contains 
10-12 amino acids long helical motifs, the so-called KI motifs, which contribute to the  
function of Knl1 as scaffold for the recruitment of the SAC components Bub1 and 
BubR1, thereby indicating an important role of Knl1 in maintaining SAC activity in 
human cells (Krenn et al., 2012). However, the main contribution to the kinetochore 
recruitment of Bub1 and BubR1 does not come from the KI motifs, but from 
phosphorylated MELT repeats (Krenn et al., 2014). Consistent with these findings, 
depletion of Knl1 displaces Bub1 and BubR1 from kinetochores and results in cells 
that undergo accelerated mitosis and enter anaphase with misaligned chromosomes 
due to a checkpoint failure (Kiyomitsu et al., 2007). Furthermore, Knl1 is important for 
the recruitment of protein phosphatase 1 (PP1) to the outer kinetochore. PP1 
counteracts the activity of the Aurora B kinase, which is part of the chromosomal 
passenger complex (CPC) and is involved in regulation of kinetochore-microtubule 
attachments as discussed in more detail in section 1.5. The C-terminal coiled-coil 
domain of Knl1 forms a tight interaction with a binding partner named Zwint, thereby 
recruiting it to kinetochores (Kiyomitsu et al., 2007; Petrovic et al., 2010). Zwint is 
involved in the kinetochore recruitment of ZW10 (Starr et al., 2000), a component of 
the Rod-Zwilch-ZW10 (RZZ) complex. The RZZ is another outer kinetochore protein 
complex that is essential for both SAC activation, by recruiting the crucial SAC 
component Mad1/Mad2 to unattached kinetochores (Kops et al., 2005), and SAC 
silencing, by recruiting Spindly that in turn recruits dynein/dynactin upon microtubule 
attachment (Starr et al., 1998; Griffis et al., 2007). The dynein/dynactin complex is a 
minus end directed motor protein complex that is required for a process called 
kinetochore shedding, during which RZZ and Mad1/Mad2 are removed from 
kinetochores and transported along the microtubules towards the spindle poles 
(Karess, 2005). 
The 170 kD Ndc80 complex consists of the four proteins Ndc80 (Hec1), Nuf2, Spc24 
and Spc25, which are associated as two subcomplexes, Ndc80/Nuf2 and 
Spc24/Spc25 (Cheeseman et al., 2006). The Ndc80 complex forms a 57 nm long 
dumbbell-like structure with the ends of the dumbbell separated by a long coiled-coil 
domain (Ciferri et al., 2005; Wei et al., 2005). The inner end of the Ndc80 complex 
comprising the Spc24/Spc25 subcomplex binds to the CCAN protein CENP-T as well 
as the Mis12 complex (Petrovic et al., 2010; Nishino et al., 2013; Malvezzi et al., 
2013). The outward pointing end of the Ndc80 complex is formed by the Ndc80/Nuf2 
subcomplex and serves as primary binding site for the plus ends of the spindle 
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microtubules (DeLuca & Musacchio, 2012). The interface for microtubule interaction 
is created by the N-terminal tail of the Ndc80 subunit and two calponin homology 
(CH) domains in the Ndc80 and Nuf2 subunits (Ciferri et al., 2008), although the CH 
domain of Nuf2 was found not to be directly involved in microtubule binding (Alushin 
et al., 2010). The 80 amino acid long, disordered and positively charged N-terminal 
tail of Ndc80 is important for its high-affinity microtubule binding by interacting with 
the negatively charged C-terminal tails of tubulin, the so-called E-hooks, and 
represents the site of phosphoregulation by Aurora B (Cheeseman et al., 2006). This 
interaction site is also involved in self-assembly of the Ndc80 complex into clusters 
upon microtubule binding (Alushin et al., 2010) explaining its cooperative binding to 
microtubules (Ciferri et al., 2008). A key microtubule-binding region of the Ndc80 
complex is the so-called ‘toe’ located in the CH domain of Ndc80. It recognizes a site 
at the α-/β-tubulin interface of both intra- and inter-tubulin dimers, also known as ‘toe 
print’ (Alushin et al., 2010). Microtubule binding by the Ndc80 complex is sensitive to 
the conformation of tubulin, since the Ndc80 complex binds preferentially to straight 
microtubules. Recent studies have identified near the microtubule binding CH domain 
of Ndc80 a conserved loop domain that is important for stabilizing kinetochore-
microtubule attachments (Maure et al., 2011), providing a third microtubule-binding 
feature within the Ndc80 complex. The function of the Ndc80 complex as key player 
of kinetochore-microtubule attachments is reflected in the phenotype from its ablation 
by RNA interference. Depletion of its components causes defects in the 
establishment of stable kinetochore-microtubule attachments and induces mitotic 
cells to undergo cell death making the Ndc80 complex essential for cell viability 
(DeLuca et al., 2002). Furthermore, a regulated interaction of the Ndc80 complex 
with the checkpoint kinase Mps1 is important for Mps1 recruitment to kinetochores, 
which is essential for SAC activity by subsequent recruitment of the SAC 
components Bub1/Bub3 and the Mad1/Mad2 complex (Martin-LLuesma et al., 2002; 
London et al., 2012; Shepperd et al., 2012; Yamagishi et al., 2012; Vleugel et al., 
2014; Krenn et al., 2014; London & Biggins, 2014; Overlack et al., 2014). 
 
The question how the KMN network couples chromosome movement to assembling 
and disassembling microtubules is an active area of research. Cooperative 
microtubule binding of Ndc80 and Knl1, which is further enhanced in presence of the 
complete KMN network (Cheeseman et al., 2006), only provides a partial answer, 
even if this core attachment site contributes significantly to the fidelity of chromosome 
segregation. The two attachment sites are arranged in a high-density array to build 
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multiple contacts on a single microtubule. Quantitative fluorescence microscopy 
revealed that there might be eight Ndc80 complexes per microtubule in budding 
yeast (Joglekar et al., 2006). The specific arrangement of these complexes in defined 
clusters might contribute to increasing the strength of microtubule binding (Alushin et 
al., 2010).  
Other proteins like the motor proteins dynein and CENP-E as well as the large coiled-
coil protein CENP-F, which shows weak microtubule-binding activity (Feng et al., 
2006), might function in parallel to Ndc80 and Knl1 (Cheeseman & Desai, 2008). In 
budding yeast, the Dam1/Dash complex is also involved in kinetochore-microtubule 
attachments. This 10-subunit complex, which is present with 16-20 copies per 
microtubule (Joglekar et al., 2006), forms a ring-like structure around microtubules 
and can move processively at the end of depolymerizing microtubules (Westermann 
et al., 2005; Westermann et al., 2006). Since the Dam1 complex is able to couple the 
energy of microtubule disassembly with motion of a cargo along the microtubules, it 
has been suggested to function as processive coupler of chromosome movement 
(Asbury et al., 2006; Grishchuk et al., 2008). The Dam1 complex directly interacts 
with the Ndc80 complex, which enhances the ability of the Ndc80 complex to track 
dynamic microtubule ends and is regulated by yeast Aurora B kinase Ipl1 (Tien et al., 
2010). No structural homolog of the Dam1 complex has been discovered in higher 
eukaryotes, but the spindle and kinetochore associated (Ska) complex has been 
proposed as its functional homolog in vertebrates (Hanisch et al., 2006; Varma & 
Salmon, 2012). The Ska complex consists of the three subunits Ska1, Ska2 and 
Ska3/Rama1 and is important for the formation of kinetochore-microtubule 
attachments in human cells (Hanisch et al., 2006; Daum et al., 2009; Gaitanos et al., 
2009; Theis et al., 2009). The Ska complex forms a 35 nm wide W-shaped dimer with 
two copies of each subunit (Jeyaprakash et al., 2012). The N-terminal ends of the 
subunits build the dimerization interphase, whereas the C-terminal domains of Ska1 
and Ska3, which exhibit microtubule-binding ability, form the ends of the two arms of 
the ‘W’ thereby creating four putative microtubule-binding sites of the Ska complex. 
Although the human Ska complex and the yeast Dam1 complex exhibit a completely 
different structure, their functional properties are similar. The Ska complex binds 
cooperatively to microtubules and forms oligomers that track depolymerizing 
microtubule ends (Welburn et al., 2009; Schmidt et al., 2012). In contrast to the 
Ndc80 complex, which preferably binds straight microtubules, the Ska complex can 
bind both the straight microtubule lattice and curved protofilaments (Schmidt et al., 
2012; Abad et al, 2014). It recognizes the globular regions of tubulin monomers by 
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interacting with the microtubules in multiple orientations through several positively 
charged amino acid clusters (Abad et al., 2012). The Ska complex promotes the 
association of the Ndc80 complex with disassembling microtubule ends and their 
synergistic interaction maintains the movement of cargo along the depolymerizing 
microtubule (Schmidt et al., 2012). The localization of the Ska complex to 
kinetochores depends on all three members of the KMN network and the 
phosphorylation by Aurora B negatively regulates its interaction with the KMN 
network and thereby its kinetochore recruitment (Chan et al., 2012). A model 
showing the functional homology of the Ska complex and the Dam1 complex in 
stabilizing kinetochore-microtubule attachments together with the Ndc80 complex is 
presented in figure 1.7. 
 
 
Figure 1.7: Model showing the functional homology of the human Ska complex and the yeast 
Dam1 complex. Both the W-shaped Ska complex and the ring-shaped Dam1 complex function together 
with the Ndc80 complex to stabilize kinetochore-microtubule attachments. Figure is adapted from 
Jeyaprakash et al., 2012. 
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1.5 Establishment and regulation of kinetochore-
microtubule attachments 
Since biorientation of all sister chromatids to kinetochore microtubules is crucial for 
the fidelity of chromosome segregation, this complex process is highly regulated. The 
establishment of kinetochore-microtubule attachments takes place stepwise (Tanaka, 
2008; Tanaka, 2010). First, a kinetochore interacts with the lateral surface of a single 
microtubule. Then it is transported along the microtubule towards the spindle pole 
and subsequently gets tethered at the plus end of the microtubule thereby converting 
the lateral attachment to an end-on attachment. Finally, the sister kinetochore 
attaches to microtubules emanating from the opposite spindle pole. In case the 
chromosomes get attached with an improper orientation, such as in syntelic 
attachments in which both sister chromatids are connected to the same spindle pole, 
these erroneous attachments need to be corrected before the cell goes into 
anaphase.  
The initial interaction of kinetochores with the lateral surface of astral microtubules 
was first discovered in newt lung cells (Hayden et al., 1990) and subsequently in 
yeast (Tanaka et al., 2005). This lateral capture is due to the much larger contact 
surface of the lattice compared to the microtubule tip. The proposed search-and-
capture model (Kirschner & Mitchison, 1986; Holy & Leibler, 1994), describing a 
random search for kinetochores by the dynamic microtubules, is not efficient enough 
to explain the typical duration of prometaphase (Wollman et al., 2005). Another 
mechanism that contributes to the establishment of initial kinetochore-microtubule 
attachments involves the small GTPase Ran, which also functions in nuclear 
trafficking (Moore & Blobel, 1994). A concentration gradient of Ran-GTP is supposed 
to form around chromosomes, which acts as guide for microtubules towards 
chromosomes (Tanaka, 2010). Since this Ran-dependent mechanism is - due to the 
fast diffusion of Ran - only effective over relatively long distances (e.g. 10 µm), but 
not within short distances, a contribution of kinetochore-derived microtubules to initial 
kinetochore-microtubule attachments has been proposed (Khodjakov et al., 2003). 
Kinetochore fibers initiate from the centromere region and subsequently interact with 
spindle pole microtubules facilitating attachment of kinetochores to spindle 
microtubules. After the lateral attachment kinetochores slide along the microtubule 
towards the spindle pole, which is promoted by the minus-end directed motor protein 
dynein (Sharp et al., 2000). When the plus end of the shrinking microtubules reaches 
the kinetochore, the lateral attachment is converted to an end-on attachment, which 
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stabilizes the kinetochore-microtubule attachment. This conversion probably requires 
the association of the Ndc80 with the Dam1 complex (Tien et al., 2010) as described 
in section 1.4. Finally, the sister chromatid becomes attached to spindle microtubules 
emanating from the opposite pole.  
In order to achieve biorientation, erroneous kinetochore-microtubule attachments 
need to be corrected. In 1969, it was first discovered in meiosis I that tension plays 
an important role in such an error correction mechanism (Nicklas & Koch, 1969). 
During meiosis I, kinetochores undergo repeated connection to and disconnection 
from spindle microtubules until the two homologous kinetochores are bioriented. 
Micro-needle manipulation in grasshopper spermatocytes revealed that erroneous 
kinetochore-microtubule attachments known as syntelic attachments could be 
stabilized, when tension was artificially applied on chromosomes away from the poles 
to which both kinetochores are attached. In the absence of tension, these erroneous 
configurations were invariably corrected. 
The conserved serine/threonine kinase Aurora B was identified as crucial component 
of the error correction machinery. It is involved in destabilization of kinetochore-
microtubule attachments thereby promoting chromosome biorientation and alignment 
(Tanaka et al., 2002; Welburn et al., 2010; Carmena et al. 2012). Aurora B is a 
subunit of the CPC, which also contains INCENP, Survivin and Borealin. The location 
of the CPC changes in the course of mitosis in order to ensure spatially restricted 
substrate phosphorylation and thereby regulation of different key events including 
correction of kinetochore-microtubule attachment errors, activation of the SAC as 
well as construction and regulation of the contractile apparatus during cytokinesis 
(Carmena et al., 2012). In prometaphase, Aurora B localizes to centromeres and 
phosphorylates kinetochore components to weaken kinetochore-microtubule 
attachments and facilitate their turnover. Important targets of Aurora B 
phosphorylation are the Ndc80 complex, the Dsn1 subunit of the Mis12 complex and 
Knl1. Phosphorylation of the Ndc80 complex modulates the microtubule binding 
affinity of the KMN network (Cheeseman et al., 2006; De Luca et al., 2006; Alushin et 
al., 2012; Welburn et al., 2010). The nine Aurora B phosphorylation sites on Ndc80 
(Guimaraes et al., 2008) are located in two segments in the N-terminal tail, one at the 
tubulin binding interface and the other at the binding interface with an adjacent 
microtubule bound Ndc80 complex (Alushin et al., 2012). Phosphorylation by 
Aurora B at these target sites serves to fine-tune the interaction of the Ndc80 
complex with microtubules and with neighboring Ndc80 complexes. In budding yeast, 
phosphorylation of the Dam1 complex is important for the regulation of its interaction 
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with the Ndc80 complex (Cheeseman et al., 2002; Tien et al., 2010). In agreement 
with these findings, non-phosphorylatable mutants of the Dam1 complex, the Ndc80 
complex and Knl1 exhibit defects in chromosome alignment suggesting that Aurora B 
phosphorylation is crucial for proper establishment of biorientation (Cheeseman et 
al., 2002; DeLuca et al., 2006; Welburn et al., 2010). 
Upon biorientation, the turnover of kinetochore-microtubule attachments needs to be 
prevented to ensure the stability of attachments. Indeed, when sister kinetochores 
are bioriented and tension is applied, Aurora B substrates are dephosphorylated 
(Welburn et al., 2010). A model explaining the phosphorylation of Aurora B targets in 
absence of tension and their dephosphorylation in presence of tension is shown in 
figure 1.8. When no tension is present in prometaphase, kinetochore components are 
phosphorylated by Aurora B leading to SAC activation and destabilization of 
kinetochore-microtubule attachments. Upon biorientation, when tension is applied, 
intrakinetochore stretch spatially separates outer kinetochore components from the 
reach of Aurora B leading to stabilization of kinetochore-microtubule attachments 
through dephosphorylation by phosphatases, such as PP1 and PP2A (Santaguida & 
Musacchio, 2009). In agreement with this model, Aurora B substrates become 
dephosphorylated when placed within the kinetochore at a sufficiently large distance 
from the centromere, while positioning Aurora B closer to the kinetochore prevented 
stabilization of kinetochore-microtubule attachments (Liu et al., 2009). Indeed, the 
distance along the intra-kinetochore longitudinal axis between the C-terminus of 
Ndc80 and CENP-A increases from 65 nm, when chromosomes are not under 
tension, to 102 nm in the presence of tension upon biorientation (Maresca & Salmon, 
2009). However, the separation model would predict that unattached kinetochores, 
which lack tension, would be permanently prevented from forming stable 
attachments. The actual situation is probably that Aurora B generates a state of initial 
labile attachments to prevent premature stabilization of attachments, which remain 
amenable to become corrected if tension fails to manifest because of the lack of 
biorientation (Santaguida & Musacchio, 2009). Thus, current models of attachment 
and biorientation are oversimplifications, while the complete correction mechanism 
and the question how kinetochores create stable attachments in the first place 
remain unclear. 
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Figure 1.8: Model of error correction. In the absence of tension (left), kinetochore components are 
phosphorylated by Aurora B, leading to SAC activation and destabilization of kinetochore-microtubule 
attachments. In the presence of tension (right), outer kinetochore components are removed from the 
reach of Aurora B, leading to stabilization of kinetochore-microtubule attachments through 
dephosphorylation by a phosphatase (PPase). Figure adapted from Santaguida & Musacchio, 2009. 
 
There is a close interplay between the error correction and the SAC, since the 
destabilization of improper kinetochore-microtubule attachments by the error 
correction machinery creates unattached kinetochores that recruit checkpoint 
proteins and induce SAC signaling (Santaguida & Musacchio, 2009). However, error 
correction and SAC are distinct mechanisms with different functions. Error correction 
promotes biorientation, whereas the SAC monitors the state of kinetochore-
microtubule attachments and coordinates it with the progression of the cell cycle by 
delaying anaphase onset until all sister chromatids are properly attached to opposite 
spindle poles (Musacchio & Salmon, 2007; Welburn & Cheeseman, 2008; 
Santaguida & Musacchio, 2009). In addition to its crucial role in error correction, the 
Aurora B kinase plays a direct role also in SAC control. In the presence of 
microtubule-depolymerizing drugs, and therefore in the absence of microtubules, 
Aurora B is required for the kinetochore recruitment of SAC proteins and its inhibition 
severely impairs SAC signaling (Hauf et al., 2003; Santaguida et al., 2011), showing 
that the role of Aurora B in the SAC is not limited to creating unattached kintochores. 
The link between error correction and SAC control is underlined by the importance of 
intrakinetochore stretch both in controlling Aurora B phosphorylation of kinetochore 
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components and in determining the state of checkpoint signaling (Maresca & 
Salmon, 2009).  
Besides Aurora B, several other proteins are involved in the SAC, including Mad1, 
Mad2, Bub1, BubR1, Bub3 and the kinase Mps1 (Musacchio & Salmon, 2007; Nezi & 
Musacchio, 2009). Aurora B and Mps1 are the key players in the recruitment of 
downstream SAC components. Mps1 is recruited through phosphorylation of Ndc80 
by Aurora B (Saurin et al., 2011; Nijenhuis et al., 2013). Subsequently, Mps1 recruits 
Bub1 through phosphorylation of Knl1 and further phosphorylation of Bub1 by Mps1 
recruits the Mad1/Mad2 complex (Brady & Hardwick, 2000; Krenn et al., 2014; 
Overlack et al., 2014; London & Biggins, 2014; Moyle et al., 2014). When SAC 
proteins are recruited to unattached kinetochores, they generate a ‘wait-anaphase’ 
signal corresponding to the formation of an anaphase inhibitor, the mitotic checkpoint 
complex (MCC). The MCC consists of the three SAC proteins Mad2, BubR1 and 
Bub3 as well as its target Cdc20, whose incorporation in the MCC prevents it from 
binding and activating the anaphase promoting complex or cyclosome (APC/C), 
which is required for anaphase onset. The APC/C is an E3 ubiquitin ligase that 
mediates polyubiquitylation and thereby proteasomal degradation of its two key 
substrates cyclin B and securin (Peters, 2006). Cyclin B is an activator of the major 
mitotic kinase Cdk1, whose inactivation promotes exit from mitosis. Securin is an 
inactivator of separase, which cleaves sister chromatid cohesions during anaphase. 
The initial step in the generation of the MCC is described in the Mad2 template model 
(De Antoni et al., 2005). Mad2 is a two-state protein that adopts distinct topologies 
known as closed and open Mad2. A closed conformer of Mad2 bound to Mad1 acts 
as kinetochore receptor for cytosolic open Mad2 and converts it into closed Mad2 
thereby allowing it to bind to Cdc20. The formed closed Mad2/Cdc20 may 
subsequently amplify the conformational change of open Mad2 in the cytosol by 
acting itself as template, but this remains hypothetical. As long as the MCC remains 
bound to the APC/C, the latter is unable to initiate anaphase onset, which ensures 
enough time for the establishment of proper kinetochore-microtubule attachments. 
The RZZ recruits Spindly and dynein/dynactin (Starr et al., 1998; Griffis et al., 2007), 
which removes RZZ and Mad1/Mad2 from kinetochores upon microtubule 
attachment (Karess, 2005). Furthermore, APC/C dependent non-degradative 
autoubiquitylation of Cdc20 and binding of p31comet to closed Mad2 promote MCC 
disassembly and release of Cdc20 from the MCC (Foley & Kapoor, 2013) resulting in 
SAC silencing and thereby allowing mitotic exit. The relationship between the SAC 
and the cell cycle machinery is schematically shown in figure 1.9. 
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Figure 1.9: Function of the SAC. To enter mitosis, activity of Cdk1 by binding to cyclin B is required. 
Prior to anaphase, separase is kept inactive by binding of securin. Unattached kinetochores contribute 
to generation of the MCC, which prevents Cdc20 from activating the APC/C. Biorientation silences the 
SAC leading to MCC disassembly and Cdc20 release. Subsequent activation of the APC/C results in 
ubiquitylation and degradation of securin and cyclin B, thereby activating separase and inactivating 
Cdk1, which leads to mitotic exit. Figure adapted from Musacchio & Salmon, 2007. 
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Figure 1.10 schematically summarizes the complexity of the kinetochore-microtubule 
attachment process, which requires a close interplay of the microtubule-attachment 
machinery, error correction and the SAC, as discussed in sections 1.4 and 1.5, but it 
is still not entirely understood. 
 
 
Figure 1.10: Complexity of the kinetochore-microtubule attachment process. Black arrows indicate 
an action, such as recruitment or microtubule binding. Dotted black arrows suggest an uncertainty 
regarding the functional significance of the involved species. Green arrows define positive regulation, 
whereas red lines with a small perpendicular line indicate negative regulation. The KMN network 
mediates several actions, including kinetochore recruitment of the RZZ complex and of the SAC proteins 
Mps1, Bub1, BubR1 and Bub3, and the formation of stable end-on microtubule attachments. The 
actions of the KMN network are positively regulated by Aurora B. Aurora B also suppresses improper 
kinetochore-microtubule attachments. The checkpoint proteins (in blue) positively regulate the process 
of end-on attachment. Aurora B recruits Mps1, which is required for subsequent recruitment of the SAC 
components Bub1/Bub3 and Mad1/Mad2. After recruitment to prometaphase kinetochores, the RZZ 
complex recruits Spindly, dynein, Mad1 and Mad2. Dynein mediates lateral attachment to microtubules, 
which in turn favors end-on attachment. The establishment of end-on attachment suppresses the 
kinetochore accumulation of the RZZ and of the other proteins whose kinetochore localization depends 
on the RZZ, due to their stripping from kinetochores. Figure modified from Civril & Musacchio, 2008. 
 
 
 
 
Chapter 1: INTRODUCTION 
 27 
1.6 The Astrin/SKAP complex 
Yet another protein complex playing a role in mitotic progression is the Astrin/SKAP 
complex. The 134 kD protein Astrin (also called SPAG5 or MAP126) was identified in 
2001 as a spindle associated protein and a component of sperm flagella (Mack & 
Compton, 2001; Chang et al., 2001; Shao et al., 2001). The 35 kD small kinetochore 
associated protein SKAP (also called Kinastrin or TRAF4-associated factor 1) was 
independently identified in 2009 as the product of a gene (FLJ14502) whose 
transcription is induced at the G2/M transition of the cell cycle (Fang et al., 2009). 
Later, it was discovered that Astrin and SKAP form a tight complex that may 
comprise sub-stoichiometric amounts of the dynein light chain LC8, Polo-like kinase 
1 (Plk1) and Shugoshin 2 (Sgo2) (Schmidt et al., 2010; Dunsch et al., 2011).  
Astrin and SKAP show identical cellular localizations (Mack & Compton, 2001; Thein 
et al., 2007; Fang et al., 2009; Schmidt et al., 2010; Dunsch et al., 2011). During 
interphase, they associate with centrosomes; in prophase, they localize to the 
spindle, concentrating at spindle poles; in metaphase and anaphase, they localize 
throughout the spindle and to kinetochore; and in anaphase and telophase, they are 
at the spindle midzone. At metaphase, when biorientation is established, the 
Astrin/SKAP complex is recruited to outer kinetochores of properly aligned 
chromosomes. In early mitosis, its localization to kinetochores is counteracted by 
Aurora B activity, so that the Astrin/SKAP complex only becomes recruited to 
kinetochores in case of correct chromosome alignment (Schmidt et al., 2010). 
Therefore, the presence of the Astrin/SKAP complex at kinetochores indicates a 
mature end-on attachment (Shrestha et al., 2013). Furthermore, the Astrin/SKAP 
complex was found to localize to the plus ends of growing microtubules (Dunsch et 
al., 2011; Wang et al., 2012; Tamura et al., 2015). 
Several interactions have been proposed to account for the complex cellular 
localization of the Astrin/SKAP complex and its function in mitotic progression and 
chromosome alignment. Targeting of the Astrin/SKAP complex to centrosomes in the 
S and G2 phases may be due to an interaction with Ninein, which is implicated in 
centrosomal microtubule nucleation and microtubule anchoring (Cheng et al., 2007). 
Phosphorylation of Astrin by glycogen synthase kinase 3β, which is involved in 
several pathways including regulation of cell fate, mitosis and apoptosis, was found 
to be important for Astrin association with spindle microtubules and kinetochores 
(Cheng et al., 2008). The two motor proteins CENP-E and Kif18a have also been 
implicated in the kinetochore recruitment of the Astrin/SKAP complex (Manning et al., 
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2010; Huang et al., 2012). Furthermore, the KMN network was shown to be essential 
for kinetochore localization of SKAP, since depletion of subunits of the Ndc80 
complex or the Mis12 complex significantly decreases SKAP levels at the 
kinetochore, possibly through a direct interaction with the Dsn1 subunit of the Mis12 
complex (Wang et al., 2012). Astrin and SKAP were both found to bind microtubules 
in vitro (Schmidt et al., 2010; Dunsch et al., 2011). In vitro, microtubule binding by 
SKAP may be mediated through its C-terminal coiled-coil domains, ranging from 
amino acid 159 to 316, which is consistent with its minimal microtubule-binding 
domain in vivo and the failure of SKAP N-terminus comprising amino acids 1 to 158 
to localize to the spindle (Dunsch et al., 2011). On the other hand, the N-terminal 
region of SKAP was also proposed to be a major determinant of the localization of 
SKAP to the mitotic spindle (Tamura et al., 2015; Wang et al., 2012). Astrin was 
shown to bind microtubules in vitro with its C-terminal domain encompassing amino 
acids 955 to 1193 (Schmidt et al., 2010), but this C-terminal region is unable to 
associate with the spindle in vivo, while a construct comprising amino acids 482 to 
850 and lacking the C-terminal region retains spindle localization (Dunsch et al., 
2011; Mack & Compton, 2001). The regions encompassing amino acids 482 to 850 
in Astrin and 159 to 316 in SKAP may not only be the minimal microtubule-binding 
domains in vivo, but also the minimal interaction sites of the two subunits within the 
Astrin/SKAP complex (Dunsch et al., 2011). An interaction between SKAP and the 
kinesin CENP-E was found to synergistically enhance the microtubule binding of 
SKAP (Huang et al., 2012). The plus end tracking properties of the Astrin/SKAP 
complex depend on a SXIP-motif in the N-terminal domain of SKAP (Tamura et al., 
2015; Wang et al., 2012), which, as discussed above, is known to mediate the 
interaction of many microtubule-associated proteins with EB proteins that track 
microtubule plus ends (Honnappa et al., 2009). Indeed, SKAP directly interacts with 
EB1 and EB3 in a SXIP-dependent manner and this interaction is important for SKAP 
function in controlling microtubule growth rates and anaphase onset (Wang et al., 
2012; Tamura et al., 2015). In cells, SKAP may exist in two distinct pools: a spindle 
microtubule associated pool that influences microtubule growth in a SXIP-motif 
dependent manner and a kinetochore associated pool that binds congressed 
kinetochores in a SXIP-motif independent manner (Tamura et al., 2015).  
Cells that are depleted of either Astrin or SKAP behave normally during interphase, 
but are unable to progress through mitosis resulting in a mitotic delay and finally 
ending in apoptotic cell death (Gruber et al., 2002). The Astrin/SKAP complex is 
suggested to play a role in the assembly and orientation of the bipolar spindle 
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structure, since a depletion of either of its subunits leads to the formation of 
multipolar and highly disordered spindles (Gruber et al., 2002; Thein et al., 2007; 
Schmidt et al., 2010; Dunsch et al., 2011). The formation of multipolar spindles is 
mainly caused by a premature disengagement of the two centrioles of each 
centrosome. In addition, Astrin depletion causes the loss of sister chromatid cohesion 
before anaphase onset. These two processes involve the activity of separase, 
indicating that a subpopulation of separase can be activated despite the general 
mitotic arrest in these cells (Thein et al., 2007; Dunsch et al., 2011). Thus, Astrin may 
contribute to the regulatory network that controls separase activity. The N-terminal 
domain of Astrin encompassing amino acids 4 to 239 may interact with the 
centrosomal kinase Aurora A to regulate its localization to mitotic spindles, 
microtubule organization and spindle pole integrity (Du et al., 2008). Aurora A was 
also found to phosphorylate Astrin at serine 115 (Chiu et al., 2014). A 
phosphorylation-deficient mutant of Astrin appears to activate the SAC and to 
decrease spindle stability, and it fails to bind its interaction partners including SKAP, 
whereas a phospho-mimicking mutant may bind securin and induce its ubiquitylation 
and degradation. This suggests a role of Astrin in separase activation, since the 
degradation of securin leads to activation of separase. In rotary shadowing electron 
microscopy (EM), a sample of Astrin refolded from bacterial inclusion bodies was 
shown to build an 80 nm large ‘lollipop’-shaped structure with a 15 nm N-terminal 
globular head domain and a 65 nm rod predicted to encompass the C-terminal 
coiled-coil domains (Gruber et al., 2002). The 2-fold symmetry of this ‘lollipop’ 
structure suggests that Astrin forms parallel dimers that oligomerize through the 
globular head domain to form aster-like structures. This oligomerization may allow 
Astrin to bundle microtubules and crosslink other binding partners, thereby providing 
a scaffold for crosslinking regulatory and structural components of the mitotic spindle 
(Gruber et al., 2002). 
The Astrin/SKAP complex is also suggested to promote metaphase-to-anaphase 
transition by contributing to chromosome alignment and stabilizing kinetochore-
microtubule attachments, since depletion of its subunits leads to an impaired 
chromosome alignment and a SAC-dependent mitotic arrest (Thein et al., 2007; Fang 
et al., 2009; Schmidt et al., 2010; Dunsch et al., 2011). The stabilizing effect of the 
Astrin/SKAP complex on microtubule plus end dynamics may be due to participation 
of Astrin, together with CLASP1 and Kif2b, in a functional switch at outer 
kinetochores that temporally regulates kinetochore-microtubule attachments 
(Manning et al., 2010). Kif2b is a member of the kinesin-13 family with microtubule 
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depolymerizing activity (Manning et al., 2007). In early mitosis, the Kif2b/CLASP1 
complex is recruited to kinetochores, where it promotes chromosome movement, 
kinetochore-microtubule turnover and maintenance of SAC signaling. During 
metaphase, this complex is replaced by an Astrin/CLASP1 complex that promotes 
kinetochore-microtubule stability, chromosome alignment and SAC silencing 
(Manning et al., 2010). In late mitosis, the interaction of Astrin/SKAP and dynein may 
promote dynein-mediated transport of kinetochore components required for 
chromosome congression from microtubule plus ends toward spindle poles. It may 
also promote kinetochore-microtubule attachment and SAC regulation (Dunsch et al., 
2011). Besides its function in mitosis, Astrin was also found to be important for 
spindle organization and cell cycle progression in meiosis (Yuan et al., 2009). 
Taken together, the Astrin/SKAP complex is essential for spindle organization, 
chromosome alignment, stabilization of kinetochore-microtubule attachments and 
mitotic progression. However, the required protein interactions and the molecular 
mechanisms underlying its complex cellular localization and its diverse functions 
remain elusive. 
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2 OBJECTIVE 
As accurate chromosome segregation is crucial for cell viability, it is important to 
understand this complex process on the molecular level. In order to elucidate the 
underlying mechanisms, the essential protein interactions have to be identified and 
characterized in detail. This thesis deals with the molecular dissection of the spindle 
and kinetochore associated Astrin/SKAP complex, which is essential for mitotic 
progression and chromosome alignment. The overall goal of this project is to 
characterize the interactions of the Astrin/SKAP complex within the complex and with 
other kinetochore components. First of all, Astrin and SKAP will be expressed 
recombinantly in order to obtain soluble constructs of the two proteins and to 
reconstitute the protein complex in vitro. These recombinant proteins will be used to 
identify the minimal binding domains for the interactions of the Astrin/SKAP complex, 
which will be functionally investigated in more detail both in vitro and in vivo using a 
combinatorial approach of biochemical, biophysical and cell biological methods. 
Furthermore, attempts will be made to structurally characterize the reconstituted 
Astrin/SKAP complex as well as the individual proteins by means of electron 
microscopy and X-ray crystallography in order to obtain more detailed information 
about their molecular architecture. The results will advance our understanding of the 
functional role of the Astrin/SKAP complex during mitosis and give closer insights 
into the mechanisms leading to the establishment of functional kinetochore-
microtubule attachments. 
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3  RESULTS 
3.1 Domain organization of the Astrin/SKAP complex 
A bioinformatic characterization of Astrin and SKAP was performed in order to obtain 
initial hints regarding the structural and functional organization of the two proteins. 
The secondary structure predictions of Astrin and SKAP by PSIPRED (Buchan et al., 
2013) can be found in supplementary figures 6.1 and 6.3. The models of Astrin and 
SKAP with the highest confidence, i.e. with the highest probability that the sequence 
and the template match, predicted by Phyre2 (Kelley & Sternberg, 2009) are 
depicted in figures 3.1 and 3.2. For Astrin, the central 462 residues (39 % of the total 
sequence) were modeled with a confidence of 99.5 % by the single highest scoring 
template. The remaining residues could be modeled with > 90 % confidence using 
multiple templates. For SKAP, 310 residues (98 % of the total sequence) were 
modeled with a confidence of 98.4 % by the single highest scoring template. 
The predictions by the servers and programs Jpred, PSIPRED, Phyre2 and I-
TASSER (Cole et al., 2008; Buchan et al., 2013; Kelley & Sternberg, 2009; Roy et 
al., 2010; Zhang, 2008) suggest that both Astrin and SKAP consist mainly of 
disordered and helical regions. The N-terminal region of Astrin up to amino acid 481 
is predicted to be mainly unstructured apart from several small helical sections. This 
region is followed by two long helical fragments comprising amino acids 482 to 903 
and 966 to 1175 that are connected by a disordered linker region. The coiled-coil 
domains of Astrin that were predicted by Paircoil2 (McDonnell et al., 2006) as shown 
in supplementary figure 6.2 lie within these helical parts of the protein. For SKAP, the 
N-terminal domain comprising amino acid 1 to 158 is suggested to be mainly 
unstructured, whereas the central part ranging from amino acid 159 to 225 and the  
 
 
Figure 3.1: Model of the tertiary structure of Astrin predicted by the Phyre2 server. The illustration 
of the model was done with PyMOL (DeLano Scientific, San Francisco, US-CA). Coloring proceeds 
along the chain from blue (N-terminus) to red (C-terminus). 
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Figure 3.2: Model of the tertiary structure of SKAP predicted by the Phyre2 server. The illustration 
of the model was done with PyMOL (DeLano Scientific, San Francisco, US-CA). Coloring proceeds 
along the chain from blue (N-terminus) to red (C-terminus). 
 
following C-terminal segment each consist of one long α-helix. These predicted 
helical regions are also consistent with the coiled-coil domain prediction by Paircoil2 
(McDonnell et al., 2006) as shown in supplementary figure 6.4. 
Although Astrin and SKAP have not been recognized for being homologous proteins, 
the bioinformatic characterization indicates that their overall domain organization, 
which is shown in figure 3.3, is similar, despite conspicuous size differences. 
Specifically, both Astrin and SKAP consist mainly of three domains: The N-terminal 
domain of both proteins is predicted to be mainly unstructured. In both proteins, this 
region is followed by two coiled-coil domains of different lengths, separated by 
predicted intervening gaps. These observations suggest that both Astrin and SKAP 
exhibit an elongated structure. 
 
 
Figure 3.3: Domain organization of Astrin and SKAP. Domain organization is based on secondary 
structure predictions by Jpred, PSIPRED, Phyre2 and I-TASSER. CC: coiled-coil. 
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3.2 Expression and purification of Astrin and SKAP 
constructs 
3.2.1  Expression of Astrin and SKAP full-length constructs 
To allow the in vitro characterization of the Astrin/SKAP complex, attempts were 
made to produce recombinant forms of the two proteins. Therefore, wild type and 
codon-optimized coding sequences were subcloned into several expression vectors 
for individual expression as well as for coexpression. In case of the full-length 
proteins different affinity tags were tested including N- or C-terminal hexahistidine 
(His6) tags and a glutathione S transferase (GST) tag. Escherichia coli and insect 
cells were used as expression systems.  
A test expression of GST-Astrin is depicted in figure 3.4. The expression was 
performed in E. coli C41 cells at 18 °C for 16 h. The comparison of the whole cell 
extracts before (-) and after (+) induction with IPTG shows that GST-Astrin was 
expressed at a high level with the expected molecular weight of 160 kD. During the 
subsequent batch purification all the expressed protein was found in the pellet 
fraction (P) after clearing the cell lysate. No corresponding band was visible in the 
fraction of the washed beads, revealing that GST-Astrin was insoluble. Similarly, in 
other expression systems and with different affinity tags, Astrin full-length protein 
showed good expression levels, but could not be expressed in a soluble form.  
 
 
Figure 3.4: Test expression and batch purification of GST-Astrin full-length. Coomassie stained 
SDS-PAGE gel showing the test expression in C41 cells and batch purification of codon-optimized 
Astrin full-length with a PreScission cleavable (3C) GST tag. The arrow marks the expected position of 
GST-Astrin at a molecular weight of 160 kD. -: whole cell extract before induction, +: whole cell extract 
after induction, P: pellet after clearing the lysate, S: supernatant after clearing the lysate, B: sample of 
washed bead fraction, M: molecular weight standard with molecular weights indicated on the right. 
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Figure 3.5 shows a test expression of GST-SKAP full-length in E. coli C41 cells at 
18 °C for 16 h. A band with the expected molecular weight of 61 kD could be found in 
the sample of the whole cell extract after induction of expression, indicating a high 
expression level of GST-SKAP. As for Astrin, the pellet fraction after clearing the cell 
lysate shows the corresponding band of GST-SKAP that could not be found in the 
soluble fraction, thus indicating that most of the expressed protein is insoluble. The 
sample of the washed beads reveals that a small fraction of GST-SKAP was soluble. 
However, during large-scale expression trials, GST-SKAP could not be expressed in 
a soluble form. Other expression systems and affinity tags as well as a coexpression 
strategy with Astrin full-length did not lead to soluble protein.  
 
 
Figure 3.5: Test expression and batch purification of GST-SKAP full-length. Coomassie stained 
SDS-PAGE gel showing the test expression in C41 cells and batch purification of SKAP full-length with 
a PreScission cleavable (3C) GST-tag. The arrow marks the expected position of GST-SKAP at a 
molecular weight of 61 kD. -: whole cell extract before induction, +: whole cell extract after induction, P: 
pellet after clearing the lysate, S: supernatant after clearing the lysate, B: sample of washed bead 
fraction, M: molecular weight standard with molecular weights indicated on the left. 
 
A summary of expression level and solubility from test expressions of the different 
Astrin and SKAP full-length constructs is shown in table 3.1. The highest expression 
levels of Astrin and SKAP could be obtained with the N-terminal GST-tag, whereas 
His6-tags only resulted in lower amounts of expressed proteins. Also during 
coexpressions studies, the two proteins showed only low expression levels. In case 
of the C-terminal His6-tags on Astrin and SKAP the test expressions of both proteins 
revealed additional protein bands at the expected molecular weights as well as 
bands with lower molecular weights, thus indicating degradation of the proteins when 
no affinity tags are placed at the N-terminus. 
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Table 3.1: Expression levels and solubility of Astrin and SKAP full-length constructs. 
construct expression level solubility comments 
His6-Astrin + -  
His6-TEV-Astrin + -  
Astrin-His6 + - degradation 
GST-3C-Astrin +++ -  
His6-SKAP ++ -  
His6-TEV-SKAP ++ -  
SKAP-His6 ++ - degradation 
GST-3C-SKAP +++ (✓) 
small amounts of 
soluble protein only in 
test expression in C41 
at 18 °C for 16 h 
His6-Astrin/SKAP + -  
His6-SKAP/Astrin + -  
GST-3C-Astrin/SKAP + -  
GST-3C-SKAP/Astrin + -  
 
3.2.2  Expression and purification of Astrin and SKAP truncation 
constructs 
Based on the bioinformatic characterization discussed in section 3.1 different 
truncation constructs of Astrin and SKAP, in addition to the full-length proteins, were 
generated by subcloning and tested for their solubility. Purification protocols were 
successfully established for the soluble constructs as described in section 5.4.1.4.  
The designed truncation constructs for Astrin are depicted in figure 3.6. The three 
domains, combinations of them, and two truncations based on previously published 
results were tested. These two constructs are a truncated version of the central 
coiled-coil domain ranging from amino acid 482 to 850, which has been suggested to 
be the SKAP binding domain of Astrin (Dunsch et al., 2011), and the Aurora A 
binding domain comprising amino acids 1 to 239 (Du et al., 2008). 
As an example of a successful purification, the size exclusion chromatography of 
Astrin1-239 that was expressed in E. coli C41 cells at 18 °C for 14 h and purified by a 
two step procedure including affinity and ion-exchange chromatography is shown in 
figure 3.7. The chromatogram reveals four peaks, of which the first three contain 
Astrin1-239. The front peak belongs to a fraction of Astrin1-239 that is contaminated with 
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DNA as judged by the ratio of absorbance at 260 nm to 280 nm of 2.1. The following 
two peaks correspond to Astrin1-239, which shows the expected molecular weight of 
26 kD and is free of contaminants based on the SDS-PAGE gel and absorption 
spectra of the pooled sample. The fact that, despite its small molecular weight of 
26 kD, Astrin1-239 elutes very early during size exclusion chromatography with elution 
volumes corresponding to molecular weights of more than 150 kD suggests that it 
exists in an oligomeric state, or alternatively, and not exclusively, that it may have an 
elongated structure. The presence of two peaks is an indication for different 
oligomeric states of Astrin1-239.  
A summary of the expression levels, solubility and yields of the truncated Astrin 
constructs is listed in table 3.2. Apart from this truncated N-terminal domain of Astrin, 
a GST fusion of the whole N-terminal domain as well as the C-terminal coiled-coil 
domain could be expressed in a soluble form and purified with yields between 0.2 mg 
and 0.5 mg per liter of expression culture. All constructs containing the central coiled-
coil domain of Astrin, which is believed to interact with SKAP, were expressed in an 
insoluble form, indicating that the interaction partner is required for stabilization.  
 
 
Figure 3.6: Truncations constructs of Astrin. Constructs were designed based on the domain 
organization depicted on top and previously published results. 
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Figure 3.7: Purification of Astrin1-239. Top, elution profile of Astrin1-239 during size exclusion 
chromatography. Dashed line indicates elution profile of a molecular weight marker with the indicated 
molecular weights of the proteins in kD. Bottom, Coomassie stained SDS-PAGE gel with samples of 
indicated fractions from the size exclusion chromatography depicted on top. M: molecular weight 
standard with molecular weights indicated on the left, L: appearance of the sample loaded on the size 
exclusion chromatography column. 
 
Table 3.2: Expression levels, solubility and yields of Astrin truncation constructs. All constructs 
were tagged with an N-terminal, PreScission cleavable GST-tag. 
construct expression level solubility yield 
Astrin1-481 ++ ✓ 0.2 mg/L (only soluble as GST 
fusion) 
Astrin1-239 ++ ✓ 0.3 mg/L 
Astrin482-850 +++ -  
Astrin482-903 +++ -  
Astrin966-1175 +++ ✓ 0.5 mg/L 
Astrin482-1175 + -  
Astrin1-850 + -  
Astrin1-903 + -  
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The truncation constructs for SKAP shown in figure 3.8 are the three isolated 
domains and their combinations. In order to map the microtubule-binding domain of 
SKAP (see section 3.3.2) several constructs were designed based on the predicted 
secondary structure of SKAP that consist of the central coiled-coil domain and N-
terminal extensions of different lengths.  
 
 
Figure 3.8: Truncations constructs of SKAP. Constructs were designed based on the domain 
organization depicted on top and predicted secondary structure. 
 
Figure 3.9 presents the size exclusion chromatography of SKAP159-316 that was 
expressed in E. coli C41 cells at 18 °C for 16 h and purified by affinity and ion-
exchange chromatography. The chromatogram reveals a single peak, which shows 
that SKAP159-316 was successfully purified to homogeneity. This is confirmed by the 
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SDS-PAGE gel that displays a single band at the expected molecular weight of 
19 kD. As already seen in the elution profile of Astrin1-239, SKAP159-316 eluted from the 
size exclusion chromatography column at low elution volumes corresponding to 
molecular weights of more than 150 kD. This suggests that SKAP159-316 has an 
elongated structure or that it exists in a dimeric or oligomeric state. This elongated 
structure is in agreement with the secondary structure predictions that suggest the 
existence of two coiled-coil domains in this region of SKAP.  
A summary of the expression levels, solubility and yields of the tested SKAP 
truncations is listed in table 3.3. In addition to SKAP159-316, all single domains as well 
as the N-terminal extension constructs of the central coiled-coil domain up to amino 
acid 103 could be expressed in a soluble form. The purifications of these constructs 
resulted in yields between 2 mg and 9 mg per liter of expression culture.  
 
 
Figure 3.9: Purification of SKAP159-316. Top, elution profile of SKAP159-316 during size exclusion 
chromatography. Dashed line indicates elution profile of a molecular weight marker with the indicated 
molecular weights of the proteins in kD. Bottom, Coomassie stained SDS-PAGE gel with samples of 
indicated fractions from the size exclusion chromatography depicted on top. M: molecular weight 
standard with molecular weights indicated on the left, L: appearance of the sample loaded on the size 
exclusion chromatography column. 
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Table 3.3: Expression levels, solubility and yields of SKAP truncation constructs. All constructs 
were tagged with an N-terminal, PreScission cleavable GST-tag. 
construct expression level solubility yield 
SKAP1-158 ++ ✓ 2 mg/L (only soluble as GST 
fusion) 
SKAP159-225 +++ ✓ 4 mg/L 
SKAP226-316 + ✓ 9 mg/L 
SKAP159-316 +++ ✓ 3 mg/L 
SKAP1-225 + -  
SKAP46-225 ++ -  
SKAP74-225 ++ -  
SKAP103-225 +++ ✓ 2 mg/L 
SKAP120-225 +++ ✓ 3 mg/L 
SKAP135-225 +++ ✓ 3 mg/L 
SKAP146-225 +++ ✓ 4 mg/L 
 
3.2.3 Expression and purification of SKAP135-225 
Since the SKAP construct comprising amino acids 135 to 225 plays a major role in 
this study, a more detailed purification procedure of this construct is discussed 
below. The established purification protocol is explained in section 5.4.1.4. In brief, 
the construct was expressed in E. coli C41 cells at 18 °C for 16 h after induction with 
0.1 mM IPTG. The cleared lysate was loaded onto a GSH column for affinity 
purification. After extensive washes the GST tag was cleaved on the column with 
PreScission protease for 16 h at 4 °C in order to obtain untagged SKAP135-225. The 
eluate was subsequently purified by anion exchange chromatography to remove 
DNA and other protein contaminants. As a final purification step, the concentrated 
protein was loaded onto a S200 size exclusion chromatography column. A 
representative chromatogram can be found in figure 3.10. As for SKAP159-316, the low 
elution volume of SKAP135-225 suggests an elongated structure, which is in agreement 
with the predicted coiled-coil structure. The SDS-PAGE gels of the size exclusion 
chromatography and of the pooled fraction show two bands. The more intense 
protein band corresponds to SKAP135-225, whose expected molecular weight is 11 kD, 
whereas the less intense band at about 25 kD probably consists of a GST 
contamination that could not be removed during purification. The purity of SKAP135-225 
amounts to over 90 % as quantified by band intensity and it could be purified with 
yields of 3 mg per liter of expression culture. 
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Figure 3.10: Purification of SKAP135-225. Top, elution profile of SKAP135-225 during size exclusion 
chromatography. Dashed line indicates elution profile of a molecular weight marker with the indicated 
molecular weights of proteins in kD. Bottom left, Coomassie stained SDS-PAGE gel with samples of 
indicated fractions from the size exclusion chromatography shown on top. Bottom right, pooled and 
concentrated sample of SKAP135-225 after final size exclusion chromatography (P). M: molecular weight 
standard with molecular weights indicated on the right. 
 
In order to determine the molecular weight and thereby the oligomeric state of 
SKAP135-225, analytical ultracentrifugation (AUC) experiments were performed. 
Figure 3.11 A shows the sedimentation coefficient distribution of a sample containing 
SKAP135-225. The distribution is based on the radial signals of the sedimentation 
velocity experiment depicted in figure 3.11 B. The sedimentation coefficient 
distribution reveals two peaks. The smaller peak with a sedimentation coefficient of 
2.2 S belongs to a contamination of the sample with a molecular weight of 80.6 kD. 
The larger peak, with a sedimentation coefficient of 1.2 S and a frictional ratio of 2.7, 
belongs to SKAP135-225. This peaks corresponds to a molecular weight of 32.84 kD 
indicating that SKAP135-225 - which has a monomeric size of 11 kD - forms a trimer. 
The frictional ratio takes the shape-dependent hydrodynamics of the molecule into 
account. A perfect sphere has a frictional ratio of 1, whereas elongated structures 
have values over 2. A frictional ratio of the analyzed molecule of 2.7 suggests that 
SKAP135-225 exhibits a very elongated structure, which is in agreement with the high 
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predicted coiled-coil content. The result that SKAP135-225 forms a trimer is also 
supported by crosslinking analysis (see figure 3.11 C). In this experiment a sample 
containing SKAP135-225 was incubated with the crosslinker bis(sulfosuccinimidyl)-
glutarate (BS2G), which covalently links primary amines of lysine side chains that are 
within a distance compatible with the crosslinker length of 7.7 Å. It can be seen that 
with increasing amounts of the crosslinker two bands appeared apart from the 
monomeric band of SKAP135-225 at 11 kD. The lower of these bands, with an apparent 
molecular weight of 22 kD, corresponds to a SKAP dimer, whereas the upper band at 
around 33 kD corresponds to a SKAP trimer. 
 
 
Figure 3.11: SKAP135-225 forms a trimer. (A) Sedimentation coefficient distribution c(S) of 
sedimentation velocity experiments of SKAP135-225. (B) Top, plot of radial signals of the AUC of 
SKAP135-225. Bottom, residuals of the fit showing the deviation of the c(S) model from the observed 
signals. (C) Detail of supplementary figure 8.13 A showing the crosslinking of SKAP135-225 in presence of 
increasing amounts of crosslinker BS2G. 
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3.2.4 Expression and purification of a truncated Astrin/SKAP 
complex 
Since the individual expression of Astrin constructs that contain its central coiled-coil 
domain resulted in insoluble protein, attempts were made to solubilize this Astrin 
domain by coexpression with SKAP159-316 in insect cells. Figure 3.12 shows the 
constructs of Astrin and SKAP that were tested in these coexpression trials.  
 
 
Figure 3.12: Constructs of Astrin and SKAP for coexpression in insect cells.  
 
All constructs were expressed, but only the Astrin construct comprising amino acids 
482 to 850 could be expressed in a soluble form upon coexpression with SKAP159-316 
(see table 3.4) suggesting that the two proteins interact directly via these minimal 
interaction domains in the absence of other binding partners. In case of the N-
terminal His6-tag on Astrin, the complex could not be enriched by affinity purification 
(see supplementary figure 6.5) suggesting that the N-terminus of Astrin482-850 is 
buried within the complex and thereby not accessible to the affinity matrix. With a C-
terminal His6 tag on Astrin and untagged SKAP an expression and purification 
protocol was established for the Astrin482-850/SKAP159-316 complex (see sections 
5.4.1.3.3 and 5.4.1.5).  
Figure 3.13 shows a representative chromatogram and the corresponding SDS-
PAGE gel of the final size exclusion chromatography purification step of the 
Astrin482-850/SKAP159-316 complex. It can be seen that the complex reveals two 
dominant protein bands at the expected molecular weights of 43 kD for Astrin482-850 
and 19 kD for SKAP159-316. Other bands in the SDS-PAGE gel and several peaks in 
the chromatogram point to the contaminations of the sample. Therefore, only the 
purest fractions were pooled resulting in low yields of about 50 µg per liter of insect 
cell culture. 
To find out whether SKAP159-316 is the minimal interaction domain for Astrin, 
coexpression trials in insect cells of Astrin482-850-His6 with the single domains of SKAP 
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were tested. All coexpressions with the single SKAP domains resulted in insoluble 
Astrin482-850 and only SKAP159-316 was able to solubilize Astrin482-850.  
 
 
Figure 3.13: Purification of Astrin482-850-His6/SKAP159-316. Top, elution profile of Astrin482-850-
His6/SKAP159-316 during size exclusion chromatography. Dashed line indicates elution profile of a 
molecular weight marker with the indicated molecular weights of proteins in kD. Bottom, Coomassie 
stained SDS-PAGE gel with samples of indicated fractions from the size exclusion chromatography 
depicted on top. M: molecular weight standard with molecular weights indicated on the left. 
 
Table 3.4: Summary of coexpression tests in insect cells with different Astrin and SKAP 
constructs. n.t.: not tested. 
  SKAP 
  1-158 159-225 226-316 159-316 
Astrin 
482-850 
only SKAP 
soluble 
only SKAP 
soluble 
only SKAP 
soluble 
+ 
482-903 n.t. n.t. n.t. 
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soluble 
482-1175 n.t. n.t. n.t. 
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3.3 Interaction of the Astrin/SKAP complex with tubulin 
3.3.1  The Astrin/SKAP complex binds to microtubules through SKAP 
As mentioned in chapter 1.6, the Astrin/SKAP complex is able to bind to 
microtubules. In order to map the binding sites in more detail, the microtubule-
binding properties of the recombinant Astrin and SKAP constructs were analyzed in 
microtubule cosedimentation assays. In these assays the protein of interest is 
incubated with taxol-stabilized microtubules and, after ultracentrifugation, the 
supernatant and pellet fractions are analyzed by SDS-PAGE. The supernatant 
contains unpolymerized tubulin and the proteins that do not bind to microtubules, 
whereas the pellet consists of the microtubules and bound proteins. In a control 
experiment without microtubules the proteins are treated in the same way as in the 
actual experiment in order to check their pelleting behavior under the assay 
conditions.  
 
Figure 3.14 shows the microtubule cosedimentation assays with the single domains 
of SKAP. In case of the SKAP1-158 N-terminal domain (see figure 3.14 A), it can be 
seen that in the absence of microtubules (- MT) most of the protein was found in the 
supernatant (S), whereas the pellet (P) only contained a small fraction of SKAP1-158. 
In comparison to this, in the experiment together with microtubules (+ MT) the 
amount of SKAP1-158 was shifted from the supernatant to the pellet fraction. Under 
these conditions, 42 % of SKAP1-158 was bound to the microtubules indicating that the 
N-terminal domain of SKAP is able to bind to microtubules. The central coiled-coil 
domain of SKAP comprising amino acids 159 to 225 showed similar microtubule-
binding properties as SKAP1-158 (see figure 3.14 B). While SKAP159-225 hardly pelleted 
in the control experiment without microtubules, the assays in the presence of 
microtubules revealed that 53 % of the protein was found in the pellet fraction. This 
suggests that the central coiled-coil domain of SKAP can also bind to microtubules. 
In contrast to the N-terminal domain and the central coiled-coil domain of SKAP, the 
C-terminal coiled-coil domain of SKAP ranging from amino acid 226 to 316 did not 
pellet in the presence of microtubules indicating that this domain is not able to bind to 
microtubules.  
Next, the N- and C-terminal domains of Astrin were tested for their microtubule 
binding. As it can be seen in figure 3.15, both Astrin1-239 and Astrin966-1175 could only 
be found in the supernatant fractions, thus demonstrating lack of microtubule-binding 
affinity.  
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Figure 3.14: SKAP binds to microtubules with its N-terminal domain and central coiled-coil 
domain. Representative SDS-PAGE gels of microtubule cosedimentation assays with 3 µM taxol-
stabilized microtubules (MT), 1 µM BSA and 3 µM GST-SKAP1-158 (A), SKAP159-225 or SKAP226-316 (B). 
S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with microtubules and 
bound proteins. M: molecular weight marker with molecular weights indicated on the left. 
 
 
Figure 3.15: Astrin does not bind to microtubules. Representative SDS-PAGE gel of microtubule 
cosedimentation assays with 3 µM taxol-stabilized microtubules (MT), 1 µM BSA and 3 µM Astrin1-239 or 
Astrin966-1175. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. 
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Since the tested Astrin constructs were not able to bind to microtubules on their own, 
it was tested if they show pelleting in the presence of SKAP159-316, the Astrin 
interacting domain of SKAP. Therefore, the N- and C-terminal domains of Astrin were 
incubated together with microtubules and SKAP159-316 in microtubule cosedimentation 
assays as shown in figure 3.16. As in the experiments lacking SKAP, the Astrin 
constructs showed no binding to microtubules when SKAP159-316 was present. This 
suggests that SKAP159-316 only binds to the central coiled-coil domain of Astrin and 
has no additional interaction site on the N- and C-terminal domains of Astrin.  
The results of the microtubule cosedimentation assays with the single Astrin and 
SKAP constructs and the combination of them are summarized in table 3.5.  
 
 
Figure 3.16: The N- and C-terminal domains of Astrin do not interact with SKAP bound to 
microtubules. Representative SDS-PAGE gels of microtubule cosedimentation assays with 3 µM taxol-
stabilized microtubules, 1 µM BSA, 3 µM SKAP159-316 and 3 µM Astrin1-239, Astrin966-1175 or Astrin1-481. 
Blue and red starlets mark the protein bands corresponding to Astrin. S: soluble fraction with proteins 
not bound to microtubules. P: pellet fraction with microtubules and bound proteins. M: molecular weight 
marker with molecular weights indicated on the left. 
 
Table 3.5: Summary of microtubule binding of Astrin and SKAP constructs. n.t.: not tested. 
  Astrin 
  none 1-239 1-481 966-1175 
SKAP 
none  - - - 
1-158 + n.t. n.t. n.t. 
159-225 + n.t. n.t. n.t. 
226-316 - n.t. n.t. n.t. 
159-316 + 
only SKAP 
binding 
only SKAP 
binding 
only SKAP 
binding 
 
S P S P S P S P
- + - + 
M
BSA
tubulin
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Astrin
75 kD
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9661 239 1175
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To analyze if Astrin contributes to the microtubule binding of the Astrin/SKAP 
complex, the Astrin482-850/SKAP159-316 complex was compared to SKAP159-316 alone in 
microtubule cosedimentation assays. For this purpose either 1 µM 
Astrin482-850/SKAP159-316 complex or 1 µM SKAP159-316 was titrated with 0-10 µM taxol-
stabilized microtubules. The SDS-PAGE gels of these experiments are depicted in 
figure 3.17 A and B. The corresponding amounts of protein in the supernatant and 
the pellet were quantified using ImageJ 1.49 (NIH). The fraction of protein that was 
bound to the microtubules was calculated by dividing the amount of protein in the 
pellet by the sum of protein in the supernatant and the pellet. Bound fractions were 
plotted against the microtubule concentration and the one-site binding curves were 
fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described in section 5.4.2. 
The results of this quantification and fitting analysis are shown in figure 3.17 C and 
table 3.6. It can be seen from the SDS-PAGE gels and the corresponding 
quantification that the pelleting behavior of Astrin482-850/SKAP159-316 and SKAP159-316 
was very similar. Both showed concentration dependent microtubule binding with 
apparent dissociation constants (Kd) of 1.56 µM for the Astrin482-850/SKAP159-316 
complex and 1.62 µM for SKAP159-316. The maximal bound fractions that are reached 
when all binding sites are saturated amounted to comparable levels of 49 % and 
35 %, respectively. The similar behavior of Astrin482-850/SKAP159-316 and SKAP159-316 in 
microtubule binding indicates that Astrin482-850 does not contribute to the microtubule 
binding of the Astrin482-850/SKAP159-316 complex. Since the N- and C-terminal domains 
of Astrin also failed to show affinity for microtubules, the Astrin/SKAP complex 
presumably binds to microtubules through SKAP.  
 
Table 3.6: Summary of fitting analysis of microtubule cosedimentation assays with 
Astrin482-850/SKAP159-316 and SKAP159-316. Microtubule cosedimentation assays were performed with 
0-10 µM taxol-stabilized microtubules and 1 µM Astrin482-850/SKAP159-316 or SKAP159-316. Quantification 
was done with ImageJ 1.49 (NIH). Data were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as 
described in section 5.4.2. 
construct 
apparent dissociation 
constant Kd (µM) 
maximal bound 
fraction 
SKAP159-316 1.62 ± 0.17 0.35 ± 0.02 
Astrin482-850/SKAP159-316 1.56 ± 0.14 0.49 ± 0.02 
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Figure 3.17: The Astrin/SKAP complex binds to microtubules through SKAP. Representative SDS-
PAGE gels of microtubule cosedimentation assays with 0-10 µM taxol-stabilized microtubules (MTs), 
1 µM BSA and 1 µM Astrin482-850/SKAP159-316 (A) or SKAP159-316 (B). S: soluble fraction with proteins not 
bound to microtubules. P: pellet fraction with microtubules and bound proteins. M: molecular weight 
marker with molecular weights indicated at the side. (C) Quantification and fitting analysis of microtubule 
cosedimentation assays shown in (A) and (B). Quantification was done with ImageJ 1.49 (NIH). Data 
were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described in section 5.4.2. 
 
 
 
A
B
75 kD
50 kD
25 kD
MPS PS P
0 105 µM MTs
BSA
tubulin
SKAP159-316 
Astrin482-850 
1.250.630.31 2.5
S PS PS PS PS
C
SKAP159-316
Astrin482-850/SKAP159-316
75 kD
50 kD
25 kD
M PS PS P
0 105 µM MTs
BSA
tubulin
SKAP159-316 
1.250.630.31 2.5
S PS PS PS PS
Kd = 1.56 ± 0.14 µM
Kd = 1.62 ± 0.17 µM
Chapter 3: RESULTS 
 51 
3.3.2 The microtubule-binding domain of SKAP is located at amino 
acids 135 to 225 
In section 3.3.1 it was shown that SKAP is able to bind to microtubules both with its 
N-terminal domain and its central coiled-coil domain. In order to identify the complete 
microtubule-binding domain of SKAP, different constructs of SKAP that contain the 
central coiled-coil domain and varying extensions to the N-terminus were created 
and analyzed in microtubule cosedimentation experiments. As mentioned in 
section 3.3.1, 1 µM of the respective protein was titrated with 0-10 µM taxol-
stabilized microtubules, the bound fractions were quantified with ImageJ (NIH), 
plotted against the microtubule concentration and fitted with Origin7.0 (OriginLab, 
Northampton, US-MA). The SDS-PAGE gels as well as the corresponding 
quantifications can be found in figure 3.18 and the results of the fitting analysis are 
summarized in table 3.7. It can be seen that SKAP159-225 and SKAP146-225 showed a 
very similar behavior in microtubule binding. The apparent dissociation constants 
obtained for these constructs were 2.5 µM and 2.4 µM, respectively. Also the 
maximal bound fractions that amounted to 77 % and 71 %, respectively, were 
comparable. The longer constructs SKAP135-225 and SKAP103-225 revealed higher 
affinities for microtubules and at a microtubule concentration of 10 µM complete 
binding of SKAP could be reached. The calculated apparent dissociation constants 
were 0.58 µM and 1.1 µM, respectively, indicating a four times higher affinity for 
microtubules of SKAP135-225 and a two times higher one for SKAP103-225 compared to 
the shorter SKAP constructs. The comparison of the microtubule cosedimentation 
assays of these SKAP constructs reveals that SKAP135-225 possessed the highest 
affinity for microtubules and that additional amino acids at the N-terminus do not 
further increase the affinity.  
The comparison of the microtubule-binding affinities of SKAP159-225 and SKAP159-316 
shows that the apparent dissociation constant for SKAP159-225 (2.5 µM) is only 
1.5-times higher than the one of SKAP159-316 (1.62 µM). Together with the observation 
that SKAP226-316 does not bind microtubules (see section 3.3.1, figure 3.14), this 
indicates that the C-terminal coiled-coil domain of SKAP comprising residues 226 to 
316 is neither sufficient nor necessary for microtubule binding. 
Taken together, it can be concluded that the domain comprising amino acids 135 to 
225 represents the microtubule-binding domain of SKAP.  
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Figure 3.18: The microtubule-binding domain of SKAP is located at amino acids 135 to 225. 
Representative SDS-PAGE gels of microtubule cosedimentation assays with 0-10 µM taxol-stabilized 
microtubules (MTs), 1 µM BSA and 1 µM SKAP146-225 (A), SKAP135-225 (B) or SKAP103-225(C). S: soluble 
fraction with proteins not bound to microtubules. P: pellet fraction with microtubules and bound proteins. 
M: molecular weight marker with molecular weights indicated on the left. (D) Quantification and fitting 
analysis of microtubule cosedimentation assays shown in (A)-(C). Quantification was done with ImageJ 
1.49 (NIH). Data were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described in section 
5.4.2. 
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Table 3.7: Summary of fitting analysis of microtubule cosedimentation assays with different 
SKAP constructs. Microtubule cosedimentation assays were performed with 0-10 µM taxol-stabilized 
microtubules and 1 µM SKAP159-225, SKAP146-225, SKAP135-225 or SKAP103-225. Quantification was done 
with ImageJ 1.49 (NIH). Data were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described 
in section 5.4.2. 
construct 
apparent dissociation 
constant Kd (µM) 
maximal bound 
fraction 
SKAP159-225 2.5 ± 0.6 0.77 ± 0.07 
SKAP146-225 2.4 ± 0.8 0.71 ± 0.09 
SKAP135-225 0.58 ± 0.08 1.08 ± 0.03 
SKAP103-225 1.1 ± 0.4 1.17 ± 0.07 
 
3.3.3 SKAP binds to the interface of α-/β-tubulin 
After mapping the microtubule-binding domain of SKAP, the location of SKAP 
binding on the microtubules was investigated. For this purpose, a crosslinking 
analysis with microtubules and SKAP was performed in order to identify residues of 
both proteins that lie close to each other and point to proximate interfaces in the 
formed complex.  
Bis(sulfosuccinimidyl)glutarate (BS2G) and di(succinimidyl)suberate (DSS), which 
covalently link primary amines of lysine side chains that are within a distance 
compatible with the length of the crosslinker of 7.7 Å and 11.4 Å, respectively, were 
used as crosslinkers. In an initial experiment, different ratios of crosslinker to protein 
were screened for the crosslinking of taxol-stabilized microtubules and SKAP135-225 
(see supplementary figure 6.13). The large scale crosslinking reactions with 
crosslinker:protein ratios of 1:1 for BS2G and 2.5:1 for DSS resulted in the crosslinks 
visualized in figure 3.19 A. Intermolecular crosslinks found between SKAP135-225 and 
the ubiquitous tubulin isotypes α-1B and β-2B tubulin are colored in blue and 
intramolecular ones in red. A list of all identified crosslinks is shown in supplementary 
tables 6.1 and 6.2. Besides a high number of intramolecular crosslinks on 
SKAP135-225, several intermolecular crosslinks could be identified between SKAP135-225 
and α-tubulin and a few between SKAP135-225 and β-tubulin. These crosslinks 
occurred mainly with the N-terminal part of SKAP135-225, suggesting that this part is 
important for microtubule binding (see section 3.3.5). In order to present the spatial 
distribution of the identified residues on tubulin, the crystal structure of tubulin 
(PDB-ID: 3RYC) was depicted in figure 3.19 B with tubulin residues involved in 
crosslinks with SKAP highlighted in stick representation. The font size of the 
indicated residues reflects their frequency of occurrence during mass spectrometric 
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analysis. Crosslinking of SKAP135-225 to ten residues of tubulin was observed 
including nine residues on α-tubulin (K60, K96, K112, K163, K311, K336, K370,  
 
 
Figure 3.19: SKAP binds microtubules at the α-/β-tubulin interface. (A) Intermolecular (blue) and 
intramolecular (red) crosslinks found between SKAP135-225 and α-1B and β-2B tubulin in crosslinking 
reactions with 10 µM SKAP135-225 and 10 µM taxol-stabilized microtubules in presence of the 
crosslinkers DSS and BS2G. Crosslinks were visualized using the xVis web server (Grimm et al., 2015). 
(B) Cartoon representation of tubulin (PDB-ID: 3RYC) highlighting residues involved in crosslinking with 
SKAP135-225. Respective residues are highlighted in stick representation. The font size reflects the 
frequency of occurrence of the crosslinks during mass spectrometric analysis. The illustration was done 
with PyMOL (DeLano Scientific, San Francisco, US-CA). 
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K394 and K401) and only one residue on β-tubulin (K252). Eight of these ten 
residues that showed the highest occurrence during mass spectrometric analysis are 
located at the intra- and inter-tubulin dimer interfaces (K96, K112, K163, K311, K336, 
K394 and K401 on α-tubulin and K252 on β-tubulin), whereas only two residues with 
low occurrence lie on the surface of α-tubulin (K60 and K370). These results indicate 
that SKAP is preferentially binding to the interface of α- and β-tubulin like the Ndc80 
complex (Alushin et al., 2010; Ciferri et al., 2008), while it does not interact 
prominently with the globular regions of tubulin monomers like the Ska complex 
(Abad et al., 2014).  
For validation of the crosslinking results, the inter- and intramolecular crosslinks of α- 
and β-tubulin were analyzed in context of the tubulin crystal structure (PDB-ID: 
3RYC). Indeed, many of the crosslinked lysine residues lie within a short distance to 
each other. The remaining identified lysine residues are located further apart from 
each other, but at positions that are exposed on the surface and that presumably 
come into close proximity upon microtubule bundling through SKAP135-225 (see 
section 3.3.6). Thus, all identified crosslinks of α- and β-tubulin are located at 
positions of the tubulin crystal structure that make for a consistent set, thereby 
validating the identified crosslinks between SKAP and tubulin.  
 
To confirm SKAP binding to the dimeric interface of tubulin, microtubule 
cosedimentation assays were performed in which SKAP135-225 was incubated either 
with taxol-stabilized microtubules or with subtilisin A-treated microtubules. Subtilisin 
A is a protease that cleaves the acidic C-termini of tubulin, the so-called E-hooks, a 
region often involved in interactions of tubulin with MAPs. The SDS-PAGE gel of this 
experiment and the corresponding quantification in figure 3.20 A and B show that 
cosedimentation of SKAP with subtilisin A-treated microtubules was decreased to 
24 % in comparison to 64 % with taxol-stabilized microtubules. Since the E-hooks of 
tubulin are highly negatively charged, the interaction with SKAP is probably 
electrostatic. Therefore, it was tested if the addition of salt reduced microtubule 
binding of SKAP. Figure 3.20 C and D present the SDS-PAGE separation and 
quantification of the microtubule cosedimentation assay with taxol-stabilized 
microtubules and SKAP135-225 in the presence of increasing concentrations of NaCl. 
There is a significant decrease of SKAP microtubule binding from 63 % in the 
presence of 150 mM NaCl to 24 % in the presence of 400 mM NaCl. In summary, 
these experiments show that SKAP binds to the E-hooks of tubulin in a salt-
dependent manner.  
Chapter 3: RESULTS 
 56 
 
 
Figure 3.20: SKAP binds to the E-hooks of tubulin in a salt-dependent manner. (A-B) 
Representative SDS-PAGE (A) and quantification (B) of microtubule cosedimentation assays with 3 µM 
SKAP135-225, 1 µM BSA and 3 µM taxol-stabilized or subtilisin A-treated microtubules (t-test: p < 0.005). 
(C-D) Representative SDS-PAGE (C) and quantification (D) of microtubule cosedimentation assays with 
3 µM SKAP135-225, 1 µM BSA and 3 µM taxol-stabilized microtubules in the presence of increasing 
concentrations of NaCl. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. Quantification was done with ImageJ 1.49 (NIH). 
 
3.3.4 SKAP competes with the Ndc80 complex for microtubule 
binding 
As shown in the previous section, SKAP binds to the interface of α- and β-tubulin. 
Since this is also the binding site of the Ndc80 complex (Alushin et al., 2010), the 
question arose whether SKAP and the Ndc80 complex can bind simultaneously to 
microtubules, possibly through a cooperative binding mechanism, or rather compete 
for microtubule binding. This question was addressed with a microtubule 
cosedimentation assay, in which taxol-stabilized microtubules were first incubated 
with the Ndc80 complex and then increasing concentrations of SKAP135-225 up to 
80 µM were added. The SDS-PAGE gel of the pellet fraction and the corresponding 
quantification are shown in figures 3.21 A and B. By following the protein bands of 
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the 4-subunit Ndc80 complex, containing the Ndc80, Nuf2, Spc24 and Spc25 
proteins, with increasing amounts of SKAP, it can be seen that the amount of Ndc80 
complex bound to microtubules decreased with higher SKAP concentrations. This 
suggests that SKAP and the Ndc80 complex compete for an at least partly 
overlapping binding site on microtubules. 
 
 
 
Figure 3.21: SKAP competes with the Ndc80 complex for microtubule binding. Representative 
SDS-PAGE of the pellet fraction (A) and quantification (B) of microtubule cosedimentation assay with 
1 µM taxol-stabilized microtubules, 1 µM Ndc80 complex and 0-80 µM SKAP135-225. Quantification was 
done with ImageJ 1.49 (NIH). 
 
To analyze if the observed competition of SKAP and the Ndc80 complex for 
microtubule binding is also true at lower protein concentrations and thereby exclude 
a potential crowding-out effect of high SKAP concentrations on Ndc80 microtubule 
binding, a competition experiment was tested with fluorescence microtubule flow cell 
assays. In these assays, fluorescently labeled proteins are used so that the 
concentrations required for efficient detection are highly reduced. GFP-tagged Ndc80 
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complex was incubated with HiLyte 647-labeled microtubules in the presence of 
0-4 µM mCherry-SKAP135-225. The images and the quantification of these 
experiments, which are presented in figure 3.22, show that the fluorescence of the 
Ndc80 complex on the microtubules drops upon addition of SKAP135-225. But the 
levels only decrease to about 50 %, and even with very high SKAP135-225 
concentrations the Ndc80 complex cannot be displaced completely from the 
microtubules. The detected decrease in Ndc80 intensity on microtubules confirms 
that there is competition between SKAP and the Ndc80 complex for microtubule 
binding at lower protein concentrations. The observation that SKAP is not able to 
displace the Ndc80 complex completely suggests that SKAP might bind to the intra- 
and inter-tubulin interface with different affinities. SKAP binding to one interface of 
tubulin might occur with higher affinity so that SKAP is able to displace the Ndc80 
complex from this interaction site, whereas its binding to the other interface might be 
weaker and have no effect on Ndc80 binding at the low concentrations used in this 
experiment.  
 
  
 
Figure 3.22: SKAP and the Ndc80 complex also compete for microtubule binding at lower protein 
concentrations. Representative images (A) and quantification (B) of fluorescence microtubule flow cell 
assays with 100 nM HiLyte 647-labeled microtubules, 35 nM GFP-tagged Ndc80 complex and 0-4 µM 
mCherry-SKAP135-225. Quantification was done with ImageJ 1.49 (NIH). 
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Next, the binding of SKAP135-225 to microtubules in flow cells was compared in the 
absence and presence of the Ndc80 complex. As it can be seen from figure 3.23, 
SKAP binding to microtubules occurred at lower concentrations in the absence of the 
Ndc80 complex. Also, its intensity on the microtubules increased in the absence of 
the Ndc80 complex. This strengthens the idea that SKAP135-225 and the Ndc80 
complex compete for microtubule binding and shows that there is no cooperative 
binding to microtubules.  
 
 
Figure 3.23: SKAP does not show cooperative microtubule binding in the presence of the Ndc80 
complex. Representative images of fluorescence microtubule flow cell assays with 100 nM HiLyte 647-
labeled microtubules and 0.06-4 µM mCherry-SKAP135-225 in the presence or absence of 35 nM GFP 
tagged Ndc80 complex. 
 
Next, it had to be verified that SKAP and the Ndc80 complex indeed bind to at least 
partly overlapping binding sites on microtubules and that their competition is not due 
to binding to each other, which might induce conformational changes or steric 
clashes preventing the Ndc80 complex from binding. Therefore, the interaction of 
SKAP135-225 and the Ndc80 complex was analyzed by migration shift assays with size 
exclusion chromatography. For this purpose, the elution properties of SKAP135-225 
(black) and the Ndc80 complex (blue) were analyzed in comparison to a sample 
containing both together (red). The elution profile of the size exclusion 
chromatography and the corresponding SDS-PAGE gels in figure 3.24 reveal that 
there is no migration shift of either proteins, when they are loaded on the size 
exclusion chromatography column alone or together, indicating that SKAP135-225 and 
the Ndc80 complex do not interact in solution. This confirms that SKAP and the 
Ndc80 complex indeed bind to at least partly overlapping binding sites on 
microtubules.  
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Figure 3.24: SKAP135-225 and the Ndc80 complex do not interact in solution. Chromatogram (left) 
and SDS-PAGE gels (right) of migration shift size exclusion chromatography experiments on a 
Superdex 200 5/150 column with 20 µM SKAP135-225 (black), Ndc80 complex (blue) or both together 
(red). M: molecular weight marker with molecular weights indicated on the left.  
 
3.3.5 Multiple positively charged residues are important for 
microtubule binding of SKAP both in vitro and in vivo 
After locating the binding sites of SKAP on microtubules, attempts were made to 
identify SKAP residues involved in microtubule binding. Therefore, a sequence 
alignment of SKAP from different species was performed in order to check for 
conserved residues. As shown in figure 3.25, this sequence alignment reveals a high 
degree of conservation within the microtubule-binding domain of SKAP. It can be 
seen that this domain contains several conserved charged residues (colored in green 
and red). Especially the N-terminal part of the microtubule-binding domain of SKAP, 
which was found to be involved in microtubule binding in crosslinking analysis (see 
section 3.3.3), possesses a high fraction - a third to be specific - of positively charged 
residues (colored in green). This conservation of positively charged residues 
supports the finding that SKAP binds electrostatically to the negatively charged E-
hooks of tubulin (see section 3.3.3).  
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Figure 3.25: The microtubule-binding domain of SKAP possesses several conserved positively 
charged residues. Sequence alignment of the microtubule-binding domain of SKAP showing amino 
acid conservation between Homo sapiens (Hs), Mus musculus (Mm) and Rattus norvegicus (Rn). 
Alignment was performed with Clustal Omega (Sievers et al., 2011). Coloring: green: positively charged 
residues, red: negatively charged residues, purple: hydrophobic residues. Red asterisks indicate amino 
acids identified in crosslinking analysis and subjected to mutational analysis.  
 
In order to identify specific residues of SKAP that are important for microtubule 
binding, positively charged residues that were found in the crosslinking analysis (see 
section 3.3.3) were mutated to alanine and analyzed for their microtubule binding 
properties. First, single mutations of the amino acids found with highest occurrence 
in the mass spectrometric analysis of the crosslinking experiments (K140A, K149A, 
K161A and K164A) were created. Figure 3.26 shows the quantification of 
microtubule cosedimentation assays with 1 µM of the indicated SKAP135-225 construct 
and 0-10 µM taxol-stabilized microtubules. The corresponding SDS-PAGE gels can 
be found in supplementary figures 6.6 to 6.9. The results of the fitting analysis are 
summarized in table 3.8. These experiments reveal that all single mutants exhibited 
a decreased ability to bind microtubules compared to the wild type SKAP135-225 
construct. The mutants displayed apparent dissociation constants in the range of 
1.7-2.9 µM, compared to 0.58 µM for the wild type, indicating a 3- to 5-fold lower 
affinity for microtubules. This suggests that these positively charged residues are 
important for microtubule binding of SKAP and that each contributes to microtubule 
binding to a similar extent.  
Since all residues identified in the mutational analysis contribute to the microtubule 
binding of SKAP, it was tested next if a combination of these mutations had an 
additive effect on the microtubule-binding properties of SKAP. In addition to the 
already mentioned four residues, two more amino acids (K168 and K170) that were 
found in the mass spectrometric analysis of the crosslinking experiments were 
mutated to alanine. As combinations of the mutation sites, double (K161/164A), 
quadruple  (K140/149/161/164A) and sextuple (K140/149/161/164/168/170A) 
mutants were created, which all showed identical behavior during purification 
compared to wild type SKAP135-225.  
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Figure 3.26: Multiple positively charged residues are important for microtubule binding of SKAP. 
Quantification and fitting analysis of microtubule cosedimentation assays with 0-10 µM taxol-stabilized 
microtubules and 1 µM SKAP135-225 wild type (WT) or indicated mutants. Corresponding SDS-PAGE 
gels of the assays are shown in supplementary figures 6.6 to 6.9. Quantification was done with ImageJ 
1.49 (NIH). Data were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described in section 
5.4.2. 
 
The different SKAP135-225 mutants were analyzed for their microtubule-binding 
abilities in microtubule cosedimentation assays. A SDS-PAGE gel and the 
corresponding quantification of these experiments are presented in figure 3.27 A and 
B. It was found that the amount of SKAP bound to the microtubules was slightly 
decreased from 57 % for the wild type to 50 % for the double mutant, and 
significantly reduced to 31 % for the quadruple mutant and to 12 % for the sextuple 
mutant. These results clearly show an additive effect of the mutations on the 
microtubule binding of SKAP indicating that SKAP binds to microtubules with multiple 
positively charged residues. Interestingly, when comparing the amount of tubulin in 
the soluble and the pellet fractions it can be seen that the amount of polymerized 
tubulin was increased for the wild type construct compared to the mutants (see 
figure 3.27 A), even if the prepared microtubules belonged to the same batch. This 
suggests that SKAP has an effect on the stability and/or polymerization behavior of 
tubulin and that this effect is dependent on its ability to bind to microtubules (see 
section 3.3.6).  
In order to determine the dissociation constants of the interactions of microtubules 
and the SKAP mutants, titration experiments with 1 µM of the respective mutant and 
0-10 µM taxol-stabilized microtubules were performed. The quantification of these 
assays is shown in figure 3.27 C and the corresponding SDS-PAGE gels can be 
found in supplementary figures 6.10 to 6.12. The results of the fitting analysis are 
summarized in table 3.8. These quantifications confirm the additive effect of the 
mutations. Whereas the double mutant K161/164A showed an apparent dissociation 
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constant of 2.2 µM, the quadruple mutant K140/149/161/164A showed an about 
8-fold higher apparent dissociation constant of 18.3 µM, and the sextuple mutant 
K140/149/161/164/168/170A showed nearly no microtubule binding, so that no fitting 
was possible. These findings indicate that multiple positively charged residues are 
important for the microtubule binding of SKAP in vitro.  
 
 
 
 
Figure 3.27: Multiple positively charged residues are required for microtubule binding of SKAP 
in vitro. (A-B) Representative SDS-PAGE (A) and quantification (B) of microtubule cosedimentation 
assays with 3 µM taxol-stabilized microtubules and 3 µM SKAP135-225 wild type (WT) or indicated 
mutants (t-test: p < 0.001). S: soluble fraction with proteins not bound to microtubules. P: pellet fraction 
with microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on 
the left. (C) Quantification and fitting analysis of microtubule cosedimentation assays with 0-10 µM taxol-
stabilized microtubules and 1 µM SKAP135-225 wild type (WT) or indicated mutants. Corresponding SDS-
PAGE gels of the assays are shown in supplementary figures 6.10 to 6.12. Quantification was done with 
ImageJ 1.49 (NIH). Data were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described in 
section 5.4.2. 
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Table 3.8: Summary of fitting analysis of microtubule cosedimentation assays with SKAP135-225 
mutants. Microtubule cosedimentation assays were performed with 0-10 µM taxol-stabilized 
microtubules and 1 µM SKAP159-225, SKAP146-225, SKAP135-225 or SKAP103-225. Quantification was done 
with ImageJ 1.49 (NIH). Data were fitted with Origin7.0 (OriginLab, Northampton, US-MA) as described 
in section 5.4.2. 
SKAP135-225 construct 
apparent dissociation 
constant Kd (µM) 
maximal bound 
fraction 
WT 0.58 ± 0.08 1.08 ± 0.03 
K140A 1.7 ± 0.5 1.10 ± 0.11 
K149A 1.8 ± 0.4 1.18 ± 0.08 
K161A 2.1 ± 0.6 1.10 ± 0.10 
K164A 2.9 ± 0.5 1.43 ± 0.09 
K161/164A 2.2 ± 0.5 1.12 ± 0.09 
K140/149/161/164A 18.3 ± 7.3 1.2 ± 0.4 
K140/149/161/164/168/170A no fitting possible no fitting possible 
 
Next, it was tested whether the region comprising the identified amino acids is only 
necessary or also sufficient for microtubule binding of SKAP. For this purpose, two 
constructs were created: one ranging from amino acid 135 to 174 and comprising the 
identified residues, and another ranging from amino acid 175 to 225. These two 
constructs were analyzed in microtubule cosedimentation assays and compared to 
the complete microtubule-binding domain. A representative SDS-PAGE gel and the 
corresponding quantification are depicted in figure 3.28. This experiment showed that 
in contrast to SKAP135-225, both truncated constructs were hardly able to bind 
microtubules, since no significant protein amounts could be seen in the pellet 
fraction. The bound fractions of SKAP135-174 and SKAP175-225 were reduced to 10 % 
and 4 %, respectively, compared to 65 % of SKAP135-225, suggesting that the 
identified residues are necessary, but not sufficient, for the microtubule binding by 
SKAP. This indicates that SKAP possesses a multipartite mode of microtubule 
binding, in which probably several other residues are involved in addition to the 
identified ones.  
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Figure 3.28: Amino acids 135 to 174 are necessary, but not sufficient for microtubule binding of 
SKAP. Representative SDS-PAGE (A) and quantification (B) of microtubule cosedimentation assays 
with 3 µM taxol-stabilized microtubules and 3 µM GST-SKAP135-225, GST-SKAP135-174 or GST-
SKAP175-225 (t-test: p < 0.001). S: soluble fraction with proteins not bound to microtubules. P: pellet 
fraction with microtubules and bound proteins. M: molecular weight marker with molecular weights 
indicated on the left. Quantification was done with ImageJ 1.49 (NIH).  
 
To test if the SKAP residues involved in microtubule binding mediate SKAP 
localization in vivo, Flp-In T-REx cell lines expressing wild type or mutant full-length 
GFP-SKAP were generated. The levels of expression of wild type and mutant GFP-
SKAP after doxycycline induction for 24 h were approximately equal (see 
supplementary figure 6.16). Cells were arrested in metaphase by treatment with the 
proteasome inhibitor MG132 and the cellular localization of GFP-SKAP to 
kinetochores and spindle microtubules was analyzed by immunofluorescence. 
Representative images and corresponding quantifications are presented in figure 
3.29. GFP signals of the mutants were normalized to GFP signals of the wild type 
SKAP construct. As mentioned in the introductory section 1.6, wild type GFP-SKAP 
showed a dual localization to both spindle microtubules and - predominantly 
bioriented - kinetochores. When comparing the GFP intensity of wild type SKAP at 
kinetochores to those of the mutants, it can be seen that the intensities display only 
small variations, indicating that the mutations have no effect on the kinetochore 
localization of SKAP. In contrast to this, the mutants revealed reduced intensities at 
spindle microtubules compared to the wild type construct, and the degree of signal 
reduction corresponded to the number of inserted mutations. For the sextuple 
mutant, the localization to spindle microtubules was not abolished completely, but 
reduced to 45 %, indicating that the role in localization is not limited to the six 
identified residues. It is possible that interactions with other proteins are also 
important for the interaction of SKAP with microtubules. These results confirm that 
the mutation sites are necessary, but not sufficient for microtubule binding, both in 
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vivo and in vitro. In summary, these findings suggest that the identified residues of 
SKAP are not only required for its microtubule binding in vitro, but also in vivo, 
although other amino acids seem to play a role as well.  
 
  
  
Figure 3.29: Multiple positively charged residues are required for microtubule binding of SKAP 
in vivo. (A) Representative immunofluorescence images of stable Flp-In T-REx cell lines expressing 
GFP-SKAP full-length (f.l.) wild type (WT) or indicated mutants. Cells were treated with 0.1 µg/mL 
doxycycline for 24 h and 10 µM MG132 for 1.5-2 h prior to fixation. Scale bar: 5 µm. (B) Plot of 
normalized GFP fluorescence at the kinetochores or the spindle microtubules for experiments shown in 
(A). Quantification was done with Imaris 7.3.4 (Bitplane, Zurich, CH).  
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Since cells expressing GFP-SKAP behaved comparably to control cells without 
expression, the overexpression of SKAP did not reveal any dominant phenotypic 
effect. Therefore, the phenotypic effects of depletion of SKAP by RNA interference 
were analyzed next. For this purpose, appropriate conditions for the RNA 
interference had to be established. Flp-In T-REx cells were transfected with two 
different siRNAs for 1, 2 or 3 days and the amounts of remaining endogenous SKAP 
were quantified by immunofluorescence and western blot as shown in figure 3.30.  
 
 
Figure 3.30: Test of SKAP siRNA. (A) Representative immunofluorescence images of RNA 
interference experiment with Flp-In T-REx cells incubated with two different SKAP siRNAs for 1,2 or 
3 days. -: control without siRNA. Scale bar: 5 µm.  
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Figure 3.30 (continued): Test of SKAP siRNA. (B) Western blots with cell lysates of Flp-In T-REx cells 
incubated with two different SKAP siRNAs for 1,2 or 3 days stained for SKAP and tubulin as loading 
control. (C) Quantification of SKAP intensities in immunofluorescence (IF) and western blot (WB) for 
experiments shown in (A) and (B). Quantification for immunofluorescence was done with Imaris 7.3.4 
(Bitplane, Zurich, CH). The SKAP intensity at kinetochores was normalized to CREST signals. 
Quantification for western blot was done with ImageJ 1.49 (NIH). Intensities were normalized to those of 
control cells.  
 
Whereas the western blot suggested a complete depletion of endogenous SKAP 
after 2 days of treatment with both SKAP siRNA 1 and 2, the immunofluorescence 
images revealed a less efficient depletion. After a 3-day treatment with SKAP siRNA 
1 the level of endogenous SKAP was only reduced to 16 %. The transfection with 
SKAP siRNA 2, however, resulted in depletion to 9 % after 2 days and to < 1 % after 
3 days. Therefore, the condition with 72 h transfection of SKAP siRNA 2 was chosen 
for further RNA interference and rescue experiments. 
On closer observation of figure 3.30 A, it can be seen that the reduction of 
endogenous SKAP levels generated kinetochores that did not align to the metaphase 
plate. The RNA interference experiment depicted in the upper images of figure 3.31 
also showed that SKAP depletion affected biorientation, since cells in a pseudo-
metaphase state with several unattached kinetochores (indicated by white arrows) 
could be observed. These cells with disturbed biorientation amounted to 74 % of all 
metaphase or pseudo-metaphase cells. Another phenotype, which was observed in 
31 % of SKAP depleted mitotic cells, was the formation of multipolar spindles, as 
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shown in the second image series in figure 3.31. This shows that SKAP is required 
for spindle organization and establishment of biorientation in vivo. The following 
image series of figure 3.31 display the rescue experiments in which wild type or 
mutant GFP-SKAP was expressed after treatment with SKAP siRNA to deplete 
endogenous SKAP. The quantification of observed phenotypes for the RNA 
interference and rescue experiments is summarized in table 3.9. Upon expression of 
wild type GFP-SKAP and GFP-SKAP K161/164A phenotypes were rescued 
completely, since these experiments showed only a very small fraction of cells with 
multipolar spindles and pseudo-metaphase states, comparable to control cells that  
 
 
Figure 3.31: SKAP is required for spindle organization and establishment of biorientation in vivo. 
Representative immunofluorescence images of RNA interference and rescue experiments with stable 
Flp-In T-REx cell lines expressing GFP-SKAP full-length (f.l.) wild type (WT) or indicated mutants. Cells 
were treated with SKAP siRNA 2 for 72 h and gene expression was induced with 0.1 µg/mL doxycycline 
for 24 h. White arrows show unaligned kinetochores. Scale bar: 5 µm.  
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Table 3.9: Quantification of phenotypes observed in RNA interference and rescue experiments 
with GFP-SKAP expressing cells. Flp-In T-REx cell lines expressing GFP-SKAP full-length wild type 
(WT) or indicated mutants were treated with SKAP siRNA 2 for 72 h and GFP-SKAP expression was 
induced with 0.1 µg/mL doxycycline for 24 h. 
SKAP 
siRNA 
expressed SKAP 
construct 
mitotic 
index 
(%) 
mitotic cells 
with multipolar 
spindles (%) 
(pseudo-) metaphase 
cells with unaligned 
kinetochores (%) 
- - 6 <1 5 
+ - 42 31 74 
+ WT 7 <1 4 
+ K161/164A 7 <1 6 
+ K140/149/161/164A 15 6 14 
+ K140/149/161/164/ 
168/170A 
33 24 57 
 
were not treated with SKAP siRNA. However, the quadruple and sextuple mutants of 
GFP-SKAP, which showed disturbed ability to bind microtubules, were only partly 
able to rescue the observed phenotypes. For the quadruple mutant, 6 % of mitotic 
cells revealed multipolar spindles and 14 % of metaphase cells exhibited unattached 
kinetochores, whereas for the sextuple mutant, these statistics amounted to 24 % 
and 57 %, respectively. These levels of perturbed mitosis were also reflected in the 
mitotic index, which specifies the percentage of cells that are in mitosis. An increased 
mitotic index indicates a delay in mitosis because of problems during mitotic 
progression. For control cells, the mitotic index amounts to 6 % and SKAP depleted 
cells expressing GFP-SKAP wild type or the double mutant show a comparable 
mitotic index of 7 %. In SKAP depleted cells, 42 % of all cells are in mitosis, 
indicating a mitotic delay. SKAP depleted cells that expressed quadruple and 
sextuple GFP-SKAP mutants showed more penetrant phenotypes, with a mitotic 
index of 15 % and 33 %, respectively. In summary, these findings show that the 
ability of SKAP to bind microtubules is important for its cellular function in spindle 
organization, biorientation and mitotic progression. 
 
3.3.6 SKAP binds to tubulin in solution and can induce its 
polymerization 
Since SKAP is able to bind to microtubules, as shown in the previous sections, the 
question arose if SKAP also binds to unpolymerized tubulin. This question was 
addressed with tubulin that formed a complex with either tubulin tyrosine ligase (TTL) 
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or with the stathmin-like domain of the RB3 protein (RB3), which prevent tubulin from 
polymerizing. TTL is an enzyme that posttranslationally tyrosinates detyrosinated 
α-tubulin. It binds to the C-terminal tail of α-tubulin in a tubulin dimer and only 
recognizes the curved conformation of tubulin dimers (Prota et al., 2013). The RB3 
protein is part of the stathmin family whose members are known to have microtubule 
destabilizing activity (Gavet et al., 1998). The stathmin-like domain of RB3 binds two 
tubulin dimers and induces a curvature of the complex, while its N-terminal region 
binds a hydrophobic groove of α-tubulin that is involved in intermolecular contacts 
within microtubules (Gigant et al., 2000; Gigant et al., 2005). This stabilization of 
tubulin in a curved conformation and the binding to interfaces important for 
microtubule assembly cause inhibition of tubulin polymerization by TTL and RB3. 
The binding of SKAP135-225 to tubulin/TTL or tubulin/RB3 was analyzed by monitoring 
the elution volume in size exclusion chromatography experiments, as shown in 
figures 3.32 and 3.33. In these experiments, the elution of SKAP135-225 (black) and 
tubulin/TTL or tubulin/RB3 (blue) was compared to samples containing both SKAP135-
225 and either of the tubulin complexes (red). The chromatograms and the 
corresponding SDS-PAGE gels reveal that in both cases there was a migration shift 
of the tubulin complex peak to lower elution volumes and thereby higher molecular 
weights in the presence of SKAP135-225. Furthermore it can be seen on the SDS-
PAGE gels that the peak fraction of SKAP135-225 shifted from lane 10 in the control 
sample with SKAP135-225 alone to lanes 8 or 6 in the presence of tubulin/TTL or 
tubulin/RB3, respectively. The comigration of SKAP135-225 with the tubulin complexes 
at lower elution volumes than the single components indicate that SKAP135-225 is able 
to bind to both the tubulin/TTL and the tubulin/RB3 complex in solution. In summary, 
these experiments show that SKAP is not only able to bind to polymerized 
microtubules, but also to unpolymerized tubulin.  
Interestingly, both tubulin/TTL and tubulin/RB3 contained a fraction of free tubulin 
that peaked in lane 2 and that was not detectable after incubation of these samples 
with SKAP135-225. When taking a closer look at the reaction mixtures, it could be seen 
that their turbidity was increased upon addition of SKAP135-225 and after centrifugation 
a pellet was visible. Together with the absence of free tubulin upon addition of 
SKAP135-225, this suggests that SKAP135-225 polymerized the free tubulin. A similar 
effect was already mentioned during the description of figure 3.27 A in section 3.3.5, 
which showed an increased amount of polymerized tubulin when microtubules were 
incubated with wild type SKAP135-225 compared to the mutants. These two 
observations give a first hint that SKAP may influence the polymerization of tubulin. 
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Figure 3.32: SKAP135-225 binds to tubulin/TTL in solution. Chromatogram (top) and SDS-PAGE gels 
(bottom) of migration shift size exclusion chromatography experiments on a Superdex 200 5/150 column 
with 15 µM SKAP135-225 (black), tubulin/TTL (blue) or both together (red). M: molecular weight marker 
with molecular weights indicated on the right.  
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Figure 3.33: SKAP135-225 binds to tubulin/RB3 in solution. Chromatogram (top) and SDS-PAGE gels 
(bottom) of migration shift size exclusion chromatography experiments on a Superdex 200 5/150 column 
with 15 µM SKAP135-225 (black), tubulin/RB3 (blue) or both together (red). M: molecular weight marker 
with molecular weights indicated on the right.  
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In order to test whether SKAP indeed has an effect on the polymerization of tubulin, 
tubulin polymerization in the absence and presence of different SKAP constructs was 
analyzed in turbidity experiments by following the absorbance at 350 nm at a 
temperature of 37 °C (Mirigian et al., 2013). Hereby, a change in light scattering that 
is caused by the microtubule suspension can be measured. First, control 
experiments with tubulin alone and in the presence of BSA were performed. Tubulin 
concentrations up to 15 µM were tested and no polymerization was detected (see 
supplementary figure 6.14), indicating that the critical concentration, at which tubulin 
was able to polymerize on its own, lay above 15 µM under the assay conditions. To 
stay below the critical tubulin concentration, the assays with SKAP were performed 
at a tubulin concentration of 5 µM. Upon addition of SKAP135-225, a concentration 
dependent increase in the absorbance at 350 nm could be observed, with the largest 
effects observed at a stoichiometric ratio (see figure 3.34 A), whereas the constructs 
SKAP159-225 or SKAP159-316 exhibited no ability to polymerize tubulin (see 
supplementary figure 6.15). This shows that SKAP135-225 is able to promote tubulin 
polymerization in vitro and to lower its critical concentration, suggesting that SKAP is 
a microtubule-stabilizing factor with effects on tubulin nucleation.  
 
 
Figure 3.34: SKAP135-225 promotes tubulin polymerization in vitro. Tubulin polymerization assays 
with 5 µM tubulin and 0.25-5 µM SKAP135-225 (A) or 1 µM SKAP135-225 wild type (WT) or indicated mutant 
(B). Tubulin polymerization was measured by following the absorbance at 350 nm at 37 °C. 
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Next, the mutants of SKAP135-225 identified in section 3.3.5 were tested for their ability 
to polymerize tubulin. As it can be seen in figure 3.34 B, the double mutant 
K161/164A already showed a significant decrease in the amount of polymerized 
tubulin, whereas the samples with the quadruple mutant K140/149/161/164A and the 
sextuple mutant K140/149/161/164/168/170A even showed no tubulin polymerization 
at all. This indicates that the ability of SKAP135-225 to promote tubulin polymerization 
corresponds with its ability to bind microtubules.  
To quantify the effects of SKAP on tubulin polymerization, total internal reflection 
fluorescence (TIRF) microscopy experiments were performed. For this purpose, 
microtubule seeds stabilized with the slowly hydrolyzable GTP analog GMPCPP 
were attached to the surface of a coverslip and then incubated with unpolymerized 
tubulin in the absence and presence of SKAP. An assay condition with a tubulin 
concentration of 14 µM and a temperature of 25 °C was chosen, which showed a 
balanced ratio of polymerization and depolymerization in the control sample with 
tubulin alone, so that the influence of SKAP was easily detectable by a shift of this 
ratio towards polymerization.  
Representative kymographs of microtubules and calculated growth rates in absence 
or presence of SKAP135-225 wild type or mutants are presented in figure 3.35. The 
kymographs are composed of image series along the microtubule axis for each 
imaged time point. It can be seen that the microtubules in the tubulin control did not 
show significant growth during the observed period of 17 min, which was reflected in 
their low growth rate of 0.10 µm/min. In the presence of SKAP135-225 wild type the 
microtubules grew up to 23 µm with an averaged growth rate of 0.78 µm/min, 
indicating that SKAP135-225 was indeed able to shift the microtubule dynamics towards 
polymerization with an 8-fold higher microtubule growth rate than the tubulin control. 
Also the double mutant K161/164A revealed a significant increase of microtubule 
growth with a 5-fold higher growth rate of 0.47 µm/min compared to the tubulin 
control. However, with the quadruple mutant K140/149/161/164A and the sextuple 
mutant K140/149/161/164/168/170A comparable microtubule growth as with the 
tubulin control was observed with growth rates of 0.13 µm/min and 0.09 µm/min, 
respectively. These findings reveal that the mutants exhibited reduced abilities to 
favor tubulin polymerization in vitro compared to the wild type construct and the 
degree of reduction corresponded to the number of inserted mutations. In summary, 
the results of the TIRF analysis are comparable to those of the turbidity assays, and 
suggest that SKAP135-225 is able to promote tubulin polymerization in vitro, in a way 
that requires its ability to bind to microtubules.  
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Figure 3.35: SKAP135-225 favors microtubule growth in vitro. Representative kymographs of 
microtubules (A) and microtubule growth rates (B) observed in TIRF experiments in absence or 
presence of 500 nM SKAP135-225 wild type or indicated mutants. 
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The TIRF experiments in the presence of SKAP135-225 wild type not only revealed an 
effect of SKAP135-225 on microtubule dynamics, but also on microtubule structure. As 
shown in figure 3.36, in addition to single microtubules, several microtubule bundles 
with different thickness and a length up to 60 µm could be observed, indicating that 
SKAP135-225 promotes microtubule bundling in vitro.  
 
 
Figure 3.36: SKAP135-225 promotes microtubule bundling in vitro. Representative TIRF image of 
microtubules in the presence of 500 nM SKAP135-225 wild type and showing microtubule bundle 
formation.  
 
To have a closer look on these microtubule bundles formed in the presence of 
SKAP135-225, negative stain electron microscopy (EM) was performed. Therefore, 
samples of taxol-stabilized microtubules were polymerized at 34 °C in the absence 
and presence of SKAP135-225 and directly imaged by EM. Figure 3.37 presents 
representative EM images of these samples at three different magnifications. In the 
absence of SKAP135-225 a lot of single microtubules could be observed. Despite their 
high density, they did not form bundles or other higher-order structures. The sample 
with 0.5 µM SKAP135-225 revealed huge polymeric tubulin structures that could clearly 
be identified as microtubule bundles in the higher magnifications. Even very short 
microtubules aligned into bundles. In the presence of 2 µM SKAP135-225 these 
structures were even bigger and contained much thicker microtubule bundles. While 
in the background of the samples with less SKAP135-225 several unpolymerized tubulin 
dimers could be seen, this sample revealed hardly any unpolymerized tubulin. 
Furthermore, in the presence of SKAP135-225 a high amount of tubulin oligomers, 
reminiscent of microtubule nuclei, was visible (see bottom image series), indicating 
10 µm
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that SKAP not only has an effect on microtubule bundling, but also on tubulin 
nucleation.  
Taken together, the EM experiments confirm the findings of the TIRF analysis that 
SKAP135-225 is able to bundle microtubules in vitro and - in addition to the observed 
lowered critical tubulin concentration in the turbidity assays - give a hint that 
SKAP135-225 is able to nucleate tubulin and thereby promote its polymerization.  
 
 
Figure 3.37: SKAP135-225 promotes microtubule bundling in vitro. Representative negative stain EM 
images of microtubules in the absence and presence of SKAP135-225. Samples with 10 µM tubulin and 
0-2 µM SKAP135-225 were incubated for 10 min at 34 °C and after addition of 50 µM taxol for another 
30 min at 34 °C.  
0 µM
0.5 µM
2 µM
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0.1 µm
0.1 µm0.5 µm
0.5 µm 0.1 µm
0.5 µm2 µm
2 µm
2 µm
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Next, the stability of microtubule bundles formed in the presence of SKAP135-225 was 
analyzed. For this purpose, cold shock assays were performed, in which tubulin was 
polymerized at 34 °C in absence or presence of SKAP135-225 wild type or mutants, 
followed by a cold shock on ice. Control samples were treated without cold shock. 
The SDS-PAGE gels of the supernatant and the pellet fractions after centrifugation 
and the corresponding quantification are shown in figure 3.38. The fraction of 
polymerized tubulin was determined by dividing the amount of tubulin in the pellet by 
its sum in supernatant and pellet. The control samples treated without cold shock 
confirm the observations of figure 3.27 A in section 3.3.5, which showed that the 
amount of polymerized tubulin was increased, when microtubules were incubated 
with the wild type SKAP135-225 construct compared to the mutants. In this case, the 
polymerized tubulin fraction amounted to 63 % in presence of SKAP135-225 wild type 
compared to 37 %, 30 % and 26 % in presence of the double, quadruple and 
sextuple mutants, respectively, revealing a correspondence of the ability of 
SKAP135-225 to promote tubulin polymerization to the number of inserted mutations. 
The tubulin control sample treated without cold shock showed a polymerized tubulin 
fraction of 23 % comparable to the sextuple mutant. When comparing the samples 
treated with and without cold shock, it was found that the amount of polymerized 
tubulin in the tubulin control was decreased to only 6 %, indicating that microtubules 
formed in the absence of SKAP are not cold stable and therefore depolymerize upon 
cold treatment. The sextuple SKAP135-225 mutant showed a similar reduction in the 
polymerized tubulin fraction to 9 %, suggesting that this mutant was not able to 
stabilize the formed microtubule during a cold shock. In contrast to this, SKAP135-225 
wild type as well as the double and quadruple mutants revealed comparable 
amounts of polymerized tubulin with and without cold shock, implying that these 
SKAP135-225 constructs were able to stabilize the formed microtubules during the cold 
treatment.  
In summary, these results suggest that SKAP135-225 is able to prevent formed 
microtubule bundles from depolymerization upon cold treatment by acting as 
microtubule-stabilizing factor.  
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Figure 3.38: Microtubule bundles formed in the presence of SKAP135-225 are cold stable. 
Representative SDS-PAGE gels (A) and quantification (B) of microtubule cold shock assays with 10 µM 
tubulin in absence or presence of 10 µM SKAP135-225 wild type or indicated mutants. Samples were 
incubated for 30 min at 34 °C followed by a cold shock for 10 min on ice. Control samples were treated 
without cold shock. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. Quantification was done with ImageJ 1.49 (NIH).  
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3.4  Kinetochore recruitment of the Astrin/SKAP complex  
3.4.1 SKAP localizes to kinetochores in the absence of microtubules 
As described in the introductory section 1.6, the localization of SKAP at kinetochores 
depends on the presence of microtubules and is counteracted by the activity of 
Aurora B kinase (Schmidt et al., 2010). In order to analyze the necessity of 
microtubules on the kinetochore localization of SKAP, immunofluorescence 
experiments with HeLa cells treated with different small molecule inhibitors were 
performed. MG132 is a proteasome inhibitor that blocks cells in metaphase. 
Hesperadin is an inhibitor of Aurora B kinase. Since Aurora B is important for 
correcting improper kinetochore-microtubule attachments and maintaining the 
spindle assembly checkpoint, an inhibition of this kinase leads to cells entering 
anaphase with a high amount of monooriented chromosomes because of missing 
correction mechanisms (Hauf et al., 2003). Nocodazole disrupts microtubule 
dynamics and thereby arrests cells in prometaphase, due to the lack of microtubules, 
which prevents kinetochores from accomplishing biorientation.  
Representative immunofluorescence images and the corresponding quantification of 
the kinetochore localization of SKAP can be found in figure 3.39. HeLa cells treated 
only with MG132 established metaphase plates and showed no unattached 
kinetochores. In those cells, SKAP was found at both spindle microtubules and 
kinetochores with high intensity. As expected, in the presence of both MG132 and 
Hesperadin, HeLa cells were unable to align chromosomes to a metaphase plate and 
showed a high number of monooriented kinetochores. SKAP showed increased 
kinetochore localization in these cells and also localized to misattached kinetochores, 
indicating that Aurora B counteracts the kinetochore localization of SKAP. Next, 
these localization experiments were performed in the presence of nocodazole 
instead of MG132. The missing signal in the tubulin channel of the images with 
nocodazole treated cells reveals the absence of microtubules arresting cells in 
prometaphase. In these cells, SKAP levels at kinetochores were decreased to below 
1 %, suggesting that SKAP was not able to localize to unattached kinetochores if 
Aurora B kinase was still functional. When HeLa cells were treated with Hesperadin 
in addition to nocodazole, kinetochore localization of SKAP could be restored to 
51 % compared to cells treated with MG132, showing that SKAP could also localize 
to unattached kinetochores if Aurora B is inhibited.  
In summary, these localization studies suggest that, although the intensity of SKAP 
at kinetochores is increased in the presence of spindle microtubules, SKAP does not 
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need microtubules to localize to kinetochores. Therefore, not only the attachment to 
microtubules brings SKAP to kinetochores, but there has to be an additional 
kinetochore receptor for SKAP.  
 
  
  
Figure 3.39: SKAP localizes to kinetochores in the absence of microtubules. (A) Representative 
immunofluorescence images of HeLa cells. Cells were treated with MG132 or nocodazole for 3 h and 
Hesperadin for 1.5 h prior to fixation. Scale bar: 5 µm. (B) Plot of endogenous SKAP signals at 
kinetochores for experiments shown in (A). Quantification was done with Imaris 7.3.4 (Bitplane, Zurich, 
CH). SKAP intensity was normalized to CREST signals (t-test: p < 0.001). 
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3.4.2 In vitro interaction studies to identify a kinetochore receptor for 
the Astrin/SKAP complex 
Since the KMN network is important for the kinetochore localization of SKAP (Wang 
et al., 2012), in vitro interaction studies with SKAP and different components of the 
KMN network were performed. The SKAP construct ranging from amino acid 159 to 
316 was used, because this region represents the minimal kinetochore localization 
domain of SKAP (Dunsch et al., 2011). Its localization with the KMN network proteins 
was investigated in GST pull-down experiments (see figure 3.40), migration shift 
assays by size exclusion chromatography (see figures 3.41 to 3.43) and with 
microscale thermophoresis (MST, see figure 3.44).  
For GST pull-down experiments, GST-Knl12000-2311 was loaded onto GSH beads and 
subsequently incubated with SKAP159-316 in absence or presence of the Mis12 and 
the Ndc80 complexes, as shown in figure 3.40 A. A protein band at a molecular 
weight of 20 kD, corresponding to SKAP159-316, was visible in the binding experiment 
with GST-Knl12000-2311. This band was still detectable when GST-Knl12000-2311 was in 
complex with the Mis12 complex or the Mis12 and Ndc80 complexes. The control 
experiment with GST bound to the beads showed no corresponding protein band, 
indicating that SKAP159-316 is able to bind to GST-Knl12000-2311 on solid phase. 
However, in pull-down assays with the slightly shorter GST-Knl12106-2316, as shown in 
figure 3.40 B, the band of SKAP159-316 was not visible, neither with Knl1 alone nor 
with Knl1 in complex with the Mis12 and Ndc80 complexes. This suggests that there 
is no interaction between SKAP and Knl1, the Mis12 complex or the Ndc80 complex. 
The binding of SKAP159-316 to the longer Knl12000-2311 construct was probably due to 
an unspecific interaction with the unpaired coiled-coil region of this Knl1 construct. 
The pull-down experiments with SKAP159-316 and Zwint presented in figure 3.40 C 
revealed a protein band at a molecular weight of 20 kD corresponding to SKAP159-316 
in the assay with GST-Zwint as well as when Zwint was in complex with its binding 
partner Knl1, indicating an interaction between SKAP159-316 and Zwint on solid phase.  
Figure 3.41 shows the binding assays on size exclusion chromatography with 
SKAP159-316 and the Mis12 complex. As seen in the chromatograms and the SDS-
PAGE gels, SKAP159-316 and the Mis12 complex showed the same elution properties 
when loaded onto the size exclusion chromatography column alone (red and blue) or 
together (black) and did not comigrate, suggesting that they do not interact in 
solution. In the experiment with SKAP159-316 and GST-Knl12000-2311 depicted in figure 
3.42, no migration shift or comigration could be observed, either. This confirms that 
Chapter 3: RESULTS 
 84 
the interaction seen for these proteins on solid phase was probably due to a weak 
unspecific interaction. As shown in figure 3.43, Zwint and SKAP159-316 shifted from 
lane 6 in the control samples to lanes 4 and 5 when loaded together. However, when 
the Zwint interaction partner Knl12000-2311 was added as well, a tight complex between 
Zwint and Knl12000-2311, but only a minor comigration of SKAP159-316 could be 
observed, indicating only a weak interaction of SKAP159-316 with the Zwint/Knl1 
complex. Taken together, apart from a possible interaction with Zwint no kinetochore 
receptor of SKAP could be clearly identified by means of GST pull-downs and size 
exclusion chromatography.  
 
 
Figure 3.40: SKAP159-316 interacts with Knl12000-2311 and Zwint in GST pull-down experiments. SDS-
PAGE gels of GST pull-down experiments with Knl12000-2311, Knl12106-2316, the Mis12 complex, the Ndc80 
complex, Zwint and SKAP159-316. M: molecular weight marker with molecular weight indicated on the left. 
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Figure 3.41: SKAP159-316 does not bind to the Mis12 complex in solution. Chromatograms (left) and 
SDS-PAGE gels (right) of migration shift size exclusion chromatography experiments on a Superdex 
200 5/150 column with 20 µM SKAP159-316 (red), the Mis12 complex (blue) or both together (black). M: 
molecular weight marker with molecular weights indicated on the left. 
 
 
Figure 3.42: SKAP159-316 does not bind to Knl12000-2311 in solution. Chromatograms (left) and SDS-
PAGE gels (right) of migration shift size exclusion chromatography experiments on a Superdex 200 
5/150 column with 20 µM SKAP159-316 (black), GST-Knl12000-2311 (blue) or both together (red). M: 
molecular weight marker with molecular weights indicated on the left. 
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Figure 3.43: SKAP159-316 binds to Zwint in solution. Chromatograms (top) and SDS-PAGE gels 
(bottom) of migration shift size exclusion chromatography experiments on a Superdex 200 5/150 column 
with 20 µM Zwint (blue), SKAP159-316 (black), both together (red), Knl12000-2311 (light green) or all three 
together (dark green). M: molecular weight marker with molecular weights indicated on the left. 
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As a third method to analyze the interaction of SKAP and the KMN network, MST 
experiments were performed. With MST, the migration of biomolecules in a local 
temperature gradient is analyzed (Jerabek-Willemsen et al., 2011). This depends on 
the size, charge and solvation shell of the observed molecules. Since upon binding of 
two or more molecules their size, charge and conformation is altered, this structural 
change can be observed via a thermophoretic change.  
Figure 3.44 shows the results of the MST experiments with fluorescent mCherry-
SKAP159-316 titrated with unlabeled Mis12 complex (A), Ndc80 complex (B) or Zwint 
(C), respectively. Fluorescence signals were analyzed with the NT Analysis software 
(NanoTemper Technologies GmbH, Munich, DE). The left panel of figure 3.44 
depicts the changes in the initial fluorescence for the different concentrations of 
unlabeled protein, whereas the right panel shows the normalized difference in 
fluorescence for the thermophoresis and the temperature jump signal. Plotted signals 
were fitted with Origin7.0  (OriginLab, Northampton, US-MA) as mentioned in 
section 5.6.1. It can be seen that the initial fluorescence signal of mCherry-
SKAP159-316 increased upon addition of the Mis12 complex, the Ndc80 complex as 
well as Zwint. The fitting analysis revealed very similar dissociation constants for the 
three observed interactions amounting to 65 nM for the Mis12 complex, 56 nM for the 
Ndc80 complex and 66 nM for Zwint. The analysis of the thermophoresis and the 
temperature jump signals resulted in a decrease of signal corresponding to the 
increase in initial fluorescence. The dissociation constants obtained by the fitting 
analysis were 37 nM for the Mis12 complex, 59 nM for the Ndc80 complex and 
35 nM for Zwint. Since the analysis of the thermophoresis and the temperature jump 
signals is based on a constant initial fluorescence for all titration points, the fitting of 
the fluorescence changes is supposed to be more accurate. Strikingly, the fitting of 
all shown interactions resulted in very similar dissociation constants between 35 nM 
and 66 nM. Since these calculated dissociation constants in the nM range assume 
very tight interactions and the interactions of SKAP159-316 with the Mis12 complex or 
the Ndc80 complex could not be detected with other methods, i.e. GST pull-downs 
and size exclusion chromatography, the MST experiments probably do not show real 
interactions, as discussed in section 4.3. 
Taken together, no receptor of the Astrin/SKAP complex could be identified by 
means of MST and the results suggest a cautious interpretation of binding data 
obtained from a single approach. 
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Figure 3.44: SKAP159-316 shows an interaction with the Mis12 complex, the Ndc80 complex and 
Zwint in MST experiments. Quantification of microscale thermophoresis assays with 150 nM mCherry-
SKAP159-316 and the Mis12 complex (A), the Ndc80 complex (B) or Zwint (C). Left, change in initial 
fluorescence. Right, normalized difference in fluorescence for the thermophoresis and the temperature 
jump signal. Signals were analyzed with the NT Analysis software (NanoTemper Technologies GmbH, 
Munich, DE) and fitted with Origin7.0 (OriginLab, Northampton, US-MA) as mentioned in section 5.6.1. 
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3.5  Structural characterization of the Astrin/SKAP 
complex 
3.5.1 The Astrin/SKAP complex is highly elongated and flexible 
In order to look closer at the structure of the Astrin/SKAP complex, the truncated 
version of this complex containing Astrin482-850 and SKAP159-316 was analyzed with 
negative stain electron microscopy. As it can be seen in figure 3.45, the 
Astrin482-850/SKAP159-316 complex showed a highly elongated structure with several 
conformations indicating a high degree of flexibility. The calculated length of the 
complex is about 40-50 nm. The EM images in the bottom panel of figure 3.45 reveal 
ring-like structures, implying that the Astrin482-850/SKAP159-316 complex is able to form 
higher-order structures. Because of the high flexibility of the complex, a single 
particle analysis was not possible.  
 
 
 
Figure 3.45: The Astrin482-850/SKAP159-316 is highly elongated and flexible. Representative negative-
stain EM images of Astrin482-850/SKAP159-316. Scale bars: 100 nm (left) and 10 nm (magnifications on the 
right). 
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Next, attempts were made to decorate microtubules with the Astrin482-850/SKAP159-316 
complex in order to investigate the binding mode. The binding to microtubules might 
reduce the flexibility of the complex and thereby allow a single particle analysis of the 
complex. The resulting EM images are depicted in figure 3.46. Panel A shows the 
images of microtubules together with the Astrin482-850/SKAP159-316 complex, panel B 
shows the control sample with undecorated microtubules. The comparison of these 
EM images reveals that the microtubules looked the same in both conditions, 
indicating that the Astrin482-850/SKAP159-316 complex did not bind to the microtubules 
under the assay conditions. Attempts with higher protein concentrations and different 
procedures to form the microtubules did not lead to a decoration of the microtubules, 
either, suggesting that the binding affinity of the Astrin482-850/SKAP159-316 complex for 
microtubules is too low to achieve binding under conditions suitable for EM analysis. 
 
 
 
Figure 3.46: Negative stain EM images of microtubules in absence and presence of 
Astrin482-850/SKAP159-316. GMPCPP-stabilized microtubule seeds were incubated either in presence of 
Astrin482-850/SKAP159-316 (A) or alone (B) for 5 min at 37 °C on the grid. Scale bars: 100 nm. 
A 
B 
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3.5.2 Towards the crystal structure of SKAP 
In order to gain insight into the atomic structure of SKAP, attempts were made to 
solve the structure of truncated SKAP constructs by means of X-ray crystallography. 
For this purpose, different SKAP constructs were crystallized via the vapor diffusion 
method with the sitting- and hanging-drop implementation.  
For the microtubule-binding domain SKAP135-225, one successful crystallization 
condition was identified. The obtained crystals, which are presented in figure 3.47, 
were rod-like and very tiny, with a maximal size of 30 µm, but they showed a clearly 
defined structure with sharp edges. The diffraction pattern of one of these crystals in 
figure 3.48 revealed a very anisotropic diffraction, which is typical for highly 
elongated structures such as coiled-coil proteins.  
 
 
Figure 3.47: Crystals of SKAP135-225. Crystals were grown at 20 °C via the sitting drop vapor diffusion 
method with reservoir solution containing 0.1 M Hepes, pH 7.0 and 30 % (w/v) PEG 6000. 
 
 
Figure 3.48: Diffraction image of a crystal of SKAP135-225. Diffraction image was collected on 
beamline PXII of the Swiss Light Source (Paul Scherrer Institute, Villigen, CH). 
100 µm 
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In addition to the wild type form of SKAP135-225, a seleno-methionine labeled version 
of this SKAP construct was crystallized for the purpose of obtaining phase 
information for computing initial electron density maps. As it can be seen in figure 
3.49, these crystals show a rod-like form with a size of up to 40 µm comparable to 
the wild type SKAP135-225 crystals. Furthermore, the introduction of heavy atoms for 
solving the phase problem was achieved by soaking native SKAP135-225 crystals with 
different heavy atom derivatives including K2PtCl4 or Pb(CH3COO)2. 
 
 
Figure 3.49: Crystals of seleno-methionine labeled SKAP135-225. Crystals of seleno-methionine 
labeled SKAP135-225 were grown at 20 °C via the hanging drop vapor diffusion method with reservoir 
solution containing 0.1 M Hepes, pH 7.5 and 20 % (w/v) PEG 6000. 
 
Collection of X-ray diffraction data from these crystals resulted in five data sets of 
native SKAP135-225 crystals, one data set of a seleno-methionine labeled SKAP135-225 
crystal and six data sets of SKAP135-225 crystals soaked with different heavy atom 
derivatives. The statistics of the data sets for the native crystal with the best 
resolution of about 2.9 Å and the seleno-methionine labeled crystal with a resolution 
of 3.6 Å are summarized in tables 3.10. The statistics of two data sets with platinum 
and lead soaks that showed an anomalous signal below 4 Å and resolutions of 3.7 Å 
and 3.0 Å, respectively, are presented in table 3.11. Processing of all these data sets 
was compatible with a tetragonal space group - either P41 2 2 or P43 2 2 - and cell 
dimensions with two short axes of 37 Å and one long axis of 201-203 Å, revealing a 
very elongated unit cell. These cell constants are in agreement with the anisotropic 
diffraction and the predicted coiled-coil structure of SKAP135-225. The data set of the 
seleno-methionine labeled crystal showed no significant anomalous signal, indicating 
that the seleno-methionine was probably located in a flexible loop. Attempts were 
made to solve the structure of SKAP135-225 by isomorphous replacement with the 
200 µm 
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Phenix AutoSol, but no model could be build, probably due to problems with high 
anisotropic diffraction and insufficient resolution.  
 
Table 3.10: Statistics of data collection of a wild type and a seleno-methionine (SeMet) labeled 
SKAP135-225 crystal. Values in parenthesis correspond to the highest resolution shell. All data sets were 
collected from one single crystal on beamline PXII of the Swiss Light Source (Paul Scherrer Institute, 
Villigen, CH). 
 SKAP135-225 SeMet-SKAP135-225 
Space group P41 2 2 or P43 2 2 P41 2 2 or P43 2 2 
Cell dimensions   
    a, b, c (Å) 37.24, 37.24, 203.25 37.15, 37.15, 201.37 
    α, β, γ (°) 90, 90, 90 90, 90, 90 
Wavelength (Å) 1.00719 0.98013 
Resolution (Å) 50.0 – 2.9 (3.0 – 2.9) 50.0 – 3.6 (3.7 – 3.6) 
Rmrgd-F 8.7 (170.4) 14.4 (245.6) 
I/σ(I) 11.2 (2.0) 14.4 (2.0) 
Completeness (%) 99.8 (100.0) 99.9 (100.0) 
Redundancy 11.4 (11.8) 26.8 (28.9) 
 
Table 3.11: Statistics of data collection of SKAP135-225 crystals soaked with K2PtCl4 or 
Pb(CH3COO)2. Values in parenthesis correspond to the highest resolution shell. All data sets were 
collected from one single crystal on beamline PXII of the Swiss Light Source (Paul Scherrer Institute, 
Villigen, CH). 
 SKAP135-225-Pt soak SKAP135-225-Pb soak 
Space group P41 2 2 or P43 2 2 P41 2 2 or P43 2 2 
Cell dimensions   
    a, b, c (Å) 37.43, 37.43, 201.91 37.31, 37.31, 201.97 
    α, β, γ (°) 90, 90, 90 90, 90, 90 
Wavelength (Å) 1.07183 0.95107 
Resolution (Å) 50.0 – 3.7 (3.8 – 3.7) 50.0 – 3.0 (3.1 – 3.0) 
Rmrgd-F 14.9 (321.6) 13.9 (293.4) 
I/σ(I) 16.1 (2.3) 17.3 (2.5) 
Completeness (%) 99.9 (100.0) 99.9 (100.0) 
Redundancy 26.5 (27.7) 26.7 (28.7) 
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In order to solve the structure of SKAP via molecular replacement, a mCherry-
SKAP135-225 fusion protein was crystallized. As shown in figure 3.50, the obtained rod-
like crystals had a long axis of 50-300 µm and possessed sharp edges.  
 
 
    
Figure 3.50: Crystals of mCherry-SKAP135-225. Crystals of mCherry-SKAP135-225 were grown at 20 °C 
via the sitting drop (top) and the hanging drop (bottom) vapor diffusion method with reservoir solutions 
containing 0.2 M KH2PO4, 20 % (w/v) PEG 3350. 
 
Strikingly, the data collection of these crystals resulted in the same space group and 
cell parameters that were obtained for the wild type SKAP135-225 crystals. This 
suggests the possibility that the mCherry-SKAP135-225 fusion protein is cleaved during 
the crystallization process. Therefore, a SDS-PAGE analysis of a crystallization drop 
containing mCherry-SKAP135-225 was performed. Figure 3.51 reveals that the fusion 
protein was indeed cleaved into mCherry and SKAP135-225, so that no data set of the 
fusion protein could be obtained. 
 
 
Figure 3.51: mCherry-SKAP135-225 is cleaved during crystallization. SDS-PAGE gel of a 
crystallization drop containing mCherry-SKAP135-225 crystals.  
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Since no higher resolution of the SKAP135-225 crystals could be achieved with crystal 
optimization, the sextuple mutant SKAP135-225 K140/149/161/164/168/170A was also 
crystallized. The mutations of lysine to alanine might facilitate the crystallization 
process, because lysines are known to be highly flexible and thereby might disturb 
crystal packing. SKAP135-225 K140/149/161/164/168/170A indeed crystallized in six 
crystallization conditions instead of just one condition for the wild type protein. 
Crystals from two different conditions are shown in figure 3.52. With a size up to 
200 µm these crystals grew much larger than the wild type crystals and they also 
showed clear defined structures with sharp edges. Different crystal forms including 
very thin needles and thicker rods could be obtained. However, these crystals only 
diffracted up to a resolution of about 5-6 Å.  
 
  
Figure 3.52: Crystals of SKAP135-225 K140/149/161/164/168/170A. Crystals of SKAP135-225 
K140/149/161/164/168/170A were grown at 20 °C via the hanging drop vapor diffusion method with 
reservoir solutions containing 0.1 M MES, pH 6.0 and 20 % (w/v) PEG 6000 (left) or 0.04 M KH2PO4, 
16 % (w/v) PEG 8000 and 20 % (v/v) glycerol (right).  
 
In addition to SKAP135-225 only the central coiled-coil domain ranging from amino acid 
159 to 225 was crystallized. After first crystallization trials that led to crystals in huge 
clusters (see figure 3.53 left), the SKAP159-225 crystals could be optimized to 
individually growing crystals with sharp edges and a size up to 200 µm (see 
figure 3.53 right). Two data sets were collected for these crystals and the statistics of 
the data set with the best resolution of 3.6 Å are summarized in table 3.12. The 
space group - P41 2 2 or P43 2 2 - is the same as for SKAP135-225 and the cell 
dimensions containing two short axes of 54 Å and one long axis of 199 Å are similar 
to those of SKAP135-225, indicating a very elongated structure.  
 
200 µm 200 µm 
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Figure 3.53: Crystals of SKAP159-225. Crystals of SKAP159-225 were grown at 20 °C via the hanging drop 
vapor diffusion method with reservoir solutions containing 0.15 M MgSO4 and 15 % (w/v) PEG 3350 
(left) or 0.2 M MgSO4 and 20 % (w/v) PEG 3350 (right). 
 
Table 3.12: Statistic of data collection of a SKAP159-225 crystal. Values in parenthesis correspond to 
the highest resolution shell. The data set was collected from one single crystal on beamline PXII of the 
Swiss Light Source (Paul Scherrer Institute, Villigen, CH). 
 SKAP159-225 
Space group P41 2 2 or P43 2 2 
Cell dimensions  
    a, b, c (Å) 53.55, 53.55, 199.40 
    α, β, γ (°) 90, 90, 90 
Wavelength (Å) 0.92045 
Resolution (Å) 50.0 – 3.59 (3.68 – 3.59) 
Rmrgd-F 7.0 (146.6) 
I/σ(I) 21.5 (3.0) 
Completeness (%) 99.0 (99.2) 
Redundancy 23.0 (21.2) 
 
In order to get insight into the binding mode of SKAP to microtubules on the atomic 
level and as alternative way to solve the SKAP structure via molecular replacement, 
crystallization experiments with the SKAP135-225/tubulin/RB3 complex were 
performed. During the crystallization of this complex, one successful crystallization 
condition could be identified, in which the SKAP135-225/tubulin/RB3 complex 
crystallized as very thin and clustered needles (see figure 3.54 left). The crushed 
needle clusters were used for microseeding experiments that resulted in small box-
like crystals with a size of about 20 µm (see figure 3.54 right). The diffraction analysis 
of these crystals showed no diffraction.  
 
100 µm 200 µm 
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Figure 3.54: Crystals of the SKAP135-225/tubulin/RB3 complex. Crystals of the 
SKAP135-225/tubulin/RB3 complex were grown at 20 °C via the hanging drop vapor diffusion method with 
reservoir solutions containing 0.1 M MES, pH 6.0 and 30 % (w/v) PEG 200. The crystal on the right was 
obtained by microseeding with crushed clustered needle-like crystals as shown on the left.  
 
In summary, the structure of SKAP could not be solved by means of X-ray 
crystallography, but several successful attempts to crystallize different SKAP 
constructs as well as the microtubule-binding domain of SKAP in complex with 
tubulin and the RB3 protein were made.  
seeding 
200 µm 
200 µm 
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4 DISCUSSION 
4.1 Domain organization of the Astrin/SKAP complex 
Studies on the intersubunit interaction of the Astrin/SKAP complex (see sections 
3.2.4 and 3.3.1.) showed that the domains encompassing amino acids 482 to 850 in 
Astrin and 159 to 316 in SKAP constitute the minimal interaction domains that are 
necessary to form a tight complex. This is in agreement with a previous analysis in 
which constructs with similar boundaries were expressed in mammalian cells and 
analyzed by immunoprecipitation (Dunsch et al., 2011). 
Analyses on the oligomeric state of SKAP by AUC and cross-linking experiments 
revealed that SKAP135-225 behaves as a trimer (see section 3.2.3, figure 3.11). 
Previously reported rotary shadowing EM analysis of full-length Astrin, refolded from 
bacterial inclusion bodies, showed a two-fold symmetry of Astrin indicating dimer 
formation (Gruber et al., 2002). Taken together with the observation that SKAP may 
form trimeric assemblies, the overall stoichiometry of the Astrin/SKAP complex may 
be expected to be 2:6. However, label-free mass spectrometric analysis of Astrin and 
SKAP immunoprecipitates from mitotic mammalian cells predicts a 1:2 stoichiometry 
of the Astrin/SKAP complex (Dunsch et al., 2011). Attempts to verify the oligomeric 
state of the Astrin482-850/SKAP159-316 complex in analytical ultracentrifugation 
sedimentation velocity experiments were hampered by the limited solubility of the 
complex. Furthermore, the N-terminal domain of Astrin seems to exist in different 
oligomeric states (see section 3.2.2, figure 3.7), which is in agreement with the 
findings by Gruber et al., 2002, according to which Astrin is able to oligomerize with 
its N-terminal domain. This suggests that the Astrin/SKAP complex with its potential 
2:6 stoichiometry may in addition show higher-order oligomerization via the N-
terminal domain of Astrin.  
More extensive in vitro analyses of the Astrin/SKAP complex will require the 
production of more stable versions of the complex as well as stable soluble larger 
segments of the two proteins, which could not be achieved in this study because of 
the poor solubility of most Astrin constructs. Attempts to obtain full-length Astrin 
through the previously described refolding approach (Gruber et al., 2002) were 
unsuccessful. Future expression and purification trials may include a modification of 
the reported refolding approach, testing of new boundaries for truncation constructs 
as well as protein purification from human cell extracts.  
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Besides the identification of the intersubunit interaction domains, the microtubule-
binding region of the Astrin/SKAP complex was mapped within SKAP to the region 
comprising amino acids 135 to 225 (see section 3.3.1 and 3.3.2). An updated domain 
organization of the Astrin/SKAP complex showing these functional domains in 
addition to its structural domains is presented in figure 4.1. Furthermore, the SXIP 
motif of SKAP, required for its interaction with EB proteins, and its adjacent Aurora B 
targeting site (Tamura et al., 2015; Wang et al., 2012), which are discussed in 
sections 4.2 and 4.3, are indicated.  
 
 
Figure 4.1: Domain organization of the Astrin/SKAP complex. In addition to the structural domain 
organization of the Astrin and SKAP subunits based on a bioinformatic characterization, functional 
domains identified in section 4 are indicated. The SXIP motif of SKAP (sequence in red) and its adjacent 
Aurora B consensus site (sequence in black) are indicated as well. 
 
4.2 Interaction of the Astrin/SKAP complex with tubulin 
It was proposed that the N-terminal region of SKAP, which contains the SXIP motif, 
mainly determines the localization of SKAP to the mitotic spindle (Tamura et al., 
2015; Wang et al., 2012). However, a SKAP construct comprising amino acids 159 to 
317, which lacks the SXIP motif and is supposed to be the minimal microtubule 
binding domain of SKAP, mediates SKAP localization to the mitotic spindle, whereas 
a construct encompassing amino acids 1 to 158 fails to localize to the spindle 
(Dunsch et al., 2011). These observations suggest that, besides binding 
microtubules via EB proteins, SKAP probably also contains a region for direct 
targeting to microtubules. There are other examples of proteins that combine a SXIP 
motif with a functional microtubule-binding domain, such as the mitotic centromere-
associated kinesin (MCAK) (Akhmanova & Steinmetz, 2010). Indeed, in this study 
the microtubule-binding domain of SKAP was mapped to the region ranging from 
amino acid 135 to 225 (see section 3.3.2), which does not contain the SXIP motif. 
Since the residues 226 to 316 of SKAP are neither sufficient nor necessary for its 
microtubule binding (see section 3.3.1, figure 3.14, section 3.3.2, figure 3.17, and 
section 3.3.3, figure 3.18), the microtubule-binding domain of SKAP does not extend 
1
1 481 903 965 1175
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to the very C-terminus as previously reported (Dunsch et al., 2011), but only to the 
end of its first predicted coiled-coil domain at amino acid 225. Conversely, extension 
towards the N-terminus up to amino acid 135 showed the highest binding affinity for 
microtubules with an apparent dissociation constant of around 0.58 µM (see section 
3.3.3, figure 3.18). Thus, the microtubule-binding domain of SKAP extends 
N-terminally beyond the previously tested boundary at amino acid 157 (Dunsch et al., 
2011). 
In addition to SKAP, Astrin was also found to bind microtubules in vitro with its 
C-terminal region encompassing amino acids 955 to 1193 in previous studies 
(Schmidt et al., 2010). However, in this study, a very similar construct of Astrin 
ranging from amino acid 966 to 1175 showed no microtubule binding (see section 
3.3.1, figure 3.15). This result is in agreement with the observation that the 
C-terminal segment of Astrin lacks spindle localization (Dunsch et al., 2011) and with 
the retained spindle localization of an Astrin construct that lacks this region (Mack & 
Compton, 2001). Since the N-terminal region of Astrin did not show microtubule 
binding either (see section 3.3.1, figure 3.15), and SKAP159-316 exhibited an 
essentially identical affinity for microtubules in absence and presence of Astrin482-850 
(see section 3.3.1, figure 3.17), Astrin probably does not contribute to the 
microtubule binding of the Astrin/SKAP complex. 
The binding sites of SKAP135-225 on microtubules were mapped in crosslinking 
analyses to both the inter- and intra-tubulin dimer interface, which was confirmed by 
significantly decreased microtubule binding of SKAP to subtilisin-treated 
microtubules lacking the E-hooks of tubulin (see section 3.3.3). Interestingly, this is 
also the binding site of the major microtubule binder within the kinetochore, the 
Ndc80 complex (Alushin et al., 2010; Ciferri et al., 2008), suggesting a possible 
competitive behavior of SKAP and the Ndc80 complex upon microtubule binding. 
Indeed, in competition experiments SKAP was able to displace the Ndc80 complex 
from microtubules (see section 3.3.4). However, this apparent competition may not 
be physiologically relevant, since the kinetochore-microtubule interface provides 
enough space for both proteins to bind concomitantly. Thus, the significance of this 
observation is limited to demonstrating that SKAP and the Ndc80 complex bind to at 
least partly overlapping binding sites on microtubules. The observation that SKAP 
was not able to displace the Ndc80 complex completely in fluorescence microtubule 
flow cell experiments, while it did so at the very high concentrations used in the 
microtubule cosedimentation assay, suggests that SKAP may bind to the intra- and 
inter-tubulin interface with different affinities. SKAP binding to one interface of tubulin 
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might occur with higher affinity, so that SKAP is able to displace the Ndc80 complex 
from this interaction site, whereas its binding to the other interface may be much 
weaker and have less effect on Ndc80 binding, so that the competition at this site 
only gets detectable upon very high SKAP concentrations. Such a binding mode with 
two distinct binding sites of different affinity would facilitate a fine-tuning in the 
establishment of kinetochore-microtubule attachments, which may additionally be 
regulated by other factors or binding partners. The weaker binding to one interface 
might also be artificially created by the presence of the N-terminal mCherry-tag. In 
microtubule cosedimentation assays, the apparent dissociation constant of mCherry-
SKAP135-225 was basically identical to the one of untagged SKAP135-225 (~0.8 µM for 
mCherry-SKAP135-225 compared to ~0.6 µM for untagged SKAP135-225), but the 
maximal bound fraction was reduced from ~1.0 to ~0.7, indicating that the tag may 
have some effect on microtubule binding. To test the influence of the mCherry-tag, 
SKAP135-225 can be terminally labeled with a small dye via the sortase labeling 
approach instead of a large fusion protein, so that a possible steric hindrance can be 
excluded. 
It was shown by mutational analyses in vitro and in vivo that microtubule binding of 
SKAP135-225 requires several conserved positively charged residues including K140, 
K149, K161, K164, K168 and K170 (see section 3.3.5). Since a construct comprising 
amino acids 135 to 174, which contains all identified residues, as well as another 
construct ranging from amino acid 175 to 225 were not able to retain microtubule 
binding of SKAP (see section 3.3.5, figure 3.28), SKAP may possess a multipartite 
mode of microtubule binding, in which several residues are involved in addition to the 
identified ones. Such a multipartite binding mode may suggest the existence of 
several binding site on microtubules that SKAP binds to with different affinities as 
discussed above.  
Depletion of SKAP by RNA interference revealed several spindle and chromosome 
alignment defects including a significant increase in the occurrence of multipolar 
spindles, the presence of pseudo-metaphase states with multiple misaligned 
chromosomes and a concomitant increase of the mitotic index indicating SAC 
activation (see section 3.3.5, figure 3.31, table 3.8). These experiments confirm the 
previously described phenotypes observed upon SKAP depletion (Gruber et al., 
2002; Thein et al., 2007; Fang et al., 2009; Schmidt et al., 2010; Manning et al., 
2010; Dunsch et al., 2011). In this study, it was shown that the ability of SKAP to 
exert its function in spindle organization and mitotic progression corresponds with the 
number of inserted mutations and thus with its ability to bind to microtubules. Thus, 
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this work demonstrates that SKAP contains a bona fide microtubule-binding domain, 
whose functional inactivation prevents rescuing the significant defects in spindle 
formation, chromosome congression and mitotic progression that are caused by 
depletion of SKAP.  
It was demonstrated that SKAP is not only able to bind to microtubules, but also to 
tubulin in solution (see section 3.3.6, figures 3.32 and 3.33). Different assays pointed 
to the ability of SKAP135-225 to promote tubulin polymerization by facilitating the 
nucleation and increasing the growth rates of microtubules, while the introduction of 
mutations, and thereby the reduction of its microtubule binding affinity, severely 
impairs these effects (see section 3.3.6, figures 3.34 and 3.35). The influence of 
SKAP on microtubule nucleation is a possible reason for its localization to 
centrosomes in early mitosis (Mack & Compton, 2001; Thein et al., 2007). SKAP may 
be part of the pericentriolar material that contains a network of proteins surrounding 
the centrosomes, including microtubule nucleation factors, such as the γ-tubulin ring 
complex (Moritz et al., 1995; Morgan, 2007). Here, it may assist in the nucleation of 
microtubules in prophase and prometaphase and subsequently facilitate the growth 
of the emerging microtubules by incorporating new α-/β-tubulin dimers in the 
microtubule lattice in a non-catalytic manner, which depends on the direct interaction 
of SKAP with the tubulin dimer. 
Furthermore, it was shown that SKAP135-225 assembles tubulin to cold stable 
microtubule bundles (see section 3.3.6, figures 3.36 to 3.38), which may be due to 
the multipartite binding mode of SKAP and its ability to form trimers. The microtubule 
stabilizing and bundling effect of SKAP may explain the importance of the 
Astrin/SKAP complex for spindle organization and its localization to the spindle 
midzone in anaphase and telophase (Mack & Compton, 2001), where it may assist in 
organizing the bipolar spindle by bundling interpolar microtubules. The key 
microtubule crosslinking proteins in mitosis are the motor proteins kinesin-5 and 
kinesin-14 that link interpolar, antiparallel microtubules (Peterman & Scholey, 2009; 
Morgan, 2007). Kinesin-5 slides the microtubules outwards apart from each other, 
thereby opposing the function of kinesin-14 that pulls the microtubules together. Also 
non-motor proteins have been identified to associate with the spindle midzone. After 
chromosome segregation, members of the Ase1p family of microtubule-associated 
proteins assist in organization of the spindle midzone and in spindle elongation in 
anaphase B (Schuyler et al., 2003; Peterman & Scholey, 2009). Like SKAP, these 
Ase1p proteins possess a microtubule-binding domain and coiled-coil domains, show 
oligomerization and are able to bundle microtubules. Thus, SKAP may participate in 
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the protein network at the spindle midzone that ensures maintenance of the spindle 
bipolarity and spindle elongation during anaphase. To test this hypothesis, live cell 
imaging of SKAP-depleted cells expressing GFP-SKAP wild type or mutants 
impaired in microtubule binding may be used to see whether these cells show a 
similar spindle collapse in anaphase as Ase1p-depleted cells (Schuyler et al., 2003). 
Also, in GFP-SKAP expressing cells, the localization of SKAP to the spindle midzone 
can be analyzed in more detail, and it can be tested in FRAP or photoactivation 
experiments whether SKAP shows similar diffusion properties along microtubules as 
Ase1p, with slower diffusion between crosslinked microtubules and faster diffusion 
on single microtubules (Schuyler et al., 2003). More detailed EM analysis on the 
microtubule bundles that form in the presence of SKAP may elucidate whether SKAP 
preferentially bundles parallel or antiparallel microtubules. In addition, cryo EM 
studies of SKAP and microtubules, as described in the optimized approach for 
studying the interaction of EB proteins with microtubules (Zhang et al., 2015), may be 
used to analyze how SKAP modulates the microtubule structure to achieve a 
stabilizing effect apart from microtubule bundling. The previously reported results that 
the stability of the microtubule lattice seems to be mainly regulated at the longitudinal 
inter-tubulin dimer interface (Alushin et al., 2014; Zhang et al., 2015) are in 
agreement with targeting of this interface by SKAP. SKAP may reverse the 
microtubule lattice compaction, which takes place upon GTP hydrolysis, and thereby 
release the destabilizing strain, similar to the effect observed for taxol. Alternatively, 
SKAP may stabilize microtubules in their compacted form by balancing the 
destabilizing tension through its binding. SKAP may even promote the microtubule 
lattice compaction, as observed in presence of EB proteins, and thereby induce fast 
GTP hydrolysis.  
The identified microtubule-binding domain of SKAP presumably cooperates with the 
SXIP motif that targets the Astrin/SKAP complex to growing microtubule plus ends 
(Dunsch et al., 2011; Wang et al., 2012, Tamura et al., 2015). A possible functional 
significance of the combination of these binding motifs is that a specific function of 
the microtubule-binding domain is delivered specifically or preferentially to the plus 
ends of microtubules. The microtubule-binding domain of SKAP stabilizes 
microtubules and favors their growth in vitro (see section 3.3.6) and it is possible that 
this is the crucial activity of the Astrin/SKAP complex that needs to be delivered to 
plus ends of microtubules and to kinetochores. The hypothesis that the microtubule-
binding domain of SKAP cooperates with the SXIP motif could be tested in tip 
tracking experiments with GFP-SKAP wild type and mutants as well as by 
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comparison of the microtubule localization of these constructs combined with a SXIP 
mutant that lacks EB interaction. These experiments are currently in progress. 
Taken together, this work shows that SKAP bundles microtubules in vitro and points 
towards the ability of SKAP to nucleate the polymerization of microtubules and to 
favor microtubule growth. Thus, SKAP may be a microtubule-stabilizing factor with 
effects on nucleation and growth of microtubules explaining its functions in spindle 
organization and stabilization of kinetochore-microtubule attachments. The exact 
molecular mechanisms underlying the effects of SKAP on microtubules, which may 
include a conformational change within the microtubule lattice upon SKAP binding, 
will need to be clarified. 
 
4.3 Kinetochore recruitment of the Astrin/SKAP complex 
The conversion from the initial lateral attachments to the final end-on attachments 
requires a highly dynamic kinetochore-microtubule interface. Several proteins that 
are initially present at kinetochores before the establishment of kinetochore-
microtubule attachments are released from kinetochores upon initial microtubule 
attachment, including the RZZ complex and its associated proteins Spindly and 
dynein/dynactin (Karess, 2005), or during conversion from lateral to end-on 
attachment, such as the microtubule depolymerases MCAK and Kif2b (Manning et 
al., 2010). Other proteins, like the Astrin/SKAP complex and the Ska complex, are 
only recruited to attached kinetochores and seem to play a role in the final 
stabilization of end-on attachment before anaphase onset (Thein et al., 2007; Fang 
et al., 2009; Schmidt et al., 2010; Dunsch et al., 2011; Hanisch et al., 2006). 
Aurora B was found to regulate this localization pattern, because it contributes to the 
recruitment of early kinetochore components and prevents the recruitment of late 
kinetochore components until it is spatially separated from its substrates, probably 
due to an increased intra-kinetochore tension upon establishment of biorientation 
(Liu et al., 2009). This is in agreement with the well-established function of Aurora B 
in the correction of erroneous kinetochore-microtubule attachments and in the 
establishment of chromosome biorientation (Carmena et al. 2012).  
The NetPhos 2.0 server (Blom et al., 1999) predicts 14 potential phosphorylation 
sites on SKAP (9 serine and 5 threonine sites), including two Aurora B consensus 
sites with the motif (R/K)-X-(S/T) at threonines 16 and 108. For Astrin, 
68 phosphorylation sites (53 serine and 15 threonine sites) are predicted, including 
11 potential Aurora B consensus sites. These possible Aurora B targeting sites of 
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Astrin and SKAP are listed in table 4.1. Since they only amount to a small fraction of 
all potential phosphorylation sites, it may be that the localization pattern of the 
Astrin/SKAP complex is not only regulated by Aurora B, but also by other kinases, 
such as glycogen synthase kinase 3β (Cheng et al., 2008) and Aurora A (Chiu et al., 
2014). Since the Aurora B consensus sites mainly lie outside the minimal kinetochore 
localization domains of Astrin and SKAP, Aurora B probably also regulates other 
functions of the Astrin/SKAP complex, such as fine-tuning of its microtubule-binding 
affinities or the binding to other interaction partners. In vitro kinase assays, in case of 
successful production of longer Astrin and SKAP constructs, or mass spectrometric 
analysis of the proteins purified from human cell extracts using appropriate 
antibodies may point to the sites that are indeed physiologically relevant.  
 
Table 4.1: Potential Aurora B phosphorylation sites of SKAP and Astrin. Phosphorylation sites 
were predicted by the NetPhos 2.0 server (Blom et al., 1999). Potentially phosphorylated residues are 
indicated in bold type.  
protein site sequence score 
SKAP 
Thr16 VFRTTWLST 0.828 
Thr108 QTRATSKSL 0.965 
Astrin 
Ser8 VKKLSLSLS 0.948 
Ser21 TGKPSMRTP 0.698 
Ser43 SGKRSPACS 0.933 
Ser115 TPKTSEEAV 0.991 
Ser183 GDRFSEVAA 0.981 
Ser289 HPKESETED 0.994 
Ser362 NLRQSLSLP 0.840 
Ser411 GTKHSTSET 0.995 
Ser490 HLKESHEMG 0.924 
Ser597 SQRISQLEQ 0.996 
Ser1154 NLRRSDKEL 0.998 
 
The kinetochore localization of the Astrin/SKAP complex was suggested not only to 
depend on Aurora B activity, but also on the presence of microtubules, since in cells 
that were treated with the microtubule-depolymerizing drug nocodazole as well as 
the Aurora B inhibitor ZM447493, SKAP was not detected at kinetochores (Schmidt 
et al., 2010). Confirming the dependency of the kinetochore localization of SKAP on 
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Aurora B, it was shown in this study that in cells treated with the proteasome inhibitor 
MG132 as well as the Aurora B inhibitor Hesperadin, SKAP exhibited a small but 
significant increase in kinetochore localization and also localized to unattached 
kinetochores (see section 3.4.1, figure 3.39). This observation indicates that 
Aurora B indeed counteracts the kinetochore localization of SKAP. In agreement with 
previously described results (Schmidt et al., 2010), SKAP localization at kinetochores 
was lost in the presence of the microtubule-depolymerizing drug nocodazole. On the 
other hand, contradicting former observations (Schmidt et al., 2010), when cells were 
treated with both nocodazole and Hesperadin, the localization of SKAP could be 
restored to about 50 %, suggesting that SKAP is also able to localize to kinetochores 
in the absence of microtubules. Thus, not only the attachment to microtubules brings 
SKAP to kinetochores, but there has to be an additional kinetochore receptor for 
SKAP.  
The KMN network was suggested to be required for the kinetochore localization of 
SKAP, since depletion of subunits of the Ndc80 complex or the Mis12 complex 
significantly decreases SKAP levels at the kinetochore (Wang et al., 2012). In yeast 
two-hybrid experiments, immunoprecipitations and GST pull-downs, a direct 
interaction of SKAP with the Dsn1 and the Nsl1 subunits of the Mis12 complex was 
found (Wang et al., 2012). However, this reported interaction could not be verified in 
this study, since SKAP and the Mis12 complex did not show binding in GST pull-
downs or size exclusion chromatography experiments (see section 3.4.2, figures 
3.40 to 3.42). The MST experiments with SKAP159-316, the Mis12 complex and the 
Ndc80 complex indicated interactions between SKAP and both complexes with 
similar dissociation constants in the nM range (see section 3.4.2, figure 3.44). Since 
these binding affinities are typical of very tight interactions, it would have been 
expected to observe binding of SKAP to the Mis12 and the Ndc80 complexes also in 
other binding assays, which instead was not the case. Therefore, we suspect that the 
MST experiments may not show real interactions, but only effects on changes in the 
hydration of the fluorescent probes that are probably not a direct cause of binding 
events, but of an altered surrounding upon addition of the unlabeled molecules. A 
similar discrepancy was observed during studies of the interaction between the 
Ndc80 complex and the Mis12 complex. This interaction was previously shown to be 
very tight with a dissociation constant of about 10 nM (Petrovic et al., 2010), but MST 
failed to detect it (see supplementary figure 6.17). Therefore, these observations 
suggest a cautious interpretation of binding data obtained from a single approach. 
Furthermore, GST pull-down, size exclusion chromatography and MST experiments 
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with SKAP159-316 and Zwint suggested an interaction of SKAP and Zwint both on solid 
and phase in solution (see section 3.4.2, figures 3.40, 3.43 and 3.44). Since the 
observed interaction of SKAP and Zwint appeared to be weaker in the presence of 
the Zwint-interacting partner Knl1, the detected binding was probably due to an 
artificial coiled-coil interaction.  
To identify other possible binding partners of the Astrin/SKAP complex, the complex 
and bound interacting partners can be enriched from human cell extracts, by using 
pull-down experiments with appropriate antibodies, and subsequently analyzed by 
mass spectrometry. Subsequent in vitro analysis of the interactions between the 
Astrin/SKAP complex and the detected proteins can be used to validate the identified 
hits. 
 
Taken together, it was shown that the kinetochore localization of the Astrin/SKAP 
complex depends only marginally on the presence of microtubules as previously 
reported. No defined kinetochore receptor could be identified, suggesting that the 
recruitment of the Astrin/SKAP complex to kinetochores may rely on several weak 
interactions that are difficult to detect by in vitro studies. Therefore, fully reconstituted 
kinetochores may be necessary to further analyze the kinetochore recruitment of the 
Astrin/SKAP complex. 
 
4.4 Structural characterization of the Astrin/SKAP 
complex 
To gain an even deeper understanding of the function of the Astrin/SKAP complex 
and its underlying molecular mechanisms, it would be useful to obtain structural 
information of the Astrin/SKAP complex. First efforts into this direction are described 
in section 3.5 and are currently being continued.  
It was shown by negative stain EM that the Astrin482-850/SKAP159-316 complex exhibits 
a highly elongated structure with a length of about 40-50 nm (see section 3.5.1). This 
is consistent with the previously reported rotary shadowing EM analysis of full-length 
Astrin refolded from bacterial inclusion bodies revealing an 80 nm ‘lollipop’ structure 
with a 35 nm central coiled-coil domain (Gruber et al., 2002). The presence of ring-
like structures may suggest that the Astrin482-850/SKAP159-316 complex is able to form 
higher order structures, which is in agreement with previously reported 
oligomerization of Astrin (Gruber et al., 2002). As SKAP was shown to bundle 
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microtubules, or other components of the kinetochore, the ability of the Astrin/SKAP 
complex to oligomerize may contribute to its function in crosslinking microtubules. 
The high flexibility of the Astrin482-850/SKAP159-316 complex hampered further single 
particle analysis. Attempts to reduce its flexibility by binding the complex to 
microtubules were not successful because decoration of microtubules was 
unsuccessful. This was probably due to the low affinity of the Astrin482-850/SKAP159-316 
complex for microtubules, which being in the low µM range may be too weak to 
achieve microtubule binding under conditions suitable for EM analysis. A crosslinking 
approach, in which the Astrin/SKAP complex is bound to microtubules at higher 
protein concentrations and subsequently crosslinked, may help to obtain decorated 
microtubules and to reveal the binding mode of the Astrin/SKAP complex. However, 
obtained results have to be critically evaluated because of potential artifacts due to 
the crosslinking reagent. 
In order to get insight into the atomic structure of SKAP, attempts were made to 
solve the structure of truncated SKAP constructs by means of X-ray crystallography. 
Different SKAP constructs, including SKAP135-225 wild type and a seleno-methionine 
version, the sextuple mutant SKAP135-225 K140/149/161/164/168/170A as well as 
SKAP159-225, were successfully crystallized by the vapor diffusion method with sitting 
and hanging drops (section 3.5.2). The subsequent diffraction analysis resulted in 
several data sets with a resolution up to 2.9 Å revealing a tetragonal space group - 
either P41 2 2 or P43 2 2 - of the crystals, with two short axes and one long axis. 
Such a highly elongated unit cell is consistent with the predicted coiled-coil structure 
of SKAP. However, attempts to solve the structure by isomorphous replacement 
were hampered by problems with high anisotropic diffraction and insufficient 
resolution and phasing power of the derivative data. Efforts to solve the structure of 
SKAP135-225 by molecular replacement failed because of protein degradation of a 
mCherry-SKAP135-225 fusion protein during the crystallization process and insufficient 
quality of the crystals obtained for the SKAP135-225/tubulin/RB3 complex. In order to 
solve the crystal structure of SKAP, several efforts are currently in progress to further 
optimize the obtained crystals. A diffraction test at room temperature can show 
whether the obtained crystals reveal a better diffraction before cryo-cooling. If this is 
the case, the conditions for cryo-cooling can be further improved by testing other 
cryoprotectants. Furthermore, since SKAP and EB1 are supposed to interact directly 
(Wang et al., 2012; Tamura et al., 2015), it can be tested whether a SKAP construct 
containing the SXIP motif, such as the soluble SKAP103-225, forms a tight complex 
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with EB1 that can be purified. Crystals of such an SKAP/EB1 complex could be later 
used to solve the structure of SKAP by molecular replacement.  
 
Taken together, no atomic structure of SKAP or the Astrin/SKAP complex could be 
obtained, but a promising step towards the crystal structure of SKAP could be 
achieved by successful crystallization of different SKAP constructs. Further attempts 
to optimize the diffraction properties of the obtained crystals are currently in 
progress.  
 
4.5 Physiological functions of the Astrin/SKAP complex in 
mitosis 
Considering together all results, including those reported previously and those in this 
study, the diverse physiological functions of the Astrin/SKAP complex in mitosis may 
be summarized as follows: 
Prior to mitosis, the Astrin/SKAP complex is recruited to centrosomes, through a 
possible interaction with Ninein during the S and G2 phases (Cheng et al., 2007), 
and may act as part of the pericentriolar material to assist in maintaining centrosome 
integrity. In early mitosis, the Astrin/SKAP complex may facilitate the nucleation of 
microtubules together with other nucleating factors, such as the γ-tubulin ring 
complex. By subsequent dissociation from Ninein and following binding to the 
emerging microtubules, the Astrin/SKAP complex may stabilize the growing 
microtubules and promote their polymerization by incorporating new α-/β-tubulin 
dimers in the microtubule lattice. Interaction with EB proteins via the SXIP-motif of 
SKAP recruits the Astrin/SKAP complex to microtubule plus ends, where it may 
further regulate microtubule dynamics by favoring their growth rate. Upon the 
establishment of chromosome biorientation, when the outer kinetochore components 
are spatially separated from the reach of the Aurora B kinase due to increasing 
intrakinetochore stretch, the Astrin/SKAP complex is recruited to kinetochores, 
possibly through multiple weak interactions, e.g. with KMN network components, in 
combination with its microtubule plus end binding. At kinetochores, the Astrin/SKAP 
complex may assist in the stabilization of proper end-on attachments together with 
other microtubule binders, such as the Ndc80 complex and the Ska complex, 
possibly by replacing a microtubule destabilizing Kif2b/CLASP1 complex with a 
stabilizing Astrin/CLASP1 complex (Manning et al., 2010). Thereby, the Astrin/SKAP 
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complex may help to ensure that kinetochore-microtubule attachments are robust 
enough to keep the kinetochores bound to the depolymerizing microtubule ends 
during anaphase. In addition, an interaction of the Astrin/SKAP complex with dynein 
may promote dynein-mediated transport of kinetochore components from 
microtubule plus ends toward spindle poles, which takes place upon microtubule 
attachment (Dunsch et al., 2011). After anaphase onset, the Astrin/SKAP complex 
may also participate in the protein network at the spindle midzone, together with 
kinesin-5, kinesin-14 and members of the Ase1p family, in order to ensure 
maintenance of the spindle bipolarity by bundling interpolar microtubules. 
 
In summary, the work described in this thesis provides a first thorough in vitro 
analysis of the structure and function of the 2-subunit Astrin/SKAP complex. By using 
a combinatorial approach including biochemical, biophysical, cell biological and 
structural methods, the Astrin/SKAP complex was identified as a microtubule-
stabilizing factor with effects on nucleation and growth of microtubules, explaining its 
functions in spindle organization and stabilization of kinetochore-microtubule 
attachments. Thereby, this work significantly advances our understanding of the 
functional role of the Astrin/SKAP complex during mitosis and the mechanisms 
leading to the establishment of functional end-on attachments. 
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5 MATERIALS AND METHODS 
5.1 Materials 
5.1.1 Chemicals 
Table 5.1: List of used chemicals. 
manufacturer chemical 
Applichem, Darmstadt, DE acrylamide/bisacrylamide (37.5:1, 30 %), ammonium 
sulfate, ethylene glycol-bis-(β-aminoethyl ether)-
N,N,N’,N’-tetraacetic acid (EGTA), hydrochloric acid, 
L-glutathione reduced, magnesium chloride, 
piperazine-N,N’-bis(2-ethanesulfonic acid (PIPES) 
BioRad, Hercules, US-CA gel filtration standard, Precision Plus Protein Standard 
Calbiochem, Darmstadt, DE MG132, Mowiol 
Cytoskeleton, Inc., Denver, 
US-CO 
bovine brain α-/β-tubulin, porcine α-/β-tubulin 
Fluka Analytical, Buchs, CH polyethylene glycol (PEG) 200, PEG 6000, PEG 8000 
GE Healthcare, 
Piscataway, US-NJ 
Glutathione Sepharose 4 Fast Flow 
Gerbu, Gaiberg, DE ampicillin, 1,4-dithioerythritol (DTE), ethylenediamine 
tetraacetic acid disodium salt (EDTA), glycerol 
GIBCO, Carlsbad, US-CA penicillin, streptomycin 
Gold Biotechnologie, St. 
Louis, US-MO 
4-(2-Aminoethyl) benzenesulfonyl fluoride (AEBSF) 
HellmaAnalytics, Müllheim, 
DE 
Hellmanex III 
Invitrogen, Carlsbad, US-
CA 
blasticidin, hygromycin, Sf-900 III SFM serum free 
medium complete, SYBRSafe DNA gel stain 
J.T.Baker, Deventer, NL 2-propanol, sodium hydroxide 
Life Technologies, 
Carlsbad, US-CA 
AccuPrime Pfx DNA Polymerase, ECL western 
blotting substrate 
Lonza, Rockland, US-ME agarose 
Merck, Darmstadt, DE imidazole 
New England Biolabs, 
Ipswich, US-MA 
bovine serum albumin (BSA), Crimson Taq 
Polymerase, Q5 High Fidelity 2x Master Mix, 
restriction enzymes, T4 DNA ligase 
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Table 5.1 (continued): List of used chemicals. 
manufacturer chemical 
Nippon Genetics EUROPE 
GmbH, Dueren, DE 
Midori Green advanced DNA stain 
Promega, Fitchburg, US-WI FuGENE HD Transfection Reagent 
Qiagen, Hilden, DE HyPerFect transfection reagent, JCSG Core I-IV 
Roth, Karlsruhe, DE glycine, 2-(4-(2-hydroxyethyl)-1-piperazinyl)-
ethanesulfonic acid (HEPES), isopropyl-β-D-1-
thiogalactopyranoside (IPTG), milk powder, 
tris(hydroxymethyl)-aminomethane (Tris)  
Serva Electrophoresis 
GmbH, Heidelberg, DE 
ammonium persulfate, β-mercaptoethanol, 
bromphenol blue, coomassie brilliant blue R-250/G-
250, DAPI, L-seleno-methionine, phenylmethyl 
sulfonyl fluoride (PMSF), protease inhibitor mix HP 
PLUS, sodium dodecyl sulfate (SDS), N,N,N’,N’-
tetramethylethylenediamine (TEMED), Tween-20, X-
Gal 
Sigma-Aldrich, St. Louis, 
US-MO 
acetic acid, acetonitril (ACN), doxycycline, methanol, 
PEG 3350, poly-L-lysine, Ponceau S, subtilisin A 
Thermo Fisher Scientific, 
Waltham, US-MA 
Coomassie Protein Assay Reagent (Bradford 
solution), ethanol, GeneRuler 1 kb Plus DNA Ladder 
VWR International, West 
Chester, US-PA 
sodium chloride 
 
5.1.2 Instrumentation 
Table 5.2: List of used instruments. 
instrument model manufacturer 
centrifuges Avanti J-20XP 
 
Eppendorf Centrifuge 5424/5810 R 
Hettich Universal 320R 
 
Sorvall RC3BP+ 
Beckman Coulter, Palo Alto, 
US-CA 
Eppendorf, Cologne, DE 
Hettich Lab Technology, 
Tuttlingen, DE 
Thermo Fisher Scientific, 
Waltham, US-MA 
 
 
Chapter 5: MATERIALS AND METHODS 
 113 
Table 5.2 (continued): List of used instruments. 
instrument model manufacturer 
columns GSTrap FF 5 ml 
HiLoad 16/600 Superdex 200 pg 
HisTrap FF 5 ml 
HiTrap Q FF 5 ml 
Superdex 200 5/150 GL 
Superose 6 10/300 GL 
Superose 6 prep grade XK 16/70 
Superose 6 Tricorn 5/150 GL 
GE Healthcare, 
Piscataway, US-NJ 
concentrators Amicon Ultra-15 Ultracel-10k/30k 
 
Vivacell 250, 10 000 MWCO 
inserts 
Millipore, Billerica, US-MA 
Sartorius Stedim Biotech, 
Goettingen, DE 
dialysis tubes Snake Skin Dialysis Tubing, 
MWCO: 3.5 kDa, 7 kDa 
Thermo Fisher Scientific, 
Waltham, US-MA 
ESI-MS Finnigan LCQ Advantage MAX Thermo Fisher Scientific, 
Waltham, US-MA 
FPLC instruments ÄKTA Prime Plus 
ÄKTA Purifier 
ÄKTA Micro 
GE Healthcare, 
Piscataway, US-NJ 
imager for 
crystallization 
screens  
Rock Imager 1000 Formulatrix, Waltham, US-
MA 
incubators BD 53 
Minitron 
Binder, Tuttlingen, DE 
Infors-HAT, Bottmingen, 
CH 
microscopes DeltaVision Elite imaging system 
 
3i Marianas system 
 
 
VisiTIRF Fluorescence Imaging 
System  
Applied Precision, 
Issaquah, US-WA 
Intelligent Imaging 
Innovations, Göttingen, 
DE 
Visitron Systems GmbH, 
Puchheim, DE 
NanoDrop 
spectrophotometer 
ND-1000 Spectrophotometer peQLab, Erlangen, DE 
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Table 5.2 (continued): List of used instruments. 
instrument model manufacturer 
nanoliter high-
throughput robot 
Mosquito TPP LabTech, Melbourne, 
GB 
PCR-
Thermocycler 
TProfessional TRIO Thermocycler Biometra, Goettingen, DE 
pH meter pHenomenal pH 1000 L VWR International, West 
Chester, US-PA 
plate reader POLARstar Omega BMG Labtech, Ortenberg, 
DE 
rotors JA-30.50 Ti 
TLA 100.1 
H6000A/HBB6 
 
Beckman Coulter, Palo 
Alto, US-CA 
Thermo Fisher Scientific, 
Waltham, US-MA 
SDS-PAGE Mini-PROTEAN Tetra Cell 
 
NuPAGE SDS-PAGE gel system 
BioRad, Hercules, US-CA 
Life Technologies, 
Carlsbad, US-CA 
spectrophotometer Bio Photometer Eppendorf, Hamburg, DE 
Stopped-Flow SX.18MV-R Applied Photophysics, 
Surrey, GB 
thermomixer Thermomixer comfort Eppendorf, Köln, DE 
ultracentrifuge Beckman Optima L-70K Beckman Coulter, Palo 
Alto, US-CA 
 
5.1.3. Common used buffers and media 
Table 5.3: Composition of common used buffers and media. 
buffer/medium composition 
BRB80 80 mM Pipes 
1 mM MgCl2 
1 mM EGTA 
pH 6.8 
DNA loading buffer 30 % (w/v) sucrose 
20 % (v/v) glycerol 
0.2 % (w/v) orange G 
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Table 5.3 (continued): Composition of common used buffers and media. 
buffer/medium composition 
LB medium 0.5 % (w/v) yeast extract 
1 % (w/v) trypton 
1 % (w/v) NaCl 
pH 7.4 with NaOH 
MES buffer 50 mM MES 
50 mM Tris 
0.1 % (w/v) SDS 
1 mM EDTA 
pH 7.3 
M9 minimal medium 50 mM Na2HPO4 x 2 H2O 
20 mM KH2PO4 
10 mM NaCl 
20 mM NH4Cl 
1 mM MgSO4 
0.4 % (w/v) glucose 
0.1 mM CaCl2 
PBS 137 mM NaCl 
2.7 mM KCl 
10 mM Na2HPO4 
2 mM KH2PO4 
pH 7.4 
SDS-PAGE loading buffer (5x) 0.25 M Tris-HCl, pH 6.8 
15 % (w/v) SDS 
50 % (v/v) glycerol 
25 % (v/v) β-mercaptoethanol 
0.01 % (w/v) bromophenol blue 
SDS-PAGE running buffer (10x) 0.25 M Tris-HCl 
2 M glycine 
1 % (w/v) SDS 
SDS-PAGE separating buffer (4x) 1.5 M Tris-HCl, pH 8.8 
0.4 % (w/v) SDS 
SDS-PAGE stacking buffer (4x) 0.5 M Tris-HCl, pH 6.8 
0.4 % (w/v) SDS 
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Table 5.3 (continued): Composition of common used buffers and media. 
buffer/medium composition 
SDS-PAGE staining solution 0.5 % (w/v) coomassie brillant blue R-250 
0.5 % (w/v) coomassie brillant blue G-250 
7.5 % (v/v) acetic acid 
50 % (v/v) ethanol 
TAE buffer 40 mM Tris, pH 8.0 
20 mM acetic acid 
1 mM Na2EDTA 
TB medium 2.4 % (w/v) yeast extract 
1.2 % (w/v) trypton 
0.4 % (v/v) glycerol 
17 mM KH2PO4 
72 mM K2HPO4 
TBS-T 20 mM Tris-HCl 
150 mM NaCl 
0.1 % (v/v) Tween-20 
Western blot transfer buffer 25 mM Tris-HCl 
200 mM glycine 
20 % (v/v) methanol 
 
5.1.4. Cell strains 
Table 5.4: List of used cell strains. 
cell strain 
(manufacturer) 
genotype manufacturer 
BL21-CodonPlus 
(DE3)-RIL 
E. coli B F- ompT hsdS(rB- mB-) dcm+ Tetr gal 
λ(DE3) endA Hte [argU ileY leuW Camr] 
Stratagene 
One Shot 
OmniMAX 2-T1 
E. coli F’ {proAB+ lacIq lacZΔM15 Tn10(TetR) 
Δ(ccdAB)} mcrA Δ(mrr-hsdRMS-mcrBC) 
ϕ80(lacZ)ΔM15 Δ(lacZYA-argF) U169 endA1 
recA1 supE44 thi-1 gyrA96 relA1 tonA panD 
Invitrogen 
OverExpress 
C41(DE3) 
E. coli F- ompT hsdSB(rB- mB-) gal dcm (DE3) Lucigen 
Rosetta 2(DE3) E. coli F- ompT hsdSB(rB- mB-) gal dcm (DE3) 
pRARE2 (CamR) 
Novagen 
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5.1.5. Expression vectors 
All plasmids come from the Max Planck Institute of Molecular Physiology, Dortmund, 
department of mechanistic cell biology. Plasmids #1-46, #71-76, #86-89 and 
#119-128 originate from codon-optimized DNA sequences (Invitrogen, Carlsbad, US-
CA), plasmids # 47-70, # 78-85 and # 90-111 from cDNA library sequences. 
 
Table 5.5: List of used plasmids. h: human 
plasmid # expressed protein vector 
1 hAstrin f.l. pST50Trc2-HISDHFR 
2 hAstrin f.l. pST50Trc2-HISNDHFR 
3 hAstrin f.l. pST50Trc2-DHFRHIS 
4 hAstrin f.l. pST50Trc3-HISDHFR 
5 hSKAP f.l. pST50Trc2-HISDHFR 
6 hSKAP f.l. pST50Trc2-HISNDHFR 
7 hSKAP f.l. pST50Trc2-DHFRHIS 
8 hSKAP f.l. pST50Trc3-HISDHFR 
15 hAstrin f.l. pGEX-6p-2rbs 
16 hSKAP f.l. pGEX-6p-2rbs 
17 hAstrin f.l. (MCS1) + hSKAP f.l. (MCS2) pGEX-6p-2rbs 
18 hSKAP f.l. (MCS1) + hAstrin f.l. (MCS2) pGEX-6p-2rbs 
19 His6-hAstrin f.l. + hSKAP f.l. pST50Trc2-HISDHFR 
20 His6-TEV-hAstrin f.l. + hSKAP f.l. pST50Trc2-HISNDHFR 
21 His6-hSKAP f.l. + hAstrin f.l. pST50Trc2-HISDHFR 
22 His6-TEV-hSKAP f.l. + hAstrin f.l. pST50Trc2-HISNDHFR 
23 hAstrin1-481 pGEX-6p-2rbs 
24 hAstrin1-239 pGEX-6p-2rbs 
25 hAstrin482-850 pGEX-6p-2rbs 
26 hAstrin482-903 pGEX-6p-2rbs 
27 hAstrin996-1175 pGEX-6p-2rbs 
28 hAstrin482-1175 pGEX-6p-2rbs 
29 hSKAP1-158 pST50Trc2-HISDHFR 
30 hSKAP1-225 pST50Trc2-HISDHFR 
31 hSKAP159-316 pST50Trc2-HISDHFR 
32 hSKAP159-225 pST50Trc2-HISDHFR 
33 hSKAP226-316 pST50Trc2-HISDHFR 
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Table 5.5 (continued): List of used plasmids. h: human 
plasmid # expressed protein vector 
34 hAstrin482-850 (MCS1) + hSKAP159-316 (MCS2) pGEX-6p-2rbs 
35 hAstrin482-903 (MCS1) + hSKAP159-316 (MCS2) pGEX-6p-2rbs 
36 hAstrin482-1175 (MCS1) + hSKAP159-316 (MCS2) pGEX-6p-2rbs 
37 hAstrin1-850 pGEX-6p-2rbs 
38 hAstrin1-903 pGEX-6p-2rbs 
39 hAstrin f.l. pFH 
40 hSKAP f.l. pFH 
41 hAstrin482-850 pFH 
42 hAstrin482-903 pFH 
43 hAstrin482-1175 pFH 
44 hAstrin1-850 pFH 
45 hAstrin1-903 pFH 
46 hAstrin955-1193 pGEX-6p-2rbs 
47 hAstrin f.l. pGEX-6p-2rbs 
48 hSKAP f.l. pGEX-6p-2rbs 
49 hDYNLL1 f.l. pGEX-6p-2rbs 
50 hAstrin f.l. (MCS1) + hSKAP f.l. (MCS2) pGEX-6p-2rbs 
51 hAstrin f.l. (MCS1) + hDYNLL1 f.l. (MCS2) pGEX-6p-2rbs 
52 hSKAP f.l. (MCS1) + hAstrin f.l. (MCS2) pGEX-6p-2rbs 
53 hSKAP f.l. (MCS1) + hDYNLL1 f.l. (MCS2) pGEX-6p-2rbs 
54 hDYNLL1 f.l. (MCS1) + hAstrin f.l. (MCS2) pGEX-6p-2rbs 
55 hDYNLL1 f.l. (MCS1) + hSKAP f.l. (MCS2) pGEX-6p-2rbs 
57 hSKAP f.l. pFH 
58 hDYNLL1 f.l. pFH 
59 hSKAP1-158 pGEX-6p-2rbs 
60 hSKAP159-225 pGEX-6p-2rbs 
61 hSKAP159-316 pGEX-6p-2rbs 
62 hSKAP226-316 pGEX-6p-2rbs 
63 hAstrin f.l. pFH 
64 hSKAP159-316 pFH 
65 hSKAP146-225 pGEX-6p-2rbs 
66 hSKAP135-225 pGEX-6p-2rbs 
67 hSKAP120-225 pGEX-6p-2rbs 
68 hSKAP103-225 pGEX-6p-2rbs 
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Table 5.5 (continued): List of used plasmids. h: human 
plasmid # expressed protein vector 
69 hSKAP74-225 pGEX-6p-2rbs 
70 hSKAP46-225 pGEX-6p-2rbs 
71 GST-hAstrin482-850 pFL 
72 hAstrin482-850-His6 pFL 
73 hSKAP159-316 pFL 
74 hSKAP159-316-His6 pFL 
75 GST-hSKAP f.l. pFL 
76 hSKAP159-316 (MCS1) + hAstrin482-850-His6 
(MCS2) 
pFL 
78 hSKAP135-225 L189M pGEX-6p-2rbs 
79 hSKAP135-225 L210M pGEX-6p-2rbs 
80 hSKAP135-225 L189/210M pGEX-6p-2rbs 
81 hSKAP135-225 K140A pGEX-6p-2rbs 
82 hSKAP135-225 K149A pGEX-6p-2rbs 
83 hSKAP135-225 K161A pGEX-6p-2rbs 
84 hSKAP135-225 K164A pGEX-6p-2rbs 
85 hSKAP135-225 K161/164A pGEX-6p-2rbs 
86 hSKAP159-316 K161A (MCS1) + hAstrin482-850-
His6 (MCS2) 
pFL 
87 hSKAP159-316 K164A (MCS1) + hAstrin482-850-
His6 (MCS2) 
pFL 
88 hSKAP159-316 K161/164A (MCS1) + hAstrin482-
850-His6 (MCS2) 
pFL 
89 hSKAP159-316 K267A (MCS1) + hAstrin482-850-
His6 (MCS2) 
pFL 
90 GST-mCherry-hSKAP135-225 pGEX-6p-2rbs 
91 GST-mCherry-hSKAP159-316 pGEX-6p-2rbs 
92 hSKAP135-225 K140/149A pGEX-6p-2rbs 
93 hSKAP135-225 K140/161A pGEX-6p-2rbs 
94 hSKAP135-225 K140/164A pGEX-6p-2rbs 
95 hSKAP135-225 K149/161A pGEX-6p-2rbs 
96 hSKAP135-225 K149/164A pGEX-6p-2rbs 
97 hSKAP135-225 K140/161/164A pGEX-6p-2rbs 
98 hSKAP135-225 K149/161/164A pGEX-6p-2rbs 
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Table 5.5 (continued): List of used plasmids. h: human 
plasmid # expressed protein vector 
99 hSKAP135-225 K140/149/161A pGEX-6p-2rbs 
100 hSKAP135-225 K140/149/164A pGEX-6p-2rbs 
101 hSKAP135-225 K140/149/161/164A pGEX-6p-2rbs 
102 hSKAP135-316 (MCS1) + hAstrin482-850-His6 
(MCS2) 
pFL 
103 hSKAP135-225 K168A pGEX-6p-2rbs 
104 hSKAP135-225 K170A pGEX-6p-2rbs 
105 hSKAP135-225 K168/170A pGEX-6p-2rbs 
106 hSKAP135-225 K140/149/161/164/168A pGEX-6p-2rbs 
107 hSKAP135-225 K140/149/161/164/170A pGEX-6p-2rbs 
108 hSKAP135-225 K140/149/161/164/168/170A pGEX-6p-2rbs 
109 hSKAP135-216 pGEX-6p-2rbs 
110 hSKAP135-174 pGEX-6p-2rbs 
111 hSKAP175-225 pGEX-6p-2rbs 
119 hSKAP135-225  pCDNA5/FRT/TO-
EGFP-IRES 
120 hSKAP135-225 K161/164A pCDNA5/FRT/TO-
EGFP-IRES 
121 hSKAP135-225 K140/149/161/164A pCDNA5/FRT/TO-
EGFP-IRES 
122 hSKAP f.l.  pCDNA5/FRT/TO-
EGFP-IRES 
123 hSKAP f.l. K161/164A pCDNA5/FRT/TO-
EGFP-IRES 
124 hSKAP f.l. K140/149/161/164A pCDNA5/FRT/TO-
EGFP-IRES 
127 hSKAP135-225 K140/149/161/164/168/170A pCDNA5/FRT/TO-
EGFP-IRES 
128 hSKAP f.l. K140/149/161/164/168/170A pCDNA5/FRT/TO-
EGFP-IRES 
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5.2 Molecular biological methods 
5.2.1 Transformation 
Transformation is the uptake of genetic material into competent cells, i.e. cells that 
are able to receive the DNA from its surroundings by means of adequate stimuli 
(Lottspeich & Engels, 2006). This serves to amplify the transferred plasmids or to 
express encoded proteins. The transformation was performed via a heat shock in the 
presence of high Ca2+ concentrations. Pores are temporarily created in the bacterial 
plasma membrane with a sudden increase in temperature from 0 °C to 42 °C for 45 s 
thereby allowing the DNA to enter to cell. Afterwards, the cells were incubated in 
800 µL LB medium for 45 min at 37 °C and subsequently selected on LB agar plates 
containing the respective antibiotics overnight at 37 °C. 
 
5.2.2 Purification of DNA 
5.2.2.1 Agarose gel electrophoresis 
By means of agarose gel electrophoresis (Takahashi et al., 1969) DNA mixtures 
were separated with an electric field by the sieve effect of the agarose gel according 
to their size. 0.9 % agarose gels in TAE buffer were used and DNA was stained with 
SYBRSafe DNA gel stain or Midori Green advanced DNA stain. Samples were mixed 
with DNA loading buffer and separated by applying a voltage of 120 V to the agarose 
gel. For comparison, the GeneRuler 1 kb Plus DNA ladder (Thermo Fisher Scientific, 
Waltham, US-MA) was loaded in addition to the samples. DNA fragments were 
visualized by UV light. 
 
5.2.2.2 Purification of plasmid DNA 
Plasmid DNA was amplified in the E. coli cell strain One Shot OmniMAX 2-T1. After 
transformation a miniculture of a single colony in LB containing the respective 
antibiotics was incubated overnight at 37 °C. After cell harvest plasmid DNA was 
isolated from the bacterial cell pellet by use of the QIAprep Spin Miniprep Kit 
(Qiagen, Hilden, DE) according to the manufacturer’s instructions. DNA was eluted 
with elution buffer (10 mM Tris, pH 8.0) and stored at -20 °C. 
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5.2.3 Polymerase chain reaction 
With polymerase chain reaction (PCR) (Saiki et al., 1988) DNA was amplified 
analytically or preparatively. PCR reactions were carried out in a PCR thermocycler 
TProfessional TRIO (Biometra, Goettingen, DE).  
 
5.2.3.1 Preparative PCR 
For preparative PCR 50 µL reactions were used with 20 ng template DNA, 50 pmol 
of each primer, 10 nmol dNTPs and 1 unit AccuPrime Pfx DNA polymerase in 
AccuPrime Pfx reaction buffer. PCR was carried out with the following cycling 
parameters: 
denaturation 2 min  95 °C 
denaturing 30 s  95 °C 
annealing 30 s  ~50 °C 30 cycles 
elongation 1 min/kb 68 °C 
elongation 5 min  68 °C 
Amplification products were purified via agarose gel electrophoresis. Appropriate 
bands were cut and processed with the QIAquick Gel Extraction Kit (Qiagen, Hilden, 
DE) according to the manufacturer’s instructions. DNA was eluted with elution buffer 
(10 mM Tris, pH 8.0) and stored at -20 °C. 
 
5.2.3.2 Colony PCR 
The success of ligation (see paragraph 6.2.5) was checked via analytical PCR. For 
this purpose, single colonies of the transformation were dipped into a PCR tube and 
amplified in minicultures at 37 °C overnight. The cells in the PCR tube were mixed 
with 10 pmol of each primer, 2 nmol dNTPs and 0.5 units Crimson Taq polymerase in 
Crimson Taq reaction buffer. The PCR reaction was carried out with the protocol 
described in paragraph 6.2.3.1 and analyzed via agarose gel electrophoresis.  
 
5.2.3.3 Site-directed mutagenesis 
Site-directed mutagenesis was performed in order to selectively insert mutations into 
DNA sequences according to the Stratagene QuikChange site-directed mutagenesis 
protocol (Papworth et al., 1996). Self-complementary primers that contained the 
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desired mutations were used. In 25 µL reactions 50 ng template, 9 pmol of each 
primer, 3 % (v/v) DMSO and 12.5 µL 2x Q5 High Fidelity 2x Master Mix were 
incubated under the following cycling parameters: 
denaturation 1 min  98 °C 
denaturing 1 min  98 °C 
annealing 1 min  58 °C 25 cycles 
elongation 1 min/kb 72 °C 
elongation 10 min  72 °C 
To digest the parental methylated DNA, the samples were mixed with 1 unit DpnI for 
1-3 h at 37 °C. After analysis via agarose gel electrophoresis the reaction mixture 
was transformed into One Shot OmniMAX 2-T1 cells. 
 
5.2.3.4 DNA sequencing 
Sequences of the cloned DNA constructs were verified via DNA sequencing by 
StarSEQ GmbH, Mainz, DE, or Beckman Coulter Genomics, Takeley, UK. 
 
5.2.4 Restriction digest of DNA 
Restriction digest (Lottspeich & Engels, 2006) was used to specifically cut DNA with 
the help of restriction enzymes in order to prepare the ligation of two DNA fragments 
(see paragraph 6.2.5). 0.5-1 µg of DNA were incubated with 1 unit of each restriction 
enzyme in a recommended buffer for 1-2 h at 37 °C. Digested DNA was purified with 
the QIAquick PCR Purification Kit (Qiagen, Hilden, DE) according to the 
manufacturer’s instructions. DNA was eluted with elution buffer (10 mM Tris, pH 8.0) 
and stored at -20 °C. For digestion of plasmid DNA, 1 unit of shrimp alkaline 
phosphatase was added in addition to the restriction enzymes in order to 
dephosphorylate 5’-ends and minimize self-ligation of the vector. Purification of the 
cleaved plasmids was performed via agarose gel electrophoresis and subsequent gel 
extraction with the QIAquick Gel Extraction Kit (Qiagen, Hilden, DE) according to the 
manufacturer’s instructions. DNA was eluted with elution buffer (10 mM Tris, pH 8.0) 
and stored at -20 °C. 
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5.2.5 DNA ligation 
DNA ligation serves to covalently connect two DNA fragments after restriction 
digestion in order to obtain a covalently closed plasmid. Ligation was carried out 
using approximately 50 ng cleaved plasmid DNA, 3-5x molar excess of the digested 
insert and 1 unit of T4 DNA ligase in T4 DNA ligase reaction buffer. The reactions 
were incubated overnight at 16 °C followed by an incubation for 15 min at 65 °C and 
then transformed in competent E. coli One Shot OmniMAX 2-T1 cells. 
 
5.3 Bioanalytical methods 
5.3.1 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis (PAGE) (Laemmli, 
1970) separates protein mixtures with an electric field by the sieve effect of the 
polyacrylamide gel according to their size. Hereby, the composition and purity of the 
samples can be analyzed. The used SDS-PAGE gels consisted of a ~ 40 cm2 big 10-
18 % separating gel and a stacking gel. In some cases NuPAGE SDS-PAGE was 
used with NuPAGE Novex 4-12 % Bis-Tris precast gradient gels (Life Technologies, 
Carlsbad, US-CA) in MES buffer. The samples were mixed with 5x SDS-PAGE 
loading buffer and denatured 5 min at 95 °C. For comparison a molecular weight 
marker (Precision Plus Protein Standard, Bio-Rad, Hercules, US-CA) was loaded in 
addition to the samples. The gels were placed into a Mini-PROTEAN Tetra Cell (Bio-
Rad, Hercules, US-CA) with SDS-PAGE running buffer and a voltage of 120 V was 
applied till the dye of the loading buffer exited the gel. Proteins were visualized by 
Coomassie staining and subsequent destaining with 10 % (v/v) acetic acid.  
 
5.3.2 Determination of protein concentration 
5.3.2.1 Determination of protein concentration via Bradford assay 
The determination of protein concentrations via the Bradford assay (Bradford, 1976) 
occurs colorimetrically by binding of the dye Coomassie brilliant blue G-250 to the 
cationic side chains of arginine, lysine and histidine. For this purpose, 1-10 µg of 
protein were mixed with 1 mL of Bradford solution (Thermo Fisher Scientific, 
Waltham, US-MA). After incubation for 5 min the absorbance at a wavelength of 
595 nm was measured spectrometrically by comparison to a reference sample. The 
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protein concentration was determined by use of a standard curve with BSA of known 
concentration. 
 
5.3.2.2 Determination of protein concentration via UV absorbance 
The determination of protein concentrations via UV absorbance at a wavelength of 
280 nm is based on the Beer-Lambert law. The required extinction coefficient for 
proteins can be calculated from the number of tryptophan, tyrosine and cysteine 
(Gasteiger et al., 2005). The measurement of absorbance was carried out with a 
NanoDrop spectrophotometer ND-1000 (peQLab, Erlangen, DE). 
 
5.3.3 ESI mass spectrometry 
Electrospray ionization (ESI) mass spectrometry (MS) (Fenn et al., 1989) serves to 
determine the molecular weight of molecules. For the analysis of protein samples, 
0.3-0.5 nmol protein were used. The samples were desalted on a C4 column (HPLC 
instrument LC1100, Agilent Technologies, Santa Clara, US-CA) and eluted a 
combination of 0.1 % TFA (trifluoroacetic acid) in H2O (buffer A) and 0.08 % TFA in 
acetonitrile (buffer B). A linear gradient from 80 % buffer A and 20 % buffer B to 20 % 
buffer A and 80 % buffer B was employed. Subsequently, the MS analysis of the 
samples was carried out by a Finnigan LCQ Advantage MAX mass spectrometer 
(Thermo Fisher Scientific, Waltham, US-MA) in positive ion mode. The analysis of 
the MS spectra was done with Xcalibur and MagTran. The accuracy of the weight 
determination of proteins via ESI MS amounted to appromixately 7 Da. 
 
5.3.4 Analytical size-exclusion chromatography 
Analytical size-exclusion chromatography was used to analyze the binding of 
proteins in solution. Size-exclusion chromatography (SEC) (Porath & Flodin, 1959) 
separates molecules according to their hydrodynamic radius. The elution occurs with 
decreasing size, because small molecules preferentially enter the porous matrix of 
the column and are thereby retained longer. The SEC experiments were carried out 
using an ÄKTA micro (GE Healthcare, Piscataway, US-NJ) with a Superdex 200 
5/150 GL or Superose 6 Tricorn 5/150 GL column (GE Healthcare, Piscataway, US-
NJ), respectively.  
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For sample preparation the respective proteins were mixed at concentrations of 
5-20 µM in size exclusion chromatography buffer in a final volume of 50 µL. Samples 
containing single proteins in size exclusion chromatography buffer served as 
controls. The samples were incubated at least for 1 h on ice before injecting onto the 
size exclusion chromatography column. The columns were equilibrated in size 
exclusion chromatography buffer and after injection the samples were eluted with 
one column volume of size exclusion chromatography buffer at a flow rate of 0.1-
0.2 mL/min and fractionated. The eluted proteins were detected via their absorbance 
at a wavelength of 280 and 214 nm and subsequently analyzed via SDS-PAGE. 
Subsequently, the chromatograms and the corresponding SDS-PAGE gels of the 
samples were compared for the single proteins and the protein mixtures. 
 
5.3.5 Western blot 
Western blots were used to stain for specific proteins in cell lysates. For this purpose, 
protein samples were separated via SDS-PAGE and then transferred onto a PVDF 
membrane (Bio-Rad Laboratories, Munich, DE) via electrophoresis in 25 mM Tris, 
200 mM glycine and 20 % (v/v) methanol by applying 100 V for 90 min. Protein 
transfer was checked by staining with Ponceau S. The membrane was blocked for 
1 h at room temperature in TBS-T supplemented with 5 % (w/v) milk powder. 
Incubation with primary antibodies against α-tubulin (mouse monoclonal antibody, 
DM1A, Sigma-Aldrich, 1:10,000), SKAP (rabbit polyclonal anti-human SKAP135-225 
antibody, made in cooperation with Cogentech, Milan, IT, 1:2,000) or GFP (rabbit 
polyclonal antibody, generated in-house, 1:5,000) diluted in TBS-T supplemented 
with 5 % (w/v) milk powder was performed overnight at 4 °C. After three washes for 
5 min with TBS-T the membrane was incubated for 1 h at room temperature HRP-
conjugated donkey anti-rabbit antibody (Amersham Biosciences, Piscataway, US-NJ) 
or HRP-conjugated sheep anti-mouse antibody (Amersham Biosciences, 
Piscataway, US-NJ) diluted in TBS-T supplemented with 5 % (w/v) milk powder. The 
membrane was washed 4 times for 7 min with TBS-T, enhanced chemiluminescence 
western blotting substrate was added according to the manufacturer’s instructions 
and signals were detected with a developer machine on film. 
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5.4 Biochemical methods 
5.4.1 Protein expression and purification 
For protein expression the cell strains and plasmids listed in tables 6.4 and 6.5 were 
used. Zwint, Knl1, RB3, TTL, the Mis12 complex (Petrovic et al., 2010) and the 
Ndc80 complex (Petrovic et al., 2010) were already purified and stored at -80 °C.  
 
5.4.1.1 Protein expression in Escherichia coli 
The protein constructs (see Table 5.5) were tested for expression in the cell strains 
Rosetta 2(DE3), OverExpress C41(DE3) or BL21-CodonPlus(DE3) RIL, respectively, 
after incubation with 0.1-0.2 mM IPTG and an overnight incubation at temperatures 
of 16-20 °C in LB or TB medium. For subsequent protein purification of the Astrin and 
SKAP constructs, an overnight expression in OverExpress C41(DE3) cells at 16 °C 
in LB medium was used. The expression was induced with 0.1 mM IPTG at an 
optical density at 600 nm of 0.5-0.8 absorbance units. Cells were harvested by 
centrifugation at 5,000 g for 15-20 min at 20 °C. 
 
5.4.1.2 Seleno-methionine expression of SKAP135-225 in Escherichia coli 
By the seleno-methionine expression (Abergel et al., 2000) a protein can be labeled 
with selenium in order to solve the phase problem occurring during X-ray 
crystallography. For this purpose, 50 mL overnight culture of E. coli OverExpress 
C41(DE3) that were transformed with the pGEX-6p-2rbs-SKAP135-225 plasmid were 
centrifuged and used to inoculate 5 L M9 minimal medium. At an optical density at 
600 nm of 0.5 absorbance units the feedback inhibition of methionine biosynthesis 
was facilitated by the addition of 100 mg/L of phenylalanine, lysine and threonine as 
well as 50 mg/L of isoleucine, leucine and valine. After 15 min 60 mg/L L-seleno-
methionine were added and after another 15 min the expression was induced with 
0.1 mM IPTG. Seleno-methionine labeled protein was expressed overnight at 18 °C. 
Cells were harvested by centrifugation at 5,000 g for 15 min at 20 °C. 
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5.4.1.3 Protein expression in insect cells 
5.4.1.3.1 Generation of bacmid 
For generation of bacmid, DH10EMBacY cells, which are E. coli cells containing the 
EMBacY bacmid, were transformed with the gene-containing transfer plasmid - a 
MultiBac pFL-derived vector (Fitzgerald et al., 2006) - and recombination was 
allowed to take plate for 5 h at 37 °C. Selection for successful transposition into the 
bacmid was done via blue/white screening on LB agar containing kanamycin, 
gentamycin, tetracycline, X-gal and IPTG for 2 d at 37 °C. Bacmid was isolated from 
minicultures of white colonies with alkaline lysis of bacteria and subsequent pelleting 
of the bacmid with isopropanol. For this purpose, cell pellets of 4 mL overnight 
cultures were mixed with 300 µL each of the QIAprep Spin Miniprep Kit solution 
(Qiagen, Hilden, DE) according to the manufacturer’s instructions and incubated 
20 min on ice. Samples were centrifuged for 10 min at 20,000 g and subsequently 
the supernatant was centrifuged for another 10 min. 850 µL of isopropanol was 
added to the cleared supernatant and incubated at -20 °C overnight. After 
centrifugation for 20 min at 20000 g the pellet was washed with 70 % (v/v) ethanol. 
Under a sterile hood the ethanol was removed and the pellet allowed to dry before 
dissolving in TE buffer. The bacmid DNA was stored at -20 °C.  
 
5.4.1.3.2 Transfection of insect cells and virus amplification 
For transfection and virus amplification, the Spodoptera frugiperda cell line Sf9 
(Invitrogen, Carlsbad, US-CA) was used. Bacmid was incubated for 20 min with 
FuGENE (Promega, Fitchburg, US-WI) in Sf-900 III SFM serum free medium 
(Invitrogen, Carlsbad, US-CA) and subsequently added to a 6-well plate containing 
1x106 cells per transfection in 2 mL Sf-900 III SFM. Cells were incubated at 27 °C for 
3 d.  
For virus amplification, the transfected cells were resuspended and added to 10 mL 
of fresh medium with 1x106 Sf9 cells per mL. After incubation at 27 °C for 4 d the 
cells were centrifuged at 1,000 g for 5 min. The supernatant (V0) was sterile filtered 
and stored at 4 °C. For further virus amplification, 1x106 Sf9 cells per mL were 
incubated with 1:100 V0 in Sf-900 III SFM for 4 d at 27 °C. Afterwards, cells and 
supernatant (V1) were treated as mentioned above. 
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5.4.1.3.3 Protein expression in insect cells 
For protein expression, the Trichoplusia ni cell line BTI-Tnao38 was used. 1x106 cells 
per mL were incubated with different ratios (1:25 to 1:100) of V1 virus in Sf-900 III 
SFM and incubated for 4 d at 27 °C. Cells were harvested by centrifugation at 420 g 
for 20 min at 20 °C. 
 
5.4.1.4 Protein purification from Escherichia coli 
Following protein expression, harvested cells were resuspended in 5 volumes of ice-
cold lysis buffer (50 mM Hepes, pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol, 1 mM 
MgCl2, 0.1-0.2 % Triton X-100, DNaseI, protease inhibitor mix and 5 mM β-
mercaptoethanol for His-tagged proteins or 5 mM DTE for GST-tagged proteins) and 
lyzed by sonication. The lysate was cleared by centrifugation at 100,000 g for 30 min 
at 4 °C in a JA-30.50 Ti rotor.  
The subsequent protein purification was carried out with an ÄKTA prime plus and an 
ÄKTA purifier at 4 °C. The proteins were purified in a first step via affinity 
chromatography on a 5 mL GSTrap FF column for GST-tagged proteins or a 5 mL 
HisTrap FF column for His-tagged proteins. For this purpose, the cleared lysate was 
loaded onto the equilibrated column with a flow rate of 2 mL/min. Afterwards, the 
column was washed with at least 40 column volumes of buffer containing 50 mM 
Hepes, pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol and 2 mM reducing agent as well 
as 20 mM imidazole for His-tagged proteins. His-tagged proteins were eluted with an 
imidazole gradient from 20-500 mM imidazole, fractionated and detected via 
absorbance at 280 nm. After analysis with SDS-PAGE appropriate fractions were 
dialyzed in buffer containing 20 mM Hepes, pH 7.5, 300 mM NaCl, 10 % (v/v) 
glycerol and 2 mM DTE overnight. GST-tagged proteins were eluted with buffer 
containing 20 mM Hepes, pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol, 2 mM DTE and 
50 mM GSH to keep the GST-tag or the tag was cleaved on the column by an adding 
of GST-tagged PreScission protease to the column-bound protein for approximately 
16 h and the protein was subsequently eluted with 1.5 column volumes of buffer 
containing 20 mM Hepes, pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol and 2 mM DTE.  
The proteins were further purified by anion-exchange chromatography. They were 
loaded onto a 5 mL HiTrap Q FF equilibrated in buffer containing 20 mM Hepes, 
pH 7.5, 100-300 mM NaCl, 10 % (v/v) glycerol and 2 mM DTE. The flow-through was 
collected and the bound proteins eluted with a salt gradient up to 1 M NaCl over 20 
column volumes. Proteins were detected via absorbance at 280 nm and analyzed 
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with SDS-PAGE. Fractions containing the protein of interest were concentrated in a 
VivaCell 250 (Sartorius Stedim Biotech, Goettingen, DE) at 4 °C and further purified 
via size exclusion chromatography. Depending on the amount and size of the 
proteins one of the following size exclusion chromatography columns was used: 
Superdex 200 5/150 GL, HiLoad 16/600 Superdex 200 pg, Superose 6 10/300 GL or 
Superose 6 prep grade XK 16/70. The columns were equilibrated in size exclusion 
chromatography buffer (20 mM Hepes, pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol 
and 2 mM DTE) and after injection the samples were eluted with one column volume 
of size exclusion chromatography buffer and fractionated. The eluted proteins were 
detected via their absorbance at 280 nm and subsequently analyzed with SDS-
PAGE. Fractions containing the protein of interest were concentrated in a VivaCell 
250 (Sartorius Stedim Biotech, Goettingen, DE) at 4 °C, shock frozen in liquid 
nitrogen and stored at -80 °C. 
 
5.4.1.5 Protein purification from insect cells 
His-tagged Astrin482-850/SKAP159-316 complex was purified from insect cells. Cells were 
resuspended in 10 volumes of ice-cold lysis buffer (50 mM Hepes, pH 7.5, 300 mM 
NaCl, 10 % (v/v) glycerol, 1 mM MgCl2, 0.5 % Triton X-100, DNaseI, protease 
inhibitor mix and 5 mM β-mercaptoethanol) and lyzed by sonication. The lysate was 
cleared by centrifugation at 100,000 g for 30 min at 4 °C in a JA-30.50 Ti rotor.  
The subsequent protein purification was carried out with an ÄKTA prime plus and an 
ÄKTA purifier at 4 °C. The protein complex was purified in a first step via affinity 
chromatography on a 5 mL HisTrap FF column. For this purpose, the cleared lysate 
was loaded onto the equilibrated column at a flow rate of 2 mL/min. Afterwards, the 
column was washed with 30 column volumes of buffer containing 50 mM Hepes, 
pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol, 0.5 % Triton X-100, 20 mM imidazole and 
2 mM β-mercaptoethanol and subsequently with 20 column volumes of buffer without 
Triton X-100. Proteins were eluted with an imidazole gradient from 20-500 mM 
imidazole, fractionated and detected via absorbance at 280 nm. After analysis with 
SDS-PAGE appropriate fractions were dialyzed in buffer containing 20 mM Hepes, 
pH 7.5, 300 mM NaCl, 10 % (v/v) glycerol and 2 mM DTE for approximately 16 h.  
The proteins were concentrated in a VivaCell 250 (Sartorius Stedim Biotech, 
Goettingen, DE) at 4 °C and further purified via size exclusion chromatography on 
Superose 6 10/300 GL or Superose 6 prep grade XK 16/70 columns. The columns 
were equilibrated in size exclusion chromatography buffer (20 mM Hepes, pH 7.5, 
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300 mM NaCl, 10 % (v/v) glycerol and 2 mM DTE) and after injection the samples 
were eluted with one column volume of size exclusion chromatography buffer and 
fractionated. The eluted proteins were detected via their absorbance at 280 nm and 
subsequently analyzed with SDS-PAGE. Fractions containing the proteins of interest 
were concentrated in a VivaCell 250 (Sartorius Stedim Biotech, Goettingen, DE) at 
4 °C, shock frozen in liquid nitrogen and stored at -80 °C. 
 
5.4.2 Microtubule cosedimentation assays 
Microtubule cosedimentation assays were performed in order to analyze the ability of 
protein constructs to bind to microtubules. For this purpose, bovine α-/β-tubulin 
(Cytoskeleton, Inc., Denver, US-CO, #TL238) was diluted to a concentration of 
50 µM in BRB80 buffer. The dissolved tubulin was mixed with 2.5 mM GTP and 
placed in a PCR thermocycler TProfessional TRIO (Biometra, Goettingen, DE) to 
allow polymerization at 34 °C for 1 h. Afterwards, 0.5 mM taxol was added to 
stabilize the microtubules and incubated for 1-2 h at 34 °C. In order to obtain 
subtilisin-treated microtubules, 6 µM taxol-stabilized microtubules were incubated 
with 100 µg/mL subtilisin A for 45 min at 30 °C. The reaction was quenched by the 
addition of 10 mM phenylmethyl sulfonyl fluoride. The digested microtubules were 
pelleted at 350,000 g for 10 min at 25 °C and resuspended in BRB80 buffer. Taxol-
stabilized or subtilisin-treated microtubules were incubated with the protein of interest 
for 10 min at room temperature in a final reaction volume of 35 µL in 25 mM Hepes, 
pH 7.5, 150 mM NaCl, 1 mM MgCl2, 1 mM EGTA and 2 mM DTE. The samples were 
placed on top of 100 µL cushion buffer (25 mM Hepes, pH 7.5, 150 mM NaCl, 1 mM 
MgCl2, 1 mM EGTA, 50 % (v/v) glycerol and 50 µM taxol) and ultracentrifuged in a 
TLA 120.1 rotor at 350,000 g for 10 min at 25 °C. The upper 35 µL (soluble fraction) 
were mixed with 5x SDS loading buffer. The pellet was dissolved in 1x SDS loading 
buffer. Afterwards, the samples were analyzed with SDS-PAGE. The quantification of 
the pellet and soluble fraction was carried out with ImageJ 1.49 (NIH). To obtain 
normalized binding data, the values of the pellet fraction were divided by the sum of 
pellet and soluble fraction. The normalized data were fitted using Origin7.0 
(OriginLab, Northampton, US-MA) to the following equation (Ciferri et al., 2008): 
fraction bound= 
Bt+Kd+x - Bt+Kd+x 2- 4Btx
2
 
Bt is the maximal fractional protein-tubulin complex, Kd is the dissociation constant 
and x is the concentration of tubulin dimer.  
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5.4.3 Microtubule cold shock assay 
Microtubule cold shock assays were performed in order to test the influence of 
proteins on the stability of microtubules to a cold treatment. 10 µM bovine α-/β-
tubulin (Cytoskeleton, Inc., Denver, US-CO) were incubated at 34 °C for 30 min 
either alone or in the presence of 10 µM protein of interest in a buffer containing 
25 mM Hepes, pH 7.5, 150 mM NaCl, 5 % glycerol, 4 mM MgCl2, 1 mM EGTA, 2 mM 
DTE and 2.5 mM GTP. Afterwards, the samples were incubated for 10 min on ice 
and centrifuged on top of 100 µL cushion buffer (25 mM Hepes, pH 7.5, 150 mM 
NaCl, 1 mM MgCl2, 1 mM EGTA, 50 % (v/v) glycerol) in a TLA 120.1 rotor at 
350,000 g for 10 min at 4 °C. As a control, samples with the same composition were 
treated without cold shock and centrifuged at 350,000 g for 10 min at 34 °C. 
Supernatants and pellets were analyzed with SDS-PAGE and the amount of 
polymerized tubulin was quantified as described in section 6.4.2. 
 
5.4.4 Chemical crosslinking and MS analysis 
Chemical crosslinking (Herzog et al., 2012) was performed in order to map lysine 
residues that lie close to each other and thereby point to the binding sites of the 
interacting proteins. An equimolar mixture of isotopically light and heavy labeled 
crosslinker bis(sulfosuccinimidyl)glutarate (BS2G-H6/D6, Creative Molecules, 
www.creativemolecules.com) or di(succinimidyl)suberate (DSS-H12/D12, Creative 
Molecules, www.creativemolecules.com) was dissolved in DMSO at a concentration 
of 50 µM. In an initial experiment the appropriate amount of crosslinker was 
determined. For this purpose, 10-15 µg of total protein was incubated with varying 
amounts of crosslinker (weight ratio of 10:1 to 1:10) in a final volume of 20-25 µL. 
After incubation for 30 min at 37 °C the reaction mixture was quenched by the adding 
of 100 mM ammonium bicarbonate and incubation for 15 min at 37 °C. Samples 
were analyzed for their extent of crosslinking via NuPAGE SDS-PAGE and promising 
reaction mixtures were repeated on a larger scale. In case of the 
Astrin482-850/SKAP159-316 complex 90 µg of protein were mixed in a 1:1 ratio with DSS 
or BS2G in a final volume of 130 µL. To analyze the SKAP-microtubule interaction, 
10 µM SKAP135-225 and 10 µM taxol-stabilized microtubules (170 µg total protein) 
were mixed with DSS in a ratio of 1:2.5 or with BS2G in a ratio of 1:1 in a final 
volume of 150 µL. Crosslinked samples were send to the lab of Franz Herzog (Gene 
Center Munich, LMU Munich, DE) for further mass spectrometric analysis of 
crosslinked peptides (Herzog et al., 2012). In brief, crosslinked proteins were 
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digested and the peptides were enriched and analyzed by liquid chromatography 
coupled to tandem mass spectrometry analysis. Crosslinks were identified via the 
xQuest database and visualized using the xVis web server (Grimm et al., 2015). 
 
5.4.5 Fluorescence microtubule flow cell assays 
For the purpose of studying the microtubule binding of different proteins at low 
concentrations, fluorescence microtubule flow cell assays were performed. To make 
a hydrophilic surface and achieve a homogenous coating, the cover slips were 
cleaned prior to usage as follows: 
I. Sonication in isopropanol for 20 min. 
II. Two times sonication in Millipore water for 5 min. 
III. Sonication in 1 M KOH for 20 min. 
IV. Storage in 1 M KOH overnight. 
V. Sonication in Millipore water for 5 min before use. 
The glass slides were cleaned in the following way: 
I. Sonication in 1 % Hellmanex for 10 min. 
II. Sonication in Millipore water for 5 min. 
III. Sonication in 70 % ethanol for 10 min. 
IV. Sonication in Millipore water for 5 min. 
V. Repetition of I-III. 
VI. Storage in ethanol until use. 
VII. Sonication in Millipore water for 5 min before use. 
Porcine tubulin (Cytoskeleton, Inc., Denver, US-CO) containing 10 % biotinylated 
tubulin and 10 % fluorescently labeled tubulin was polymerized for 30-60 min at 
34 °C at a concentration of 10 mg/mL in BRB80 buffer containing 50 % glycerol. 
Glycerol was added in order to increase nucleation and to obtain a higher amount of 
shorter microtubules. Afterwards 12 µM taxol was added and the microtubules were 
incubated for about an hour at 34 °C. 
All the following steps were carried out at room temperature. To functionalize the 
cover slips, two clean and dry cover slips were incubated with 5 % biotinylated poly-
L-lysine-PEG at a concentration of 0.2 mg/mL for 30 min. Afterwards, flow cells were 
prepared by placing dry, functionalized coverslips on top of dry glass slides 
separated by double-sided tape so that the created flow cells had a width of around 
5 mm and a volume of 10-15 µL. The surface of the flow cells was passivated with 
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poly-L-lysine-PEG for 30 min and subsequently with 1 % pluronic F-127 for 
30-45 min. The chambers were then incubated with 0.33 mg/mL avidin, diluted in 
BRB80 buffer containing 1 % pluronic F-127, for 45 min. Afterwards, the flow cells 
were washed with at least 10 chamber volumes of reaction buffer containing 25 mM 
Hepes, pH 7.5, 150 mM NaCl, 10 % glycerol, 1 mM MgCl2, 1 mM EGTA, 2 mM DTE 
and 10 µM taxol. 100-200 nM HiLyte 647-labeled microtubules were added for 
10-20 min and the flow cell was washed with 3 chamber volumes. Fluorescently 
labeled proteins were added at the indicated concentrations together with 0.5 mg/mL 
BSA. The flow cells were sealed with wax and imaged with a 3i Marianas system 
(Intelligent Imaging Innovations Inc., Göttingen, DE) equipped with an Axio Observer 
Z1 microscope (Zeiss, Oberkochen, DE), a CSU-X1 confocal scanner unit 
(Yokogawa Electric Corporation, Tokyo, Japan), a Plan-Apochromat 100x/1.4NA DIC 
oil objective (Zeiss, Oberkochen, DE), an Orca Flash 4.0 sCMOS Camera 
(Hamamatsu, Hamamatsu City, Japan) and controlled by Slidebook Software 6.0 
(Intelligent Imaging Innovations Inc., Göttingen, DE). Images were acquired as z-
sections at 0.27 µm and maximal intensity projections were made with Slidebook 
Software 6.0 (Intelligent Imaging Innovations). Quantification was done with ImageJ 
1.49 (NIH) and intensities were normalized to microtubule signals.  
 
5.4.6 TIRF microscopy 
Total internal reflection fluorescence (TIRF) microscopy was used to study the 
dynamics of microtubules in the absence and presence of different proteins. The 
glass slides, coverslips and flow cells were prepared as described in section 6.4.5. 
After incubation with avidin the chambers were washed with reaction buffer (25 mM 
Hepes, pH 7.5, 150 mM NaCl, 10 % (v/v) glycerol, 1 mM MgCl2, 1 mM EGTA, 2 mM 
DTE) including an oxygen scavenger mix consisting of 4.5 mg/mL glucose, 
0.2 mg/mL glucose oxidase, 35 µg/mL catalase and 10 mM DTE. Flow cells were 
incubated for 10-20 min with 20 µL of a microtubule seed mix containing 400 nM 
GMPCPP microtubule seeds (15 % biotinylated and 15 % alexa-647 labeled; 
incubated for 30 min at 34 °C with 1 mM GMPCPP), oxygen scavenger mix, 
0.5 mg/mL casein and 0.1 % (w/v) methylcellulose in reaction buffer. After washing 
with 50 µL of reaction buffer including oxygen scavenger mix a tubulin mix (14 µM 
Rhodamine labeled tubulin, 2.5 mM GTP, oxygen scavenger mix, 0.35 mg/mL casein 
and 0.1 % (w/v) methylcellulose in reaction buffer) was added in the presence or 
absence of proteins of interest at the indicated concentrations. The chambers were 
sealed with wax and imaged at 25 °C with a VisiTIRF Fluorescence Imaging System 
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(Visitron Systems GmbH, Puchheim, DE) with a Nikon Eclipse Ti-E inverted 
microscope (Nikon, Tokyo, JP), an Apo-TIRF 100x/1.49NA oil objective (Nikon, 
Tokyo, JP) and an Evolve Delta camera (Photometrics, Tucson, US-AZ). 200 time 
points were imaged every 5 s at a penetration depth of 140 nm. Kymographs were 
made with ImageJ 1.49 (NIH). 
 
5.4.7 Tubulin polymerization assays 
Tubulin polymerization assays were performed to examine the influence of proteins 
on the polymerization of tubulin. The polymerization of tubulin was analyzed with a 
turbidity experiment (Mirigian et al., 2013) by measuring the change in light scattering 
that is caused by the microtubule suspension. For this purpose, the absorbance at 
350 nm was followed in a POLARstar Omega plate reader (BMG Labtech, 
Ortenberg, DE). Bovine α-/β-tubulin (Cytoskeleton, Inc., Denver, US-CO) was 
incubated for 50 min at 37 °C in reaction buffer (20 mM Hepes, pH 7.5, 150 mM 
NaCl, 5 % glycerol, 4 mM MgCl2, 2.5 mM GTP and 2 mM DTE) at a concentration of 
5-15 µM either alone or in the presence of other proteins at the indicated 
concentrations. A sample with reaction buffer was used as blank and subtracted from 
the raw data.  
 
5.4.8 GST pull-down assays 
In order to study the binding of proteins on a solid support, GST pull-down assays 
were carried out. For this purpose, 10 µL GSH beads were washed with reaction 
buffer (20 mM Hepes, pH 7.5, 150-300 mM NaCl, 5-10 % glycerol and 2 mM DTE) 
and saturated with GST tagged proteins by incubation for at least 1 h at 4 °C under 
slight rotation. Subsequently, the beads were washed three times with 500 µL of 
reaction buffer containing 0.05 % Tween-20 and then incubated with possible 
interaction partners. After incubation for at least 1 h at 4 °C under slight rotation the 
beads were washed again three times with 500 µL of reaction buffer containing 
0.05 % Tween-20 and the bound proteins were eluted with reaction buffer containing 
50 mM GSH. Afterwards, the eluted proteins were analyzed via SDS-PAGE.  
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5.5 Cell biological methods 
5.5.1 Cell line generation and cell culture 
Codon-optimized SKAP genes (Invitrogen, Carlsbad, US-CA) were amplified by PCR 
and subcloned into a pCDNA5/FRT/TO-EGFP-IRES vector, a modified version 
(Krenn et al., 2012) of the pCDNA5/FRT/TO vector (Invitrogen, Carlsbad, US-CA). 
Mutations were introduced via site-directed mutagenesis. All plasmids were verified 
by DNA sequencing. Flp-In T-REx HeLa cells that were used to generate stable 
doxycycline-inducible cell lines were a gift from S.S. Taylor (University of 
Manchester, Manchester, England, UK). Flp-In T-REx HeLa host cell lines were 
maintained in DMEM (PAN Biotech, Aidenbach, DE) with 10 % tetracycline-free FBS 
(Clontech, part of Takara Bio group, Shiga, Japan) supplemented with penicillin and 
streptomycin. For generation of Flp-In T-REx HeLa expression cell lines 100 µL 
optiMEM medium and 6 µL XtremeGene were incubated for 5 min and mixed with 
1.8 µg pOG44 and 0.2 µg of the pCDNA5/FRT/TO-EGFP-IRES expression plasmid. 
After 20 min the reaction mixture was added to the Flp-In T-REx HeLa host cells and 
incubated at 37 °C for 48 h. Afterwards, the cells were put under selection for two 
weeks in DMEM with 10 % tetracycline-free FBS supplemented with 250 µg/mL 
hygromycin and 5 µg/mL blasticidin. Cells of single colonies were maintained in 
DMEM with 10 % tetracycline-free FBS supplemented with hygromycin and 
blasticidin. HeLa cells were maintained in DMEM with 10 % tetracycline-free FBS. 
 
5.5.2 Immunofluorescence and RNA interference 
For the purpose of studying the cellular localization of SKAP, immunofluorescence 
experiments were performed either with GFP-SKAP WT and GFP-SKAP mutants or 
endogenous SKAP. For localization studies with endogenous SKAP HeLa cells were 
grown on coverslips precoated with poly-D-lysine and poly-L-lysine. Cells were 
treated with 10 µM MG132 or 3.3 µM nocodazole for 3 h and in some cases 500 nM 
Hesperadin was added for 1.5 h in order to inhibit AuroraB kinase. In case of GFP 
fusion constructs respective Flp-In T-REx HeLa cells were grown on coverslips 
precoated with poly-D-lysine and poly-L-lysine. To induce gene expression, 
0.1 µg/mL doxycycline was added for 24 h. Afterwards, cells were treated for 2-3 h 
with 10 µM of the proteasome inhibitor MG132 to arrest the cells in metaphase. In 
order to analyze the phenotypes of SKAP-depleted cells Flp-In T-REx HeLa cells 
were treated with small interfering RNA (siRNA). For this purpose, 100 µL medium 
were mixed with 10 µL HyPerFect transfection reagent. After incubation for 5 min 
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siRNA duplexes (SKAP1: GAAAGAGUCCGAUUCCUAG[dT][dT], SKAP2: 
AGGCUACAAACCACUGAGUAA) were added for 20 min. Cells were transfected 
with 100 nM siRNA for 24 h, 48 h or 72 h. The efficiency of the siRNA treatment was 
analyzed with cell lysates via western blot and with immunofluorescence as 
described below. To study whether SKAP WT or mutants can rescue the observed 
phenotype, the expression of GFP fusion proteins in SKAP-depleted cells was 
induced for 24 h prior to fixation of the cells.  
Cells were fixed with 4 % paraformaldehyde in PBS for 10 min and permeabilized 
with 0.1 % Triton X-100 in PBS for 5-10 min. Coverslips were blocked in 4 % BSA in 
PBS for 1 h at room temperature. Cells were stained for SKAP (rabbit polyclonal anti-
SKAP135-225 antibody made in cooperation with Cogentech, Milan, IT, 1:1,000), 
α-tubulin (mouse monoclonal anti-α-tubulin antibody, DM1A, Sigma-Aldrich, 1:500) 
and CREST/anti-centromere antibodies (Antibodies, Inc., Davis, US-CA, 1:100) 
diluted in 2 % BSA in PBS for 1.5 h at room temperature. After washing with PBS 
coverslips were incubated with donkey anti-rabbit Alexa Fluor 488 (Invitrogen, 
Carlsbad, US-CA, 1:200), goat anti-mouse Rhodamine Red-X (Jackson 
ImmunoResearch Laboratories, Inc., West Grove, US-PA, 1:200) and goat anti-
human Alexa Fluor 647 (Invitrogen, Carlsbad, US-CA, 1:200) as secondary 
antibodies for 1 h at room temperature. DNA was stained with 0.5 µg/mL DAPI for 
5 min. The coverslips were washed with PBS and water, airdried and mounted with 
Mowiol mounting media. 
Cells were imaged using a DeltaVision Elite imaging system (Applied Precision, 
Issaquah, US-WA) with an inverted Olympus IX71 microscope (Olympus, Shinjuku, 
Tokyo, JP) equipped with a U Plan-Apochromat 60x/1.42NA oil objective (Olympus, 
Shinjuku, Tokyo, JP) and a CoolSNAP HQ2 camera (Photometrics, Tucson, US-AZ). 
Images were acquired as z-sections at 0.2 µm and the deconvolution and maximal 
intensity projections were carried out with softWoRx 5.0 (Applied Precision, 
Issaquah, US-WA). The quantification of fluorescence intensities at kinetochores and 
spindle microtubules was performed with unmodified z-series images using the spot 
and the surface function of Imaris 7.3.4 software (Bitplane, Zurich, CH). After 
background subtraction the GFP signals were normalized to those of the SKAP full-
length WT cell line. For quantification of endogenous SKAP localization intensities 
obtained for SKAP were normalized to CREST signals. 
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5.6 Biophysical methods 
5.6.1 Microscale thermophoresis 
Microscale thermophoresis experiments (Jerabek-Willemsen et al., 2011) were 
performed to analyze protein-protein interactions. Protein samples were prepared as 
serial 1:1 dilutions with 150 nM mCherry-SKAP159-316 as fluorescent binding partner 
and 1.53-12,500 nM Mis12 complex, 0.76-6,250 nM Ndc80 complex or 
1.53-12,500 nM Zwint as unlabeled titrated binding partner, respectively. For the 
interaction of the Mis12 complex and the Ndc80 complex, 2 nM GFP-tagged Ndc80 
complex were incubated with 0.12-500 nM Mis12 complex in 20 mM Hepes, pH 7.5, 
150 mM NaCl, 5 % (v/v) glycerol, 0.05 % (v/v) Triton X-100 and 10 mM β-
mercaptoethanol. Reactions were performed in 20 mM Hepes, pH 7.5, 150 mM 
NaCl, 0-5 % (v/v) glycerol, 0.5 mg/mL BSA and 2 mM DTE. After spinning for 5 min 
at 20,000 g samples were transferred to standard glass capillaries (NanoTemper 
Technologies GmbH, Munich, DE) and analyzed with a Monolith NT.115 instrument 
(NanoTemper Technologies GmbH, Munich, DE). Experiments were controlled with 
NT Control software and analyzed with NT Analysis software. The signals of the 
initial fluorescence or the thermophoresis and temperature jump were normalized to 
signals of sample with lowest concentration of titrated unlabeled protein. The 
normalized data were plotted against the concentration of titrated unlabeled protein 
and fitted with Origin7.0 (OriginLab, Northampton, US-MA) using following equation 
(NanoTemper Technologies GmbH, Munich, DE): 
f(c) = unbound + bound − unbound ∙ F+c+Kd − F+c+Kd 2 − 4Fc
2F
 
with f(c) as concentration dependent signal, unbound as signal of unbound state, 
bound as signal of bound state, F as fluorophore concentration, c as concentration of 
titrated unlabeled protein and Kd as dissociation constant. 
 
5.6.2 Sedimentation velocity analytical ultracentrifugation 
Sedimentation velocity experiments were used to determine the molecular weight 
and thereby the oligomeric state of the analyzed proteins. The experiments were 
performed in an Optima XL-A analytical ultracentrifuge (Beckman Coulter, Palo Alto, 
US-CA) with Epon charcoal-filled double-sector quartz cells and an An-60 Ti rotor 
(Beckman Coulter, Palo Alto, US-CA). Before the analysis samples were dialyzed 
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against buffer (20 mM Hepes, pH 7.5, 300 mM NaCl, 10 % glycerol and 2 mM DTE) 
that was used as blank. Samples were centrifuged at 42,000 rpm at 20 °C and 500 
radial absorbance scans at 280 nm were collected with a time interval of 1 min. The 
data were analyzed using the SEDFIT software (Schuck, 2000) in terms of 
continuous distribution function of sedimentation coefficients (c(S)). The protein 
partial specific volume was estimated from the amino acid sequence using the 
program SEDNTERP. Data were plotted using the program GUSSI. 
 
5.7 Structural methods 
5.7.1 Bioinformatic methods 
A bioinformatic characterization of Astrin and SKAP was performed in order to obtain 
possible hints regarding the structural and functional organization of the two proteins, 
which could be used to design appropriate truncation constructs. For this purpose, 
the servers and programs listed in Table 5.6 were used.  
 
Table 5.6: List of used servers and programs for the bioinformatic characterization of Astrin and 
SKAP. 
program predicted feature homepage 
Jpred (Cole et al., 
2008) 
secondary structure http://www.compbio.dundee.ac.uk/w
ww-jpred/  
PSIPRED (Buchan et 
al., 2013) 
secondary structure http://bioinf.cs.ucl.ac.uk/psipred/ 
Phyre2 (Kelley & 
Sternberg, 2009) 
tertiary structure http://www.sbg.bio.ic.ac.uk/phyre2/ 
I-TASSER (Roy et al., 
2010; Zhang, 2008) 
tertiary structure http://zhanglab.ccmb.med.umich.edu
/I-TASSER/  
Paircoil2 (McDonnell 
et al., 2006) 
coiled-coil regions http://groups.csail.mit.edu/cb/paircoil
2/  
 
5.7.2 X-ray crystallography 
5.7.2.1 Protein crystallization 
In order to determine the crystal structure of SKAP, crystallization experiments were 
performed with appropriately truncated SKAP constructs. For this purpose, the 
crystallization behavior of the proteins was first tested via sitting-drop vapor diffusion 
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with the screens JCSG Core I-IV (Qiagen, Hilden, DE) in 96-well Corning 3550 plates 
(Corning, New York, US-NY). In these initial crystallization experiments 100 nL 
protein solution were mixed with 100 nL reservoir solution with a Mosquito nanoliter 
high-throughput robot (TPP LabTech, Melbourne, GB) and incubated with 75 µL 
reservoir solution at 20 °C.  
Successful conditions of the initial crystallization experiments were reproduced and 
refined via hanging-drop vapor diffusion in 24-well plates Linbro 24 Conical Flat 
Bottom Wells (MP Biomedicals, Santa Ana, US-CA). Therefor, 1 µL of protein 
solution was mixed with 1 µL of reservoir solution and incubated with 500 µL of 
reservoir solution at 20 °C.  
 
5.7.2.2 Soaking with heavy atom derivatives 
To obtain the phase information, heavy atoms were introduced into the crystals via 
soaking experiments with heavy atom derivatives, including K2PtCl4, Pt(NH3)2Cl2, 
UO2(CH3COO)2 and Pb(CH3COO)2. For this purpose, native SKAP135-225 crystals 
were soaked with different concentrations of the heavy atom derivatives diluted in 
reservoir solution for 1-30 min before freezing the crystals.  
 
5.7.2.3 Data collection and processing 
Crystals were cryo-cooled in liquid nitrogen. If required, the crystals were soaked 
before with cryo solution containing reservoir solution and 20-30 % (v/v) glycerol or 
30-40 % PEG 200 in order to avoid ice formation. Crystal diffraction was tested in-
house at 100 K with a Nonius MICRO Star generator (Bruker AXS, Karlsruhe, DE) 
and a mar345 CCD detector (mar research, Norderstedt, DE). Data sets were 
collected on the beamline PXII of the Swiss Light Source (SLS) at the Paul Scherrer 
Institute, Villigen, CH, with a transmission of 20 %, an exposure time of 0.1 s, a 
rotation of 0.25°/image and a total rotation of 180-360°.  
For data processing the following programs were used: XDS for indexing and 
integration of the reflections of all diffraction images; XSCALE for scaling the related 
intensities; XDSCONV to convert the hkl file to an mtz-file; Phenix AutoSol for 
identifying heavy atom positions and isomorphous replacement.  
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5.7.3 Negative stain electron microscopy 
Prior to electron microscopy experiments Astrin482-850/SKAP159-316 complex was 
freshly purified and diluted appropriately after final size-exclusion chromatography. 
The specimens were prepared using the conventional negative staining procedure 
(Bröcker et al., 2012). For this purpose, 4 µl of the diluted sample were adsorbed for 
40 s on a freshly glow-discharged 400 mesh copper grid (G2400C, Plano GmbH, 
Wetzlar, DE) that was covered with a thin carbon film. The excess solution was 
blotted by touching a Whatman filter paper. The specimens were washed three times 
with a drop of size-exclusion chromatography buffer and once with freshly prepared 
0.75 % uranyl formate (SPI Supplies/Structure Probe, West Chester, US-PA). The 
samples were exposed to the staining solution for about 1 min. After removing the 
excess stain by blotting the specimen was air-dried. Image acquisition was 
performed with a Joel JEM-1400 electron microscope equipped with a LaB6 cathode 
and operated at an acceleration voltage of 120 kV. Digital micrographs were 
recorded at a corrected magnification of 82,524x using a 4k x 4k CMOS camera 
F416 (TVIPS, Gauting, DE) at a pixel size of 1.89 Å/pixel under minimal dose 
conditions. 
For experiments with Astrin482-850/SKAP159-316 complex on microtubules, GMPCPP-
stabilized microtubule seeds were prepared as follows (Gell et al., 2010). 20 µM 
tubulin (Cytoskeleton, Inc., Denver, US-CO) was mixed with 1 mM GMPCPP in 
BRB80 buffer and incubated on ice for 5 min and then at 37 °C for 30 min. After 
spinning at 126,000 g for 5 min in a TLA 120.1 rotor the pellet was resuspended in 
BRB80 buffer and incubated on ice for 20 min. After addition of 1 mM GMPCPP the 
sample was again incubated on ice for 5 min and then at 37 °C for 30 min. After 
another centrifugation at 126,000 g for 5 min the pellet was dissolved in the size-
exclusion chromatography buffer of the Astrin482-850/SKAP159-316 complex. The 
GMPCPP-stabilized microtubule seeds were mixed with the Astrin482-850/SKAP159-316 
complex and incubated on the grid for 5 min at 37 °C. Subsequently, the negative 
stain specimens were prepared as described above. Digital micrographs were 
recorded at a corrected magnification of 34,110x at a pixel size of 4.66 Å/pixel.  
To analyze the effect of SKAP on the structure of microtubules, 10 µM bovine tubulin 
(Cytoskeleton, Inc., Denver, US-CO) was mixed with 0-10 µM SKAP135-225 in reaction 
buffer (25 mM Hepes, pH 7.5, 150 mM NaCl, 5 % (v/v) glycerol, 4 mM MgCl2, 1 mM 
EGTA, 2 mM DTE and 2.5 mM GTP) and incubated 10 min at 34 °C. After addition of 
50 µM taxol the samples were incubated for 30 min at 34 °C. 4 µL of undiluted 
samples were adsorbed onto grids for 10 s and prepared as described above.  
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6 SUPPLEMENT 
6.1 Supplementary figures 
 
 
Figure 6.1: Secondary structure of SKAP predicted by PSIPRED. 
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Figure 6.2: Coiled-coil domain prediction of SKAP performed with Paircoil2. 
 
 
Figure 6.3: Secondary structure of Astrin predicted by PSIPRED. 
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Figure 6.3 (continued): Secondary structure of Astrin predicted by PSIPRED. 
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Figure 6.3 (continued): Secondary structure of Astrin predicted by PSIPRED. 
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Figure 6.3 (continued): Secondary structure of Astrin predicted by PSIPRED. 
 
 
Figure 6.4: Coiled-coil domain prediction of Astrin performed with Paircoil2. 
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Figure 6.5: Test coexpression of His6-Astrin482-850 and SKAP159-316 in Tnao38 cells. M: molecular 
weight marker with molecular weights indicated on the left, 3d and 4d: whole cell extracts after 3 and 
4 days of expression, S: soluble fraction after clearing the cell lysate, E: eluate of the bead fraction. 
 
 
Figure 6.6: Microtubule cosedimentation assay of SKAP135-225 K140A. Representative SDS-PAGE 
gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized microtubules (MTs) and 1 µM 
SKAP135-225 K140A. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. 
 
 
Figure 6.7: Microtubule cosedimentation assay of SKAP135-225 K149A. Representative SDS-PAGE 
gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized microtubules (MTs) and 1 µM 
SKAP135-225 K149A. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. 
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Figure 6.8: Microtubule cosedimentation assay of SKAP135-225 K161A. Representative SDS-PAGE 
gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized microtubules (MTs) and 1 µM 
SKAP135-225 K161A. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. 
 
 
Figure 6.9: Microtubule cosedimentation assay of SKAP135-225 K164A. Representative SDS-PAGE 
gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized microtubules (MTs) and 1 µM 
SKAP135-225 K164A. S: soluble fraction with proteins not bound to microtubules. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. 
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Figure 6.10: Microtubule cosedimentation assay of SKAP135-225 K161/164A. Representative SDS-
PAGE gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized microtubules (MTs) and 
1 µM SKAP135-225 K161/164A. S: soluble fraction with proteins not bound to MTs. P: pellet fraction with 
microtubules and bound proteins. M: molecular weight marker with molecular weights indicated on the 
left. 
 
 
Figure 6.11: Microtubule cosedimentation assay of SKAP135-225 K140/149/161/164A. Representative 
SDS-PAGE gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized microtubules (MTs) 
and 1 µM SKAP135-225 K140/149/161/164A. S: soluble fraction with proteins not bound to microtubules. 
P: pellet fraction with microtubules and bound proteins. M: molecular weight marker with molecular 
weights indicated on the left. 
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Figure 6.12: Microtubule cosedimentation assay of SKAP135-225 K140/149/161/164/168/170A. 
Representative SDS-PAGE gels of microtubule cosedimentation assay with 0-10 µM taxol-stabilized 
microtubules (MTs) and 1 µM SKAP135-225 K140/149/161/164/168/170A. S: soluble fraction with proteins 
not bound to microtubules. P: pellet fraction with microtubules and bound proteins. M: molecular weight 
marker with molecular weights indicated on the left. 
 
 
 
Figure 6.13: Screen of appropriate conditions for crosslinking analysis of microtubules and 
SKAP135-225. SDS-PAGE gels of crosslinking reactions performed with 10 µM taxol-stabilized 
microtubules, 10 µM SKAP135-225 and the crosslinkers BS2G (A) and DSS (B). Crosslinker:protein weight 
ratios from left to right were 0:1, 1:10, 1:5, 1:2.5, 1:1, 2.5:1, 5:1 and 10:1. M: molecular weight marker 
with molecular weights indicated on the left. 
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Figure 6.14: Tubulin and BSA controls for tubulin polymerization assay. Tubulin polymerization 
assays with 10-15 µM tubulin and 0-5 µM BSA. Tubulin polymerization was measured by following the 
absorbance at 350 nm at 37 °C. 
 
 
Figure 6.15: SKAP159-225 and SKAP159-316 do not promote tubulin polymerization. Tubulin 
polymerization assays with 5 µM tubulin and 1 µM of SKAP135-225, SKAP159-225 or SKAP159-316. Tubulin 
polymerization was measured by following the absorbance at 350 nm at 37 °C. 
 
 
Figure 6.16: Levels of GFP-SKAP wild type and mutants after doxycycline induction. Western 
blots with cell lysates of stable Flp-In T-REx cell lines expressing GFP-SKAP full-length wild type or 
indicated mutants. Cells were treated with 0.1 µg/mL doxycycline for 24 h. Western blots were stained 
for GFP and tubulin as loading control. 
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Figure 6.17: The Mis12 complex and the Ndc80 complex do not interact in MST. Quantification of 
microscale thermophoresis assay with 2 nM GFP-tagged Ndc80 complex and the Mis12 complex. 
Normalized difference in fluorescence for the thermophoresis and the temperature jump signal. Signals 
were analyzed with the NT Analysis software (NanoTemper Technologies GmbH, Munich, DE). 
 
1 10 1000.1
[Mis 12 complex] (nM)
-10
20
0
-20
10
ΔF
no
rm
 (‰
)
  
153 
6.2 Supplementary tables 
Table 6.1: Crosslinks between microtubules and SKAP135-225 in presence of DSS. TIC: fraction of total ion current of fragment ion spectrum assigned to crosslink. Mz: 
mass to charge ratio. nseen: number of fragment ion spectra assigned to the crosslink in entire dataset. 
Summary of intermolecular crosslinks 
Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
FDLMYAKR-ITKLR-a7-b3 α-Tubulin SKAP 401 140 453,512 4 -1,3 4 0,71 41,71 
FDLMYAKR-GYKPLSK-a7-b3 α-Tubulin SKAP 401 164 494,019 4 -2,8 4 0,65 41,22 
LDHKFDLMYAK-ITKLR-a4-b3 α-Tubulin SKAP 394 140 537,802 4 -1,9 2 0,59 40,22 
LDHKFDLMYAKR-ITKLR-a11-b3 α-Tubulin SKAP 401 140 461,664 5 -1,1 2 0,58 39,58 
DVNAAIATIKTK-ITKLR-a10-b3 α-Tubulin SKAP 336 140 671,408 3 -1,1 4 0,62 38,45 
LSVDYGKK-ITKLR-a7-b3 α-Tubulin SKAP 163 140 420,004 4 -2,1 2 0,64 38,28 
GHYTIGKEIIDLVLDR-ITKLR-a7-b3 α-Tubulin SKAP 112 140 653,131 4 -1,3 8 0,61 38,17 
LDHKFDLMYAK-GYKPLSK-a4-b3 α-Tubulin SKAP 394 164 578,31 4 -1,4 3 0,44 37,86 
ENGQMKATDTATRR-LSVDYGKK-a6-b7 SKAP α-Tubulin 149 163 525,871 5 -2 3 0,49 37,43 
FDLMYAKR-KGYKPLSK-a7-b4 α-Tubulin SKAP 401 164 526,043 4 -1,9 3 0,77 37,41 
LSVDYGKK-SEEELKDK-a7-b6 α-Tubulin SKAP 163 176 506,766 4 -1 2 0,44 36,81 
LDHKFDLMYAKR-KGYKPLSK-a11-b1 α-Tubulin SKAP 401 161 519,689 5 -2,1 2 0,57 36,51 
HGKYMACCLLYR-KGYKPLSK-a3-b1 α-Tubulin SKAP 311 161 658,091 4 -2,2 3 0,41 35,49 
GHYTIGKEIIDLVLDR-KGYKPLSK-a7-b1 α-Tubulin SKAP 112 161 725,662 4 -2,1 8 0,47 34,8 
LSVDYGKK-QKSEEELK-a7-b2 α-Tubulin SKAP 163 170 510,023 4 -3,2 4 0,5 34,75 
HGKYMACCLLYR-ITKLR-a3-b3 α-Tubulin SKAP 311 140 585,561 4 0,1 3 0,51 34,72 
TIGGGDDSFNTFFSETGAGKHVPR-ITKLR-a20-b3 α-Tubulin SKAP 60 140 653,738 5 -1,5 3 0,45 34,34 
  1
54
 
Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
FDLMYAKR-QKSEEELK-a7-b2 α-Tubulin SKAP 401 170 543,531 4 -2 3 0,39 33,96 
LDHKFDLMYAK-KGYKPLSK-a4-b1 α-Tubulin SKAP 394 161 610,334 4 -1,7 1 0,34 33,76 
GHYTIGKEIIDLVLDR-ENGQMKATDTATR-a7-b6 α-Tubulin SKAP 112 149 681,152 5 -2,3 2 0,43 33,69 
DVNAAIATIKTK-KGYKPLSK-a10-b4 α-Tubulin SKAP 336 164 576,34 4 -1,3 2 0,52 33,68 
DVNAAIATIKTK-KGYKPLSK-a10-b1 α-Tubulin SKAP 336 161 576,34 4 -0,9 1 0,58 32,83 
GHYTIGKEIIDLVLDR-GYKPLSK-a7-b3 α-Tubulin SKAP 112 164 693,638 4 -2,3 5 0,5 32,39 
GYKPLSKQK-LSVDYGKK-a7-b7 SKAP α-Tubulin 168 163 419,842 5 -1,5 3 0,49 32,26 
GHYTIGKEIIDLVLDR-RENGQMKATDTATR-a7-b7 α-Tubulin SKAP 112 149 712,373 5 -2 4 0,46 31,86 
KLAVNMVPFPR-FDLMYAKR-a1-b7 β-Tubulin α-Tubulin 252 401 613,835 4 -3,3 2 0,51 31,74 
LDHKFDLMYAKR-KGYKPLSK-a11-b4 α-Tubulin SKAP 401 164 519,688 5 -2,2 1 0,39 31,08 
DVNAAIATIKTK-GYKPLSK-a10-b3 α-Tubulin SKAP 336 164 725,419 3 -1 2 0,56 30,87 
KGYKPLSK-LSVDYGKK-a1-b7 SKAP α-Tubulin 161 163 656,378 3 -2,4 2 0,34 30,65 
ENGQMKATDTATRR-FDLMYAKR-a6-b7 SKAP α-Tubulin 149 401 690,595 4 -1,4 1 0,46 30,58 
ENGQMKATDTATR-HGKYMACCLLYR-a6-b3 SKAP α-Tubulin 149 311 783,618 4 -1,5 2 0,37 30,21 
DVNAAIATIKTK-QKSEEELK-a10-b2 α-Tubulin SKAP 336 170 791,436 3 -0,4 2 0,29 29,75 
KLAVNMVPFPR-VELLEKFR-a1-b6 β-Tubulin SKAP 252 212 611,354 4 -1,1 6 0,49 29,52 
ENGQMKATDTATR-KLAVNMVPFPR-a6-b1 SKAP β-Tubulin 149 252 708,618 4 -2,2 2 0,44 29,1 
QLFHPEQLITGKEDAANNYAR-KGYKPLSK-a12-b1 α-Tubulin SKAP 96 161 695,37 5 -1,9 8 0,39 28,6 
FDLMYAKR-KGYKPLSK-a7-b1 α-Tubulin SKAP 401 161 701,055 3 -1 1 0,37 27,84 
QLFHPEQLITGKEDAANNYAR-
MSMKEVDEQMLNVQNK-a12-b4 α-Tubulin β-Tubulin 96 324 1119,79 4 -1,4 3 0,31 27,71 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
ENGQMKATDTATR-FDLMYAKR-a6-b7 SKAP α-Tubulin 149 401 868,423 3 -2,6 3 0,26 27,25 
LDHKFDLMYAKR-GYKPLSKQK-a11-b7 α-Tubulin SKAP 401 168 545,301 5 -0,4 1 0,41 26,88 
ENGQMKATDTATR-LDHKFDLMYAK-a6-b4 SKAP α-Tubulin 149 394 735,861 4 -0,6 2 0,26 26,21 
TLKLTTPTYGDLNHLVSATMSGVTTCLR-
GDVVPKDVNAAIATIK-a3-b6 β-Tubulin α-Tubulin 216 326 960,514 5 0 1 0,34 24,77 
DNCLAILESKG-KLAVNMVPFPR-a10-b1 SKAP β-Tubulin 224 252 876,8 3 -1,9 1 0,32 24,32 
GHYTIGKEIIDLVLDR-QKSEEELK-a7-b2 α-Tubulin SKAP 112 170 743,151 4 -0,9 3 0,31 23,92 
VGINYQPPTVVPGGDLAKVQR-
RENGQMKATDTATR-a18-b7 α-Tubulin SKAP 370 149 785,613 5 -1,8 2 0,58 22,79 
 
Summary of intramolecular crosslinks 
Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
VELLEKFR-ITKLR-a6-b3 SKAP SKAP 212 140 451,029 4 -1,4 7 0,73 44,44 
VELLEKFR-GYKPLSK-a6-b3 SKAP SKAP 212 164 491,536 4 -2,8 7 0,68 42,74 
SEEELKDK-ITKLR-a6-b3 SKAP SKAP 176 140 582,327 3 -2,2 4 0,62 42,49 
SEEELKDK-GYKPLSK-a6-b3 SKAP SKAP 176 164 477,506 4 -0,5 10 0,58 42,26 
KGYKPLSK-SEEELKDK-a4-b6 SKAP SKAP 164 176 407,825 5 -0,7 17 0,56 42,03 
KGYKPLSK-ITKLR-a1-b3 SKAP SKAP 161 140 422,767 4 -0,9 20 0,68 41,93 
GYKPLSK-ITKLRR-a3-b3 SKAP SKAP 164 140 429,768 4 -2,2 7 0,47 41,6 
DLTQKVELLEKFR-ITKLR-a11-b3 SKAP SKAP 212 140 597,357 4 -2 2 0,62 41,56 
  1
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
QKSEEELK-GYKPLSK-a2-b3 SKAP SKAP 170 164 480,763 4 -2,3 26 0,4 41,53 
GYKPLSKQK-GYKPLSK-a7-b3 SKAP SKAP 168 164 495,289 4 -1,8 7 0,54 41,14 
GYKPLSKQK-KGYKPLSK-a7-b1 SKAP SKAP 168 161 422,053 5 -0,7 6 0,55 40,94 
GYKPLSKQK-SEEELKDK-a7-b6 SKAP SKAP 168 176 721,723 3 -1,1 19 0,65 40,94 
GYKPLSKQK-KGYKPLSK-a7-b4 SKAP SKAP 168 164 422,052 5 -1,5 14 0,54 40,93 
SEEELKDK-VELLEKFR-a6-b6 SKAP SKAP 176 212 537,791 4 -2,2 6 0,59 40,86 
KGYKPLSK-KGYKPLSK-a1-b4 SKAP SKAP 161 164 495,299 4 -1,1 4 0,6 40,77 
NQLLEAVNKQLHQK-ITKLR-a9-b3 SKAP SKAP 187 140 486,889 5 -1,7 7 0,56 40,67 
GYKPLSK-ITKLR-a3-b3 SKAP SKAP 164 140 520,656 3 -0,2 3 0,6 40,64 
DKNQLLEAVNK-DLTQKVELLEK-a2-b5 SKAP SKAP 178 206 681,881 4 -1 2 0,48 40,58 
DLTQKVELLEKFR-DLTQKVELLEK-a11-b5 SKAP SKAP 212 206 768,685 4 -2,6 3 0,49 40,5 
KGYKPLSK-GYKPLSK-a1-b3 SKAP SKAP 161 164 463,275 4 -2 11 0,48 40,39 
DLTQKVELLEK-VELLEKFR-a5-b6 SKAP SKAP 206 212 622,358 4 -1,6 4 0,58 40,15 
GYKPLSKQK-VELLEKFR-a7-b6 SKAP SKAP 168 212 444,662 5 -1,7 2 0,56 40,1 
KGYKPLSK-ITKLRR-a4-b3 SKAP SKAP 164 140 461,793 4 0,6 10 0,52 39,75 
DKNQLLEAVNK-ITKLR-a2-b3 SKAP SKAP 178 140 510,552 4 -0,9 8 0,57 39,73 
DKNQLLEAVNK-GYKPLSK-a2-b3 SKAP SKAP 178 164 734,411 3 -0,9 8 0,53 39,39 
QKSEEELK-VELLEKFR-a2-b6 SKAP SKAP 170 212 541,049 4 -2 5 0,55 39,14 
DLTQKVELLEK-GYKPLSK-a5-b3 SKAP SKAP 206 164 562,073 4 -1,2 5 0,53 39,12 
DLTQKVELLEK-KGYKPLSK-a5-b4 SKAP SKAP 206 164 594,095 4 -2,7 7 0,6 39,02 
KGYKPLSK-SEEELKDK-a1-b6 SKAP SKAP 161 176 679,036 3 -1,2 14 0,48 38,87 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
RENGQMKATDTATR-VELLEKFR-a7-b6 SKAP SKAP 149 212 688,112 4 -2,7 13 0,67 38,76 
KGYKPLSK-ITKLR-a4-b3 SKAP SKAP 164 140 422,767 4 -1,4 13 0,61 38,62 
LTETQGELKDLTQK-VELLEKFR-a9-b6 SKAP SKAP 201 212 925,51 3 -1,7 4 0,46 38,31 
NQLLEAVNKQLHQK-DKNQLLEAVNK-a9-b2 SKAP SKAP 187 178 1024,57 3 0,4 7 0,42 38,26 
DLTQKVELLEK-DNCLAILESKG-a5-b10 SKAP SKAP 206 224 891,473 3 -1,8 4 0,52 38,25 
QKSEEELK-ITKLR-a2-b3 SKAP SKAP 170 140 440,255 4 -2 7 0,33 38,21 
QLHQKLTETQGELK-DKNQLLEAVNK-a5-b2 SKAP SKAP 192 178 613,137 5 -0,6 11 0,53 37,99 
KGYKPLSKQK-KGYKPLSK-a8-b1 SKAP SKAP 168 161 447,671 5 -1,5 2 0,51 37,95 
DNCLAILESKG-VELLEKFR-a10-b6 SKAP SKAP 224 212 797,427 3 0,4 34 0,5 37,8 
LTETQGELKDLTQKVELLEK-VELLEKFR-a9-b6 SKAP SKAP 201 212 697,992 5 -2,5 4 0,57 37,79 
KGYKPLSKQK-SEEELKDK-a8-b6 SKAP SKAP 168 176 764,421 3 -1,1 2 0,41 37,63 
DLTQKVELLEK-ITKLR-a5-b3 SKAP SKAP 206 140 521,565 4 -1,2 4 0,57 37,6 
GYKPLSKQK-QKSEEELK-a7-b2 SKAP SKAP 168 170 436,043 5 -1,9 10 0,31 37,53 
DLTQKVELLEKFR-KGYKPLSK-a11-b1 SKAP SKAP 212 161 669,889 4 -0,7 5 0,44 37,51 
RENGQMKATDTATR-GYKPLSK-a7-b3 SKAP SKAP 149 164 627,827 4 -1,8 16 0,44 37,38 
DKNQLLEAVNK-VELLEKFR-a2-b6 SKAP SKAP 178 212 814,791 3 -1,4 5 0,49 37,31 
DKNQLLEAVNK-SEEELKDK-a2-b6 SKAP SKAP 178 176 796,083 3 -1,1 6 0,47 37,3 
QLHQKLTETQGELK-GYKPLSK-a5-b3 SKAP SKAP 192 164 517,289 5 -2,2 7 0,37 37,16 
ENGQMKATDTATR-VELLEKFR-a6-b6 SKAP SKAP 149 212 649,087 4 -2,3 8 0,46 37,12 
FRDNCLAILESKG-VELLEKFR-a12-b6 SKAP SKAP 224 212 674,114 4 -1 14 0,44 37,05 
ENGQMKATDTATR-DKNQLLEAVNK-a6-b2 SKAP SKAP 149 178 708,609 4 -2,9 7 0,46 36,95 
  1
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
KGYKPLSK-ITKLRR-a1-b3 SKAP SKAP 161 140 461,792 4 -1,3 4 0,4 36,89 
ENGQMKATDTATR-GPLGSVTKITK-a6-b8 SKAP SKAP 149 137 887,466 3 -4 4 0,37 36,82 
ENGQMKATDTATR-KGYKPLSK-a6-b1 SKAP SKAP 149 161 827,434 3 2,2 30 0,35 36,8 
LTETQGELKDLTQK-ITKLRR-a9-b3 SKAP SKAP 201 140 506,295 5 -1,5 9 0,55 36,72 
DLTQKVELLEKFR-DKNQLLEAVNK-a11-b2 SKAP SKAP 212 178 1009,89 3 -2 5 0,36 36,48 
LTETQGELKDLTQK-QKSEEELK-a9-b2 SKAP SKAP 201 170 911,147 3 0,2 4 0,28 36,48 
GPLGSVTKITK-VELLEKFR-a8-b6 SKAP SKAP 137 212 757,78 3 -3,7 1 0,63 36,45 
NQLLEAVNKQLHQK-GYKPLSK-a9-b3 SKAP SKAP 187 164 648,868 4 -0,6 3 0,54 36,38 
QKSEEELK-SEEELKDK-a2-b6 SKAP SKAP 170 176 527,017 4 -1,8 5 0,53 36,35 
KGYKPLSK-QKSEEELK-a1-b2 SKAP SKAP 161 170 512,787 4 -1,6 54 0,26 36,28 
QLHQKLTETQGELK-VELLEKFR-a5-b6 SKAP SKAP 192 212 565,517 5 -2,7 12 0,36 36,27 
DKNQLLEAVNK-KGYKPLSK-a2-b4 SKAP SKAP 178 164 777,109 3 -0,1 18 0,44 36,23 
ENGQMKATDTATRR-DKNQLLEAVNK-a6-b2 SKAP SKAP 149 178 598,31 5 -1,1 4 0,48 36,11 
KGYKPLSK-QKSEEELK-a4-b2 SKAP SKAP 164 170 683,38 3 -2,2 54 0,3 35,92 
QKSEEELKDK-KGYKPLSK-a8-b4 SKAP SKAP 176 164 459,056 5 -1,2 13 0,48 35,91 
DKNQLLEAVNK-KGYKPLSKQK-a2-b8 SKAP SKAP 178 168 862,492 3 -2,9 2 0,51 35,78 
QLHQKLTETQGELK-SEEELKDK-a5-b6 SKAP SKAP 192 176 692,615 4 -0,4 6 0,31 35,72 
DLTQKVELLEK-SEEELKDK-a5-b6 SKAP SKAP 206 176 608,327 4 -0,6 4 0,45 35,47 
RENGQMKATDTATR-DKNQLLEAVNK-a7-b2 SKAP SKAP 149 178 598,31 5 -1,5 6 0,45 35,02 
ENGQMKATDTATR-KGYKPLSK-a6-b4 SKAP SKAP 149 164 620,826 4 0,2 16 0,41 35,02 
ENGQMKATDTATR-DLTQKVELLEK-a6-b5 SKAP SKAP 149 206 719,623 4 -0,9 6 0,45 34,92 
  
159 
Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
DKNQLLEAVNK-QKSEEELK-a2-b2 SKAP SKAP 178 170 600,571 4 -2 13 0,43 34,92 
GPLGSVTKITK-KGYKPLSK-a8-b1 SKAP SKAP 137 161 432,463 5 -0,3 2 0,54 34,83 
DLTQKVELLEK-ITKLRR-a5-b3 SKAP SKAP 206 140 560,59 4 -1,6 2 0,57 34,69 
LTETQGELKDLTQK-KGYKPLSK-a9-b4 SKAP SKAP 201 164 887,829 3 -0,3 10 0,35 34,65 
DLTQKVELLEK-QKSEEELK-a5-b2 SKAP SKAP 206 170 611,584 4 -1,8 4 0,47 34,59 
QLHQKLTETQGELK-ITKLR-a5-b3 SKAP SKAP 192 140 484,884 5 -0,3 6 0,3 34,57 
ENGQMKATDTATRR-ITKLR-a6-b3 SKAP SKAP 149 140 470,056 5 -3 31 0,45 34,52 
LTETQGELKDLTQK-DKNQLLEAVNK-a9-b2 SKAP SKAP 201 178 1004,87 3 -2,5 4 0,46 34,51 
ENGQMKATDTATRR-GYKPLSK-a6-b3 SKAP SKAP 149 164 502,463 5 -1,6 23 0,38 34,5 
ENGQMKATDTATR-GYKPLSK-a6-b3 SKAP SKAP 149 164 784,734 3 -0,9 6 0,45 34,38 
ENGQMKATDTATR-ITKLR-a6-b3 SKAP SKAP 149 140 730,723 3 -1 22 0,32 34,38 
DLTQKVELLEKFR-KGYKPLSK-a11-b4 SKAP SKAP 212 164 536,112 5 -2,6 5 0,67 34,28 
QLHQKLTETQGELK-QKSEEELK-a5-b2 SKAP SKAP 192 170 927,493 3 -1,5 8 0,1 34,19 
ENGQMKATDTATR-GYKPLSKQK-a6-b7 SKAP SKAP 149 168 522,473 5 -1,9 12 0,21 34,19 
NQLLEAVNKQLHQK-GYKPLSKQK-a9-b7 SKAP SKAP 187 168 712,906 4 -1,4 5 0,38 34,08 
QLHQKLTETQGELK-KGYKPLSK-a5-b1 SKAP SKAP 192 161 678,384 4 -0,8 21 0,26 34,05 
LTETQGELKDLTQK-GYKPLSKQK-a9-b7 SKAP SKAP 201 168 930,514 3 -1,4 8 0,45 34,01 
NQLLEAVNKQLHQK-QLHQKLTETQGELK-a9-b5 SKAP SKAP 187 192 863,977 4 -0,6 5 0,28 33,98 
QLHQKLTETQGELK-DNCLAILESKG-a5-b10 SKAP SKAP 192 224 753,145 4 0,3 7 0,43 33,86 
NQLLEAVNKQLHQK-VELLEKFR-a9-b6 SKAP SKAP 187 212 945,205 3 1,7 3 0,49 33,77 
ENGQMKATDTATR-SEEELKDK-a6-b6 SKAP SKAP 149 176 846,406 3 -0,2 8 0,45 33,71 
  1
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
DKNQLLEAVNK-DNCLAILESKG-a2-b10 SKAP SKAP 178 224 876,79 3 -0,5 5 0,5 33,41 
GPLGSVTKITK-ITKLRR-a8-b3 SKAP SKAP 137 140 506,82 4 -0,8 2 0,59 33,37 
LTETQGELKDLTQK-DNCLAILESKG-a9-b10 SKAP SKAP 201 224 987,508 3 -1,4 2 0,49 33,32 
DKNQLLEAVNK-GPLGSVTKITK-a2-b8 SKAP SKAP 178 137 628,113 4 1,8 2 0,35 33,18 
RENGQMKATDTATR-GYKPLSKQK-a7-b7 SKAP SKAP 149 168 691,865 4 -1,1 7 0,64 33,15 
ENGQMKATDTATRR-KGYKPLSK-a6-b4 SKAP SKAP 149 164 528,082 5 -2 28 0,45 33,14 
LTETQGELKDLTQK-ENGQMKATDTATR-a9-b6 SKAP SKAP 201 149 1055,20 3 -1,6 4 0,37 33,1 
LTETQGELKDLTQKVELLEK-KGYKPLSK-a9-b1 SKAP SKAP 201 161 843,978 4 0,6 2 0,32 32,99 
QLHQKLTETQGELK-ENGQMKATDTATR-a5-b6 SKAP SKAP 192 149 803,912 4 0,4 13 0,33 32,98 
DLTQKVELLEKFR-FRDNCLAILESKG-a11-b12 SKAP SKAP 212 224 656,554 5 -1,6 11 0,46 32,92 
NQLLEAVNKQLHQK-ENGQMKATDTATR-a9-b6 SKAP SKAP 187 149 806,417 4 -2,5 5 0,32 32,9 
LTETQGELKDLTQK-SEEELKDK-a9-b6 SKAP SKAP 201 176 906,802 3 -1,8 2 0,4 32,87 
ENGQMKATDTATRR-KGYKPLSK-a6-b1 SKAP SKAP 149 161 659,851 4 -0,2 15 0,3 32,72 
NQLLEAVNKQLHQK-KGYKPLSK-a9-b1 SKAP SKAP 187 161 680,893 4 0,4 9 0,4 32,61 
LTETQGELKDLTQK-KGYKPLSKQK-a9-b4 SKAP SKAP 201 164 584,33 5 -1,4 4 0,39 32,6 
DLTQKVELLEKFR-SEEELKDK-a11-b6 SKAP SKAP 212 176 684,119 4 -1 1 0,48 32,58 
NQLLEAVNKQLHQK-FRDNCLAILESKG-a9-b12 SKAP SKAP 187 224 831,443 4 -2,5 8 0,42 32,57 
DKNQLLEAVNKQLHQK-DKNQLLEAVNK-a11-b2 SKAP SKAP 187 178 663,767 5 -1,7 3 0,42 32,45 
QLHQKLTETQGELK-KGYKPLSKQK-a5-b4 SKAP SKAP 192 164 742,423 4 0,3 3 0,31 32,43 
QLHQKLTETQGELK-ITKLRR-a5-b3 SKAP SKAP 192 140 516,104 5 -0,7 9 0,28 32,38 
QLHQKLTETQGELK-RENGQMKATDTATR-a5-b7 SKAP SKAP 192 149 674,551 5 -0,2 16 0,41 32,38 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
FRDNCLAILESKG-DKNQLLEAVNK-a12-b2 SKAP SKAP 224 178 977,846 3 -0,6 19 0,43 32,25 
LTETQGELKDLTQK-KGYKPLSKQK-a9-b8 SKAP SKAP 201 168 730,165 4 3,7 5 0,45 32,24 
RENGQMKATDTATR-KGYKPLSK-a7-b1 SKAP SKAP 149 161 528,081 5 -3,5 10 0,22 32,12 
RENGQMKATDTATR-DNCLAILESKG-a7-b10 SKAP SKAP 149 224 979,146 3 -1,1 5 0,44 32,04 
QLHQKLTETQGELK-FRDNCLAILESKG-a5-b12 SKAP SKAP 192 224 663,35 5 -1,6 17 0,37 31,87 
ENGQMKATDTATR-QKSEEELK-a6-b2 SKAP SKAP 149 170 850,751 3 0,1 8 0,26 31,66 
NQLLEAVNKQLHQK-SEEELKDK-a9-b6 SKAP SKAP 187 176 926,495 3 0,5 3 0,43 31,54 
LTETQGELKDLTQK-NQLLEAVNKQLHQK-a9-b9 SKAP SKAP 201 187 851,717 4 0,7 5 0,31 31,5 
DLTQKVELLEK-GPLGSVTKITK-a5-b8 SKAP SKAP 206 137 639,123 4 -2,3 2 0,42 31,41 
NQLLEAVNKQLHQK-KGYKPLSKQK-a9-b8 SKAP SKAP 187 168 744,93 4 -1,5 2 0,4 31,37 
QKSEEELKDK-GYKPLSK-a8-b3 SKAP SKAP 176 164 541,544 4 -1,4 8 0,2 31,31 
LTETQGELKDLTQK-GYKPLSK-a9-b3 SKAP SKAP 201 164 634,099 4 -2 2 0,36 31,23 
NQLLEAVNKQLHQK-RENGQMKATDTATR-a9-b7 SKAP SKAP 187 149 845,446 4 1,6 13 0,41 31,05 
ENGQMKATDTATRR-QKSEEELK-a6-b2 SKAP SKAP 149 170 542,073 5 -1,4 17 0,44 30,88 
QKSEEELK-ITKLRR-a2-b3 SKAP SKAP 170 140 479,28 4 -3,1 8 0,45 30,84 
RENGQMKATDTATR-QKSEEELK-a7-b2 SKAP SKAP 149 170 542,072 5 -3,3 13 0,27 30,79 
ENGQMKATDTATR-FRDNCLAILESKG-a6-b12 SKAP SKAP 149 224 1028,17 3 1,4 5 0,44 30,71 
KGYKPLSKQK-KGYKPLSK-a8-b4 SKAP SKAP 168 164 447,671 5 -1,1 1 0,39 30,7 
LTETQGELKDLTQK-QLHQKLTETQGELK-a9-b5 SKAP SKAP 201 192 849,208 4 -1,2 9 0,24 30,66 
DLTQKVELLEK-KGYKPLSK-a5-b1 SKAP SKAP 206 161 791,794 3 0,4 2 0,41 30,6 
QLHQKLTETQGELK-GYKPLSKQK-a5-b7 SKAP SKAP 192 168 568,521 5 -0,5 7 0,26 30,46 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
ENGQMKATDTATRR-SEEELKDK-a6-b6 SKAP SKAP 149 176 898,44 3 -0,5 7 0,27 30,41 
QLHQKLTETQGELK-DLTQKVELLEK-a5-b5 SKAP SKAP 192 206 777,182 4 -0,4 5 0,32 30,33 
NQLLEAVNKQLHQK-QKSEEELK-a9-b2 SKAP SKAP 187 170 558,906 5 -0,3 4 0,39 30,18 
ENGQMKATDTATR-DNCLAILESKG-a6-b10 SKAP SKAP 149 224 927,112 3 -1,4 6 0,34 30,16 
FRDNCLAILESKG-KGYKPLSK-a12-b1 SKAP SKAP 224 161 860,799 3 -1,4 13 0,37 30,06 
LTETQGELKDLTQKVELLEK-DLTQKVELLEK-a9-b5 SKAP SKAP 201 206 754,422 5 -0,4 2 0,38 30,01 
ENGQMKATDTATRR-ITKLRR-a6-b3 SKAP SKAP 149 140 501,277 5 -1,4 6 0,45 29,91 
RENGQMKATDTATR-FRDNCLAILESKG-a7-b12 SKAP SKAP 149 224 810,403 4 -1,4 14 0,29 29,76 
DLTQKVELLEK-QKSEEELKDK-a5-b2 SKAP SKAP 206 170 672,366 4 0 1 0,31 29,59 
LTETQGELKDLTQK-DLTQKVELLEKFR-a9-b11 SKAP SKAP 201 212 672,771 5 -2,1 1 0,3 29,46 
LTETQGELKDLTQK-FRDNCLAILESKG-a9-b12 SKAP SKAP 201 224 1088,57 3 -1,6 7 0,37 29,45 
QKSEEELKDK-GYKPLSKQK-a8-b7 SKAP SKAP 176 168 484,668 5 -0,5 5 0,47 29,25 
DKNQLLEAVNKQLHQK-ITKLR-a11-b3 SKAP SKAP 187 140 535,514 5 -1,5 1 0,48 29,19 
GPLGSVTKITK-ITKLR-a8-b3 SKAP SKAP 137 140 623,391 3 -0,9 1 0,4 29,02 
FRDNCLAILESKG-QKSEEELKDK-a12-b8 SKAP SKAP 224 176 579,498 5 -1,8 4 0,3 28,89 
ENGQMKATDTATRR-GYKPLSKQK-a6-b7 SKAP SKAP 149 168 553,694 5 -0,8 8 0,41 28,73 
KGYKPLSKQK-QKSEEELKDK-a8-b8 SKAP SKAP 168 176 637,605 4 -2,2 3 0,3 28,66 
FRDNCLAILESKG-DLTQKVELLEK-a12-b5 SKAP SKAP 224 206 744,65 4 -0,6 16 0,33 28,59 
DKNQLLEAVNK-KGYKPLSKQK-a2-b4 SKAP SKAP 178 164 647,122 4 -1,1 4 0,55 28,56 
ENGQMKATDTATR-QKSEEELKDK-a6-b8 SKAP SKAP 149 176 699,093 4 -2,7 5 0,27 27,74 
QKSEEELKDK-ITKLR-a8-b3 SKAP SKAP 176 140 501,036 4 -2,3 5 0,13 27,72 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
DKNQLLEAVNK-QKSEEELKDK-a2-b8 SKAP SKAP 178 176 661,353 4 -0,7 2 0,35 27,64 
RENGQMKATDTATR-QKSEEELKDK-a7-b8 SKAP SKAP 149 176 738,12 4 -0,6 9 0,33 27,54 
LTETQGELKDLTQKVELLEK-DKNQLLEAVNK-a9-b2 SKAP SKAP 201 178 931,759 4 -3,4 3 0,36 27,34 
FRDNCLAILESKG-QKSEEELK-a12-b2 SKAP SKAP 224 170 884,118 3 -0,5 7 0,28 26,82 
DNCLAILESKG-KGYKPLSKQK-a10-b8 SKAP SKAP 224 168 634,097 4 -2 3 0,36 26,66 
QKSEEELKDK-QKSEEELK-a8-b2 SKAP SKAP 176 170 473,047 5 -0,3 2 0,11 26,34 
FRDNCLAILESKG-KGYKPLSKQK-a12-b1 SKAP SKAP 224 161 568,113 5 -1,6 3 0,5 26,31 
FRDNCLAILESKG-KGYKPLSK-a12-b4 SKAP SKAP 224 164 860,799 3 -1,4 12 0,4 25,92 
GYKPLSKQKSEEELK-GYKPLSK-a7-b3 SKAP SKAP 168 164 898,496 3 -2,1 7 0,17 25,58 
LTETQGELKDLTQKVELLEK-QLHQKLTETQGELK-a9-
b5 SKAP SKAP 201 192 1027,06 4 -3,5 2 0,25 25,29 
RENGQMKATDTATR-KGYKPLSK-a7-b4 SKAP SKAP 149 164 659,851 4 -0,4 7 0,2 25,01 
DNCLAILESKG-QKSEEELK-a10-b2 SKAP SKAP 224 170 783,06 3 -2,9 4 0,31 24,97 
FRDNCLAILESKG-SEEELKDK-a12-b6 SKAP SKAP 224 176 660,082 4 -0,9 3 0,24 24,79 
FRDNCLAILESKG-KGYKPLSKQK-a12-b8 SKAP SKAP 224 168 709,889 4 -2,1 3 0,35 24,6 
FRDNCLAILESKG-GYKPLSK-a12-b3 SKAP SKAP 224 164 818,102 3 -0,3 6 0,39 24,49 
KGYKPLSKQK-SEEELKDK-a4-b6 SKAP SKAP 164 176 573,568 4 -0,3 2 0,2 24,36 
ENGQMKATDTATRR-DLTQKVELLEK-a6-b5 SKAP SKAP 149 206 1011,20 3 -0,6 3 0,3 24,32 
LTETQGELKDLTQKVELLEK-FRDNCLAILESKG-a9-
b12 SKAP SKAP 201 224 795,827 5 0,5 2 0,37 24,21 
KGYKPLSKQK-QKSEEELKDK-a4-b8 SKAP SKAP 164 176 637,606 4 -1,1 2 0,35 23,89 
DLTQKVELLEKFR-DNCLAILESKG-a11-b10 SKAP SKAP 212 224 595,922 5 0,7 9 0,25 23,86 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC 
ID 
score 
LTETQGELKDLTQKVELLEK-ENGQMKATDTATR-
a14-b6 SKAP SKAP 206 149 969,505 4 -0,3 2 0,32 23,76 
FRDNCLAILESKG-KGYKPLSKQK-a12-b4 SKAP SKAP 224 164 568,113 5 -1,8 2 0,36 22,62 
LTETQGELKDLTQKVELLEK-QKSEEELK-a9-b2 SKAP SKAP 201 170 689,374 5 -1 1 0,17 22,47 
LTETQGELKDLTQKVELLEK-ENGQMKATDTATRR-
a9-b6 SKAP SKAP 201 149 1008,53 4 -0,2 1 0,26 22,32 
LTETQGELKDLTQKVELLEK-DNCLAILESKG-a9-b10 SKAP SKAP 201 224 918,737 4 -1,6 2 0,42 22,31 
DLTQKVELLEKFR-QKSEEELK-a11-b2 SKAP SKAP 212 170 687,377 4 -1,4 1 0,12 22,28 
NQLLEAVNKQLHQK-QKSEEELKDK-a9-b8 SKAP SKAP 187 176 759,16 4 -1,5 3 0,21 22,06 
GDVVPKDVNAAIATIK-LSVDYGKK-a6-b7 α-Tubulin α-Tubulin 326 163 665,123 4 -2,4 1 0,66 40,32 
HGKYMACCLLYR-LDHKFDLMYAKR-a3-b11 α-Tubulin α-Tubulin 311 401 649,923 5 -1,8 1 0,38 35,38 
GHYTIGKEIIDLVLDR-HGKYMACCLLYR-a7-b3 α-Tubulin α-Tubulin 112 311 710,964 5 -3,1 1 0,45 34,38 
QLFHPEQLITGKEDAANNYAR-GHYTIGKEIIDLVLDR-
a12-b7 α-Tubulin α-Tubulin 96 112 733,22 6 0,1 3 0,4 28,34 
QLFHPEQLITGKEDAANNYAR-
GDVVPKDVNAAIATIK-a12-b6 α-Tubulin α-Tubulin 96 326 833,44 5 -2,1 4 0,22 26,17 
VGINYQPPTVVPGGDLAKVQR-HGKYMACCLLYR-
a18-b3 α-Tubulin α-Tubulin 370 311 980,006 4 -1 1 0,47 22,36 
ALTVPELTQQMFDSKNMMAACDPR-
KLAVNMVPFPR-a15-b1 β-Tubulin β-Tubulin 297 252 1041,52 4 1,5 1 0,39 23,6 
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Table 6.2: Crosslinks between microtubules and SKAP135-225 in presence of BS2G. TIC: fraction of total ion current of fragment ion spectrum assigned to crosslink. Mz: 
mass to charge ratio. nseen: number of fragment ion spectra assigned to the crosslink in entire dataset. 
Summary of intermolecular crosslinks 
Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
LDHKFDLMYAK-KGYKPLSK-a4-b1 α-Tubulin SKAP 394 161 599,823 4 0,2 4 0,39 37,79 
LSVDYGKK-GYKPLSK-a7-b3 α-Tubulin SKAP 163 164 450 4 -1,8 4 0,61 36,77 
LDHKFDLMYAK-ITKLR-a4-b3 α-Tubulin SKAP 394 140 527,29 4 -2,5 3 0,56 36,6 
HGKYMACCLLYR-ITKLR-a3-b3 α-Tubulin SKAP 311 140 575,049 4 0,7 2 0,53 36,5 
DVNAAIATIKTK-ITKLR-a10-b3 α-Tubulin SKAP 336 140 657,393 3 -1,5 4 0,62 35,93 
FDLMYAKR-ITKLR-a7-b3 α-Tubulin SKAP 401 140 443 4 -1,9 2 0,6 35,62 
FDLMYAKR-KGYKPLSK-a7-b4 α-Tubulin SKAP 401 164 515,532 4 -0,4 1 0,61 35,39 
GDVVPKDVNAAIATIK-ITKLR-a6-b3 α-Tubulin SKAP 326 140 584,845 4 -0,1 4 0,56 34,19 
FDLMYAKR-KGYKPLSK-a7-b1 α-Tubulin SKAP 401 161 515,532 4 0,1 2 0,5 30,76 
LSVDYGKK-SEEELKDK-a7-b6 α-Tubulin SKAP 163 176 496,254 4 -1,9 2 0,25 30,1 
QLFHPEQLITGKEDAANNYAR-ITKLR-a12-b3 α-Tubulin SKAP 96 140 628,935 5 -2 1 0,3 29,71 
GYKPLSKQK-LSVDYGKK-a7-b7 SKAP α-Tubulin 168 163 514,039 4 -0,1 1 0,58 29,61 
LDHKFDLMYAK-QKSEEELK-a4-b2 α-Tubulin SKAP 394 170 617,312 4 0,2 1 0,24 29,4 
ENGQMKATDTATRR-HGKYMACCLLYR-a6-b3 SKAP α-Tubulin 149 311 649,908 5 1 4 0,39 28,41 
ENGQMKATDTATR-HGKYMACCLLYR-a6-b3 SKAP α-Tubulin 149 311 773,108 4 0,4 2 0,38 27,98 
ENGQMKATDTATR-DVNAAIATIKTK-a6-b10 SKAP α-Tubulin 149 336 921,473 3 1,8 2 0,3 27,16 
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Summary of intramolecular crosslinks 
Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
VELLEKFR-ITKLR-a6-b3 SKAP SKAP 212 140 440,518 4 0,1 8 0,65 42,41 
GYKPLSK-ITKLRR-a3-b3 SKAP SKAP 164 140 419,257 4 -0,7 6 0,6 42,28 
KGYKPLSK-ITKLR-a4-b3 SKAP SKAP 164 140 412,255 4 -1,7 6 0,47 41,08 
DLTQKVELLEK-VELLEKFR-a5-b6 SKAP SKAP 206 212 815,461 3 1,2 10 0,6 41,08 
QKSEEELK-GYKPLSK-a2-b3 SKAP SKAP 170 164 470,252 4 -1,2 3 0,44 41,03 
GYKPLSKQK-KGYKPLSK-a7-b1 SKAP SKAP 168 161 413,643 5 -0,3 5 0,44 40,62 
DKNQLLEAVNK-VELLEKFR-a2-b6 SKAP SKAP 178 212 800,775 3 -2,4 4 0,56 40,59 
GYKPLSKQK-GYKPLSK-a7-b3 SKAP SKAP 168 164 484,778 4 -1,1 2 0,51 40,51 
GYKPLSK-ITKLR-a3-b3 SKAP SKAP 164 140 506,641 3 0,9 2 0,54 40,42 
GYKPLSKQK-SEEELKDK-a7-b6 SKAP SKAP 168 176 707,708 3 -0,1 14 0,56 40,42 
KGYKPLSK-SEEELKDK-a1-b6 SKAP SKAP 161 176 499,018 4 0 7 0,73 40,36 
SEEELKDK-ITKLR-a6-b3 SKAP SKAP 176 140 568,313 3 0 4 0,7 40,35 
KGYKPLSK-GYKPLSK-a1-b3 SKAP SKAP 161 164 452,764 4 -0,9 5 0,57 40,35 
VELLEKFR-GYKPLSK-a6-b3 SKAP SKAP 212 164 481,025 4 -2,4 5 0,66 40,16 
KGYKPLSK-ITKLR-a1-b3 SKAP SKAP 161 140 412,256 4 -1 6 0,67 39,98 
DKNQLLEAVNK-QKSEEELK-a2-b2 SKAP SKAP 178 170 590,061 4 0 8 0,55 39,95 
DLTQKVELLEK-ITKLR-a5-b3 SKAP SKAP 206 140 681,068 3 -1,8 5 0,53 39,58 
RENGQMKATDTATR-SEEELKDK-a7-b6 SKAP SKAP 149 176 663,571 4 1,6 8 0,53 39,48 
QLHQKLTETQGELK-DKNQLLEAVNK-a5-b2 SKAP SKAP 192 178 755,657 4 -1,1 7 0,51 39,19 
KGYKPLSK-SEEELKDK-a4-b6 SKAP SKAP 164 176 665,021 3 -0,9 14 0,4 39,06 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
ENGQMKATDTATR-SEEELKDK-a6-b6 SKAP SKAP 149 176 832,392 3 0,7 7 0,42 38,57 
GYKPLSKQK-ITKLR-a7-b3 SKAP SKAP 168 140 444,27 4 -0,5 2 0,57 38,47 
ENGQMKATDTATR-ITKLR-a6-b3 SKAP SKAP 149 140 716,708 3 -0,1 13 0,45 38,43 
QKSEEELK-ITKLR-a2-b3 SKAP SKAP 170 140 429,745 4 0,3 4 0,35 38,21 
SEEELKDK-GYKPLSK-a6-b3 SKAP SKAP 176 164 466,994 4 -0,2 4 0,55 38,02 
ENGQMKATDTATR-VELLEKFR-a6-b6 SKAP SKAP 149 212 851,098 3 -1,4 8 0,42 37,65 
QKSEEELK-SEEELKDK-a2-b6 SKAP SKAP 170 176 516,507 4 0,3 9 0,39 37,56 
DLTQKVELLEK-DNCLAILESKG-a5-b10 SKAP SKAP 206 224 877,459 3 0,5 2 0,53 37,12 
RENGQMKATDTATR-GYKPLSK-a7-b3 SKAP SKAP 149 164 617,316 4 0,1 13 0,44 37,02 
DKNQLLEAVNK-ITKLR-a2-b3 SKAP SKAP 178 140 666,384 3 -1,9 8 0,45 36,73 
DNCLAILESKG-ITKLR-a10-b3 SKAP SKAP 224 140 649,018 3 -2 2 0,58 36,71 
KGYKPLSK-QKSEEELK-a1-b2 SKAP SKAP 161 170 402,023 5 0,4 19 0,32 36,68 
LTETQGELKDLTQK-ITKLRR-a9-b3 SKAP SKAP 201 140 622,106 4 -0,1 9 0,53 36,65 
HGKYMACCLLYR-LSVDYGKK-a3-b7 α-Tubulin α-Tubulin 311 163 644,817 4 -1,4 1 0,52 36,4 
RENGQMKATDTATR-KGYKPLSK-a7-b1 SKAP SKAP 149 161 519,673 5 -1 4 0,55 36,39 
DKNQLLEAVNK-GYKPLSK-a2-b3 SKAP SKAP 178 164 720,393 3 -3,3 7 0,56 36,37 
DKNQLLEAVNK-SEEELKDK-a2-b6 SKAP SKAP 178 176 782,068 3 0,4 7 0,48 36,36 
QKSEEELK-VELLEKFR-a2-b6 SKAP SKAP 170 212 707,048 3 -0,5 5 0,26 36,3 
LTETQGELKDLTQK-DKNQLLEAVNK-a9-b2 SKAP SKAP 201 178 990,862 3 2 3 0,46 36,23 
DKNQLLEAVNK-KGYKPLSK-a2-b1 SKAP SKAP 178 161 763,094 3 -0,3 2 0,48 36,2 
ENGQMKATDTATR-GYKPLSKQK-a6-b7 SKAP SKAP 149 168 856,104 3 0,9 5 0,42 36,02 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
SEEELKDK-ITKLRR-a6-b3 SKAP SKAP 176 140 465,511 4 -1,8 5 0,62 35,94 
RENGQMKATDTATR-VELLEKFR-a7-b6 SKAP SKAP 149 212 677,601 4 -1,5 4 0,58 35,87 
GYKPLSKQK-QKSEEELK-a7-b2 SKAP SKAP 168 170 534,291 4 0 5 0,3 35,8 
QKSEEELKDK-KGYKPLSK-a8-b4 SKAP SKAP 176 164 450,646 5 -1,2 5 0,47 35,76 
KGYKPLSK-ITKLRR-a1-b3 SKAP SKAP 161 140 451,281 4 0,2 4 0,39 35,52 
KGYKPLSK-QKSEEELK-a4-b2 SKAP SKAP 164 170 502,276 4 0,1 7 0,32 35,47 
DKNQLLEAVNK-KGYKPLSK-a2-b4 SKAP SKAP 178 164 763,095 3 1 11 0,44 35,39 
LTETQGELKDLTQK-ITKLR-a9-b3 SKAP SKAP 201 140 583,081 4 0,6 7 0,43 35,31 
DKNQLLEAVNK-ITKLRR-a2-b3 SKAP SKAP 178 140 539,067 4 2 14 0,55 35,29 
NQLLEAVNKQLHQK-SEEELKDK-a9-b6 SKAP SKAP 187 176 684,611 4 -0,5 4 0,57 35,19 
QLHQKLTETQGELK-GYKPLSK-a5-b3 SKAP SKAP 192 164 635,85 4 1 2 0,33 35,14 
DLTQKVELLEKFR-DLTQKVELLEK-a11-b5 SKAP SKAP 212 206 758,175 4 -0,6 3 0,44 35,08 
QLHQKLTETQGELK-ITKLR-a5-b3 SKAP SKAP 192 140 595,34 4 -1,8 4 0,3 35,06 
NQLLEAVNKQLHQK-QKSEEELK-a9-b2 SKAP SKAP 187 170 687,869 4 -0,2 5 0,4 35,06 
ENGQMKATDTATRR-SEEELKDK-a6-b6 SKAP SKAP 149 176 884,425 3 0,6 15 0,32 34,93 
LTETQGELKDLTQK-NQLLEAVNKQLHQK-a9-b9 SKAP SKAP 201 187 841,204 4 -1,6 4 0,39 34,85 
QLHQKLTETQGELK-KGYKPLSK-a5-b1 SKAP SKAP 192 161 534,501 5 2,8 9 0,4 34,83 
LTETQGELKDLTQK-QLHQKLTETQGELK-a9-b5 SKAP SKAP 201 192 671,16 5 0,9 8 0,42 34,65 
LTETQGELKDLTQK-VELLEKFR-a9-b6 SKAP SKAP 201 212 683,873 4 -0,7 4 0,43 34,59 
DLTQKVELLEKFR-DNCLAILESKG-a11-b10 SKAP SKAP 212 224 734,14 4 2 12 0,37 34,44 
FRDNCLAILESKG-ITKLR-a12-b3 SKAP SKAP 224 140 562,808 4 -1,2 8 0,6 34,37 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
ENGQMKATDTATR-DKNQLLEAVNK-a6-b2 SKAP SKAP 149 178 930,463 3 -0,6 5 0,45 34,37 
ENGQMKATDTATR-KGYKPLSK-a6-b4 SKAP SKAP 149 164 813,417 3 -0,3 1 0,38 34,34 
ENGQMKATDTATRR-GYKPLSK-a6-b3 SKAP SKAP 149 164 494,055 5 0,7 11 0,44 34,26 
DLTQKVELLEKFR-FRDNCLAILESKG-a11-b12 SKAP SKAP 212 224 648,147 5 1,1 6 0,55 34,04 
QLHQKLTETQGELK-DLTQKVELLEK-a5-b5 SKAP SKAP 192 206 766,67 4 0 5 0,4 34,02 
FRDNCLAILESKG-VELLEKFR-a12-b6 SKAP SKAP 224 212 663,605 4 3,1 5 0,52 33,97 
RENGQMKATDTATR-DKNQLLEAVNK-a7-b2 SKAP SKAP 149 178 982,496 3 -0,8 12 0,45 33,69 
QLHQKLTETQGELK-SEEELKDK-a5-b6 SKAP SKAP 192 176 682,104 4 1,1 5 0,32 33,52 
LTETQGELKDLTQK-KGYKPLSK-a9-b4 SKAP SKAP 201 164 655,613 4 1,3 3 0,44 33,43 
RENGQMKATDTATR-DLTQKVELLEK-a7-b5 SKAP SKAP 149 206 748,136 4 -1,3 3 0,38 33,43 
QLHQKLTETQGELK-VELLEKFR-a5-b6 SKAP SKAP 192 212 557,11 5 0,9 8 0,38 33,4 
DNCLAILESKG-VELLEKFR-a10-b6 SKAP SKAP 224 212 587,809 4 -1,4 43 0,54 33,32 
LTETQGELKDLTQK-KGYKPLSK-a9-b1 SKAP SKAP 201 161 524,691 5 0 6 0,53 33,28 
LTETQGELKDLTQK-GYKPLSKQK-a9-b7 SKAP SKAP 201 168 687,627 4 1,1 3 0,44 32,98 
VELLEKFR-ITKLRR-a6-b3 SKAP SKAP 212 140 639,056 3 1,5 5 0,29 32,97 
QLHQKLTETQGELK-ITKLRR-a5-b3 SKAP SKAP 192 140 507,694 5 -1,2 10 0,5 32,81 
ENGQMKATDTATR-DNCLAILESKG-a6-b10 SKAP SKAP 149 224 913,097 3 -0,3 2 0,34 32,75 
NQLLEAVNKQLHQK-VELLEKFR-a9-b6 SKAP SKAP 187 212 698,642 4 -0,3 1 0,5 32,66 
ENGQMKATDTATR-QKSEEELK-a6-b2 SKAP SKAP 149 170 836,736 3 1,6 9 0,29 32,34 
DKNQLLEAVNK-DNCLAILESKG-a2-b10 SKAP SKAP 178 224 862,773 3 -2,1 4 0,47 32,33 
LTETQGELKDLTQK-GYKPLSK-a9-b3 SKAP SKAP 201 164 623,588 4 -0,4 5 0,49 32,24 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
ENGQMKATDTATRR-DKNQLLEAVNK-a6-b2 SKAP SKAP 149 178 737,125 4 0,2 5 0,5 32,1 
ENGQMKATDTATRR-ITKLR-a6-b3 SKAP SKAP 149 140 461,648 5 -0,1 12 0,38 31,82 
ENGQMKATDTATR-KGYKPLSK-a6-b1 SKAP SKAP 149 161 488,453 5 -0,4 11 0,42 31,63 
DNCLAILESKG-SEEELKDK-a10-b6 SKAP SKAP 224 176 764,702 3 -0,2 2 0,49 31,2 
ENGQMKATDTATR-GYKPLSK-a6-b3 SKAP SKAP 149 164 578,291 4 -0,1 4 0,33 30,99 
DKNQLLEAVNK-GYKPLSKQK-a2-b7 SKAP SKAP 178 168 604,587 4 0,6 4 0,57 30,93 
LTETQGELKDLTQK-DNCLAILESKG-a9-b10 SKAP SKAP 201 224 973,494 3 -0,6 2 0,36 30,9 
FRDNCLAILESKG-GYKPLSK-a12-b3 SKAP SKAP 224 164 804,085 3 -2,2 3 0,33 30,88 
KGYKPLSKQK-SEEELKDK-a8-b6 SKAP SKAP 168 176 750,406 3 0,2 1 0,4 30,85 
FRDNCLAILESKG-DKNQLLEAVNK-a12-b2 SKAP SKAP 224 178 723,125 4 -0,9 4 0,4 30,73 
KGYKPLSKQK-KGYKPLSK-a8-b1 SKAP SKAP 168 161 439,262 5 -1,6 1 0,41 30,72 
NQLLEAVNKQLHQK-KGYKPLSK-a9-b1 SKAP SKAP 187 161 893,504 3 -1,3 2 0,35 30,66 
ENGQMKATDTATR-KGYKPLSKQK-a6-b8 SKAP SKAP 149 168 674,354 4 1,1 2 0,38 30,59 
QLHQKLTETQGELK-FRDNCLAILESKG-a5-b12 SKAP SKAP 192 224 654,943 5 1,4 9 0,4 30,56 
ENGQMKATDTATRR-KGYKPLSK-a6-b1 SKAP SKAP 149 161 519,674 5 0,3 6 0,48 30,53 
FRDNCLAILESKG-SEEELKDK-a12-b6 SKAP SKAP 224 176 865,76 3 0,9 4 0,35 30,4 
RENGQMKATDTATR-ITKLR-a7-b3 SKAP SKAP 149 140 461,648 5 -0,7 8 0,35 30,36 
GDVVPKDVNAAIATIK-LDHKFDLMYAK-a6-b4 α-Tubulin α-Tubulin 326 394 772,412 4 -0,3 2 0,56 30,36 
LTETQGELKDLTQKVELLEK-ITKLR-a9-b3 SKAP SKAP 201 140 760,934 4 -0,5 2 0,35 30,2 
ENGQMKATDTATR-FRDNCLAILESKG-a6-b12 SKAP SKAP 149 224 760,868 4 0,6 4 0,36 30,01 
DKNQLLEAVNK-QKSEEELKDK-a2-b8 SKAP SKAP 178 176 520,874 5 -1 7 0,55 29,97 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
ENGQMKATDTATRR-GYKPLSKQK-a6-b7 SKAP SKAP 149 168 681,355 4 0,6 5 0,44 29,85 
LTETQGELKDLTQK-SEEELKDK-a9-b6 SKAP SKAP 201 176 892,787 3 -0,4 1 0,46 29,83 
RENGQMKATDTATR-QKSEEELK-a7-b2 SKAP SKAP 149 170 666,83 4 1,8 5 0,36 29,8 
ENGQMKATDTATRR-KGYKPLSKQK-a6-b8 SKAP SKAP 149 168 713,379 4 1,7 2 0,37 29,62 
LTETQGELKDLTQK-QKSEEELK-a9-b2 SKAP SKAP 201 170 897,131 3 -0,1 3 0,25 29,52 
FRDNCLAILESKG-DLTQKVELLEK-a12-b5 SKAP SKAP 224 206 734,138 4 0,2 6 0,41 29,48 
ENGQMKATDTATRR-ITKLRR-a6-b3 SKAP SKAP 149 140 410,892 6 0,5 7 0,41 29,11 
QLHQKLTETQGELK-ENGQMKATDTATR-a5-b6 SKAP SKAP 192 149 793,401 4 1,2 8 0,35 29,04 
RENGQMKATDTATR-ITKLRR-a7-b3 SKAP SKAP 149 140 615,835 4 1,9 8 0,4 29 
KGYKPLSK-KGYKPLSK-a1-b4 SKAP SKAP 161 164 484,788 4 1,2 1 0,38 28,66 
DKNQLLEAVNK-KGYKPLSKQK-a2-b8 SKAP SKAP 178 168 636,611 4 -0,1 1 0,48 28,33 
ENGQMKATDTATRR-QLHQKLTETQGELK-a6-b5 SKAP SKAP 149 192 555,286 6 0,9 8 0,39 28,32 
QLHQKLTETQGELK-RENGQMKATDTATR-a5-b7 SKAP SKAP 192 149 666,142 5 0,8 5 0,35 28,01 
NQLLEAVNKQLHQK-ENGQMKATDTATR-a9-b6 SKAP SKAP 187 149 795,907 4 -0,8 4 0,4 28,01 
QLHQKLTETQGELK-QKSEEELK-a5-b2 SKAP SKAP 192 170 548,49 5 0 6 0,34 27,74 
RENGQMKATDTATR-FRDNCLAILESKG-a7-b12 SKAP SKAP 149 224 799,892 4 -0,9 3 0,38 27,73 
KGYKPLSKQK-VELLEKFR-a4-b6 SKAP SKAP 164 212 577,087 4 -0,9 1 0,54 27,6 
LTETQGELKDLTQK-ENGQMKATDTATR-a9-b6 SKAP SKAP 201 149 1041,18 3 -0,9 2 0,27 27,32 
QKSEEELKDK-GYKPLSK-a8-b3 SKAP SKAP 176 164 531,033 4 0,5 3 0,22 27,06 
ENGQMKATDTATR-DLTQKVELLEK-a6-b5 SKAP SKAP 149 206 709,112 4 0,1 1 0,3 26,81 
ENGQMKATDTATRR-QKSEEELK-a6-b2 SKAP SKAP 149 170 533,663 5 -1,7 15 0,39 26,72 
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Crosslinked peptides Protein 1 Protein 2 
Aa 
pos 1 
Aa 
pos 2 Mz z 
Error_rel 
[ppm] nseen TIC ID score 
ENGQMKATDTATR-GPLGSVTKITK-a6-b8 SKAP SKAP 149 137 873,454 3 0,3 1 0,3 26,66 
QLHQKLTETQGELK-DNCLAILESKG-a5-b10 SKAP SKAP 192 224 989,84 3 -1,5 1 0,24 25,93 
NQLLEAVNKQLHQK-QLHQKLTETQGELK-a9-b5 SKAP SKAP 187 192 853,466 4 0,1 2 0,23 25,92 
VELLEKFRDNCLAILESK-FRDNCLAILESKG-a6-b12 SKAP SKAP 212 224 759,797 5 1,8 1 0,32 25,61 
NQLLEAVNKQLHQK-FRDNCLAILESKG-a9-b12 SKAP SKAP 187 224 820,935 4 1,1 5 0,32 25,49 
QKSEEELKDK-KGYKPLSK-a8-b1 SKAP SKAP 176 161 563,057 4 0,6 2 0,33 25,26 
LTETQGELKDLTQK-RENGQMKATDTATR-a9-b7 SKAP SKAP 201 149 820,165 4 0,7 2 0,34 24,92 
ENGQMKATDTATR-QKSEEELKDK-a6-b8 SKAP SKAP 149 176 688,584 4 0,7 2 0,24 24,87 
DKNQLLEAVNK-KGYKPLSKQK-a2-b4 SKAP SKAP 178 164 636,611 4 0,6 1 0,44 24,15 
FRDNCLAILESKG-QKSEEELK-a12-b2 SKAP SKAP 224 170 870,102 3 -0,5 3 0,22 23,48 
ENGQMKATDTATRR-QKSEEELKDK-a6-b8 SKAP SKAP 149 176 582,289 5 0,2 5 0,3 23,35 
ENGQMKATDTATR-ITKLRR-a6-b3 SKAP SKAP 149 140 768,742 3 -0,1 4 0,31 23,24 
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6.3 Protein sequences 
6.3.1 Astrin 
   1 MWRVKKLSLS LSPSPQTGKP SMRTPLRELT LQPGALTNSG KRSPACSSLT 50 
  51 PSLCKLGLQE GSNNSSPVDF VNNKRTDLSS EHFSHSSKWL ETCQHESDEQ 100 
 101 PLDPIPQISS TPKTSEEAVD PLGNYMVKTI VLVPSPLGQQ QDMIFEARLD 150 
 151 TMAETNSISL NGPLRTDDLV REEVAPCMGD RFSEVAAVSE KPIFQESPSH 200 
 201 LLEESPPNPC SEQLHCSKES LSSRTEAVRE DLVPSESNAF LPSSVLWLSP 250 
 251 STALAADFRV NHVDPEEEIV EHGAMEEREM RFPTHPKESE TEDQALVSSV 300 
 301 EDILSTCLTP NLVEMESQEA PGPAVEDVGR ILGSDTESWM SPLAWLEKGV 350 
 351 NTSVMLENLR QSLSLPSMLR DAAIGTTPFS TCSVGTWFTP SAPQEKSTNT 400 
 401 SQTGLVGTKH STSETEQLLC GRPPDLTALS RHDLEDNLLS SLVILEVLSR 450 
 451 QLRDWKSQLA VPHPETQDSS TQTDTSHSGI TNKLQHLKES HEMGQALQQA 500 
 501 RNVMQSWVLI SKELISLLHL SLLHLEEDKT TVSQESRRAE TLVCCCFDLL 550 
 551 KKLRAKLQSL KAEREEARHR EEMALRGKDA AEIVLEAFCA HASQRISQLE 600 
 601 QDLASMREFR GLLKDAQTQL VGLHAKQEEL VQQTVSLTST LQQDWRSMQL 650 
 651 DYTTWTALLS RSRQLTEKLT VKSQQALQER DVAIEEKQEV SRVLEQVSAQ 700 
 701 LEECKGQTEQ LELENSRLAT DLRAQLQILA NMDSQLKELQ SQHTHCAQDL 750 
 751 AMKDELLCQL TQSNEEQAAQ WQKEEMALKH MQAELQQQQA VLAKEVRDLK 800 
 801 ETLEFADQEN QVAHLELGQV ECQLKTTLEV LRERSLQCEN LKDTVENLTA 850 
 851 KLASTIADNQ EQDLEKTRQY SQKLGLLTEQ LQSLTLFLQT KLKEKTEQET 900 
 901 LLLSTACPPT QEHPLPNDRT FLGSILTAVA DEEPESTPVP LLGSDKSAFT 950 
 951 RVASMVSLQP AETPGMEESL AEMSIMTTEL QSLCSLLQES KEEAIRTLQR 1000 
1001 KICELQARLQ AQEEQHQEVQ KAKEADIEKL NQALCLRYKN EKELQEVIQQ 1050 
1051 QNEKILEQID KSGELISLRE EVTHLTRSLR RAETETKVLQ EALAGQLDSN 1100 
1101 CQPMATNWIQ EKVWLSQEVD KLRVMFLEMK NEKEKLMIKF QSHRNILEEN 1150 
1151 LRRSDKELEK LDDIVQHIYK TLLSIPEVVR GCKELQGLLE FLS 
 
6.3.2 SKAP 
  1 MAAPEAPPLD RVFRTTWLST ECDSHPLPPS YRKFLFETQA ADLAGGTTVA 50 
 51 AGNLLNESEK DCGQDRRAPG VQPCRLVTMT SVVKTVYSLQ PPSALSGGQP 100 
101 ADTQTRATSK SLLPVRSKEV DVSKQLHSGG PENDVTKITK LRRENGQMKA 150 
151 TDTATRRNVR KGYKPLSKQK SEEELKDKNQ LLEAVNKQLH QKLTETQGEL 200 
201 KDLTQKVELL EKFRDNCLAI LESKGLDPAL GSETLASRQE STTDHMDSML 250 
251 LLETLQEELK LFNETAKKQM EELQALKVKL EMKEERVRFL EQQTLCNNQV 300 
301 NDLTTALKEM EQLLEM 
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6.4 Gene sequences 
6.4.1 Astrin 
6.4.1.1 Wild type gene 
ATGTGGCGAGTGAAAAAACTGAGCCTCAGCCTGTCGCCTTCGCCCCAGACGGGAAAACCATCTATGAGA
ACTCCTCTCCGTGAACTTACCCTGCAGCCCGGTGCCCTCACCAACTCTGGAAAAAGATCCCCCGCTTGC
TCCTCGCTGACCCCATCACTGTGCAAGCTGGGGCTGCAGGAAGGCAGCAACAACTCATCTCCAGTGGAT
TTTGTAAATAACAAGAGGACAGACTTATCTTCAGAACATTTCAGTCATTCCTCAAAGTGGCTAGAAACT
TGTCAGCATGAATCAGATGAGCAGCCTCTAGATCCAATTCCCCAAATTAGCTCTACTCCTAAAACGTCT
GAGGAAGCAGTAGACCCACTGGGCAATTATATGGTTAAAACCATCGTCCTTGTACCATCTCCACTGGGG
CAGCAACAAGACATGATATTTGAGGCCCGTTTAGATACCATGGCAGAGACAAACAGCATATCTTTAAAT
GGACCTTTGAGAACAGACGATCTGGTGAGAGAGGAGGTGGCACCCTGCATGGGAGACAGGTTTTCAGAA
GTTGCTGCTGTATCTGAGAAACCTATCTTTCAGGAATCTCCGTCCCATCTCTTAGAGGAGTCTCCACCA
AATCCCTGTTCTGAACAACTACATTGCTCCAAGGAAAGCCTGAGCAGTAGAACTGAGGCTGTGCGTGAG
GACTTAGTACCTTCTGAAAGTAACGCCTTCTTGCCTTCCTCTGTTCTCTGGCTTTCCCCTTCAACTGCC
TTGGCAGCAGATTTCCGTGTCAATCATGTGGACCCAGAGGAGGAAATTGTAGAGCATGGAGCTATGGAG
GAAAGAGAAATGAGGTTTCCCACACATCCTAAGGAGTCTGAAACAGAAGATCAAGCACTTGTCTCAAGT
GTGGAAGATATTCTGTCCACATGCCTGACACCAAATCTAGTAGAAATGGAATCCCAAGAAGCTCCAGGC
CCAGCAGTAGAAGATGTTGGTAGGATTCTTGGCTCTGATACAGAGTCTTGGATGTCCCCACTGGCCTGG
CTGGAAAAAGGTGTAAATACCTCCGTCATGCTGGAAAATCTCCGCCAAAGCTTATCCCTTCCCTCGATG
CTTCGGGATGCTGCAATTGGCACTACCCCTTTCTCTACTTGCTCGGTGGGGACTTGGTTTACTCCTTCA
GCACCACAGGAAAAGAGTACAAACACATCCCAGACAGGCCTGGTTGGCACCAAGCACAGTACTTCTGAG
ACAGAGCAGCTCCTGTGTGGCCGGCCTCCAGATCTGACTGCCTTGTCTCGACATGACTTGGAAGATAAC
CTGCTGAGCTCTCTTGTCATTCTGGAGGTTCTCTCCCGCCAGCTTCGGGACTGGAAGAGCCAGCTGGCT
GTCCCTCACCCAGAAACCCAGGACAGTAGCACACAGACTGACACATCTCACAGTGGGATAACTAATAAA
CTTCAGCATCTTAAGGAGAGCCATGAGATGGGACAGGCCCTACAGCAGGCCAGAAATGTCATGCAATCA
TGGGTGCTTATCTCTAAAGAGCTGATATCCTTGCTTCACCTATCCCTGTTGCATTTAGAAGAAGATAAG
ACTACTGTGAGTCAGGAGTCTCGGCGTGCAGAAACATTGGTCTGTTGCTGTTTTGATTTGCTGAAGAAA
TTGAGGGCAAAGCTCCAGAGCCTCAAAGCAGAAAGGGAGGAGGCAAGGCACAGAGAGGAAATGGCTCTC
AGAGGCAAGGATGCGGCAGAGATAGTGTTGGAGGCTTTCTGTGCACACGCCAGCCAGCGCATCAGCCAG
CTGGAACAGGACCTAGCATCCATGCGGGAATTCAGAGGCCTTCTGAAGGATGCCCAGACCCAACTGGTA
GGGCTTCATGCCAAGCAAGAAGAGCTGGTTCAGCAGACAGTGAGTCTTACTTCTACCTTGCAACAAGAC
TGGAGGTCCATGCAACTGGATTATACAACATGGACAGCTTTGCTGAGTCGGTCCCGACAACTCACAGAG
AAACTCACAGTCAAGAGCCAGCAAGCCCTGCAGGAACGTGATGTGGCAATTGAGGAAAAGCAGGAGGTT
TCTAGGGTGCTGGAACAAGTCTCTGCCCAGTTAGAGGAGTGCAAAGGCCAAACAGAACAACTGGAGTTG
GAAAACAGTCGTCTAGCAACAGATCTCCGGGCTCAGTTGCAGATTCTGGCCAACATGGACAGCCAGCTA
AAAGAGCTACAGAGTCAGCATACCCATTGTGCCCAGGACCTGGCTATGAAGGATGAGTTACTCTGCCAG
CTTACCCAGAGCAATGAGGAGCAGGCTGCTCAATGGCAAAAGGAAGAGATGGCACTAAAACACATGCAG
GCAGAACTGCAGCAGCAACAAGCTGTCCTGGCCAAAGAGGTGCGGGACCTGAAAGAGACCTTGGAGTTT
GCAGACCAGGAGAATCAGGTTGCTCACCTGGAGCTGGGTCAGGTTGAGTGTCAATTGAAAACCACACTG
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GAAGTGCTCCGGGAGCGCAGCTTGCAGTGTGAGAACCTCAAGGACACTGTAGAGAACCTAACGGCTAAA
CTGGCCAGCACCATAGCAGATAACCAGGAGCAAGATCTGGAGAAAACACGGCAGTACTCTCAAAAGCTA
GGGCTGCTGACTGAGCAACTACAGAGCCTGACTCTCTTTCTACAGACAAAACTAAAGGAGAAGACTGAA
CAAGAGACCCTTCTGCTGAGTACAGCCTGTCCTCCCACCCAGGAACACCCTCTGCCTAATGACAGGACC
TTCCTGGGAAGCATCTTGACAGCAGTGGCAGATGAAGAGCCAGAATCAACTCCTGTGCCCTTGCTTGGA
AGTGACAAGAGTGCTTTCACCCGAGTAGCATCAATGGTTTCCCTTCAGCCCGCAGAGACCCCAGGCATG
GAGGAGAGCCTGGCAGAAATGAGTATTATGACTACTGAGCTTCAGAGTCTTTGTTCCCTGCTACAAGAG
TCTAAAGAAGAAGCCATCAGGACTCTGCAGCGAAAAATTTGTGAGCTGCAAGCTAGGCTGCAGGCCCAG
GAAGAACAGCATCAGGAAGTCCAGAAGGCAAAAGAAGCAGACATAGAGAAGCTGAACCAGGCCTTGTGC
TTGCGCTACAAGAATGAAAAGGAGCTCCAGGAAGTGATACAGCAGCAGAATGAGAAGATCCTAGAACAG
ATAGACAAGAGTGGCGAGCTCATAAGCCTTAGAGAGGAGGTGACCCACCTTACCCGCTCACTTCGGCGT
GCGGAGACAGAGACCAAAGTGCTCCAGGAGGCCCTGGCAGGCCAGCTGGACTCCAACTGCCAGCCTATG
GCCACCAATTGGATCCAGGAGAAAGTGTGGCTCTCTCAGGAGGTGGACAAACTGAGAGTGATGTTCCTG
GAGATGAAAAATGAGAAGGAAAAACTCATGATCAAGTTCCAGAGCCATAGAAATATCCTAGAGGAGAAC
CTTCGGCGCTCTGACAAGGAGTTAGAAAAACTAGATGACATTGTTCAGCATATTTATAAGACCCTGCTC
TCTATTCCAGAGGTGGTGAGGGGATGCAAAGAACTACAGGGATTGCTGGAATTTCTGAGC 
 
6.4.1.2 Codon-optimized gene 
ATGTGGCGTGTTAAAAAACTGAGCCTGAGCCTGTCACCGAGTCCGCAGACCGGTAAACCGAGCATGCGT
ACACCGCTGCGTGAACTGACCCTGCAGCCAGGTGCACTGACCAATAGCGGTAAACGTAGTCCGGCATGT
AGCAGCCTGACCCCGAGCCTGTGTAAACTGGGTCTGCAAGAAGGTAGCAATAATTCAAGTCCGGTTGAT
TTTGTGAACAACAAACGTACCGATCTGAGCAGCGAACATTTTAGCCATAGCAGCAAATGGCTGGAAACC
TGTCAGCATGAAAGTGATGAACAGCCGCTGGACCCGATTCCGCAGATTAGCAGCACCCCGAAAACCAGC
GAAGAAGCAGTTGATCCGCTGGGCAATTATATGGTTAAAACCATTGTTCTGGTTCCGTCACCGCTGGGT
CAGCAGCAGGACATGATTTTTGAAGCACGTCTGGATACAATGGCAGAAACCAATAGCATTAGCCTGAAT
GGTCCGCTGCGTACCGATGATCTGGTTCGTGAAGAGGTTGCACCGTGTATGGGTGATCGTTTTAGCGAA
GTTGCAGCAGTTAGCGAAAAACCGATTTTTCAAGAAAGCCCGAGCCATCTGCTGGAAGAAAGTCCGCCT
AATCCGTGTAGCGAACAGCTGCATTGTAGCAAAGAAAGCCTGAGTAGCCGTACCGAAGCAGTGCGTGAA
GATCTGGTGCCGAGCGAAAGCAATGCATTTCTGCCGAGCAGCGTTCTGTGGCTGAGCCCGAGCACCGCA
CTGGCAGCAGATTTTCGTGTTAATCATGTTGATCCGGAAGAAGAAATTGTTGAGCACGGTGCTATGGAA
GAACGTGAAATGCGTTTTCCGACCCATCCGAAAGAAAGCGAAACCGAAGATCAGGCACTGGTTAGCAGC
GTTGAAGATATTCTGAGCACCTGTCTGACACCGAATCTGGTTGAAATGGAAAGCCAAGAAGCACCGGGT
CCGGCAGTTGAAGATGTTGGTCGTATTCTGGGTAGCGATACCGAAAGCTGGATGAGTCCGCTGGCCTGG
CTGGAAAAAGGTGTTAATACCAGCGTTATGCTGGAAAACCTGCGTCAGAGCCTGAGTCTGCCGAGTATG
CTGCGTGATGCAGCAATTGGCACCACCCCGTTTAGCACCTGTAGCGTTGGCACCTGGTTTACCCCGAGC
GCACCGCAAGAAAAAAGCACCAATACCAGCCAGACAGGTCTGGTTGGCACCAAACATAGCACCAGTGAA
ACCGAACAACTGCTGTGTGGTCGTCCGCCTGATCTGACCGCACTGAGCCGTCATGATCTGGAAGATAAT
CTGCTGAGCAGCCTGGTTATTCTGGAAGTTCTGAGTCGTCAGCTGCGCGATTGGAAAAGTCAGCTGGCA
GTTCCGCATCCGGAAACCCAGGATAGCAGTACCCAGACCGATACCAGTCATAGCGGTATTACCAATAAA
CTGCAGCACCTGAAAGAAAGTCATGAAATGGGTCAGGCCCTGCAGCAGGCACGTAATGTTATGCAGAGC
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TGGGTTCTGATTTCCAAAGAACTGATTAGTCTGCTGCATCTGTCACTGCTGCACCTGGAAGAGGATAAA
ACCACCGTTAGCCAAGAAAGTCGTCGTGCAGAAACCCTGGTTTGTTGCTGTTTTGATCTGCTGAAAAAA
CTGCGTGCAAAACTGCAGAGTCTGAAAGCCGAACGCGAAGAGGCACGTCATCGTGAAGAAATGGCACTG
CGTGGTAAAGATGCAGCCGAAATTGTGCTGGAAGCATTTTGTGCACATGCAAGCCAGCGTATTAGCCAG
CTGGAACAGGATCTGGCCAGCATGCGTGAATTTCGTGGCCTGCTGAAAGATGCACAGACCCAGCTGGTT
GGTCTGCATGCAAAACAAGAAGAACTGGTTCAGCAGACCGTGAGCCTGACCAGCACCCTGCAACAGGAT
TGGCGTAGTATGCAGCTGGATTATACCACCTGGACAGCACTGCTGAGCCGTAGCCGTCAACTGACCGAA
AAACTGACCGTTAAAAGCCAGCAGGCGCTGCAAGAGCGTGATGTTGCAATTGAAGAAAAACAAGAGGTT
AGCCGTGTTCTGGAACAAGTTAGCGCACAGCTGGAAGAGTGTAAAGGTCAGACCGAGCAACTGGAACTG
GAAAATAGCCGTCTGGCAACCGATCTGCGTGCCCAGCTGCAGATTCTGGCAAATATGGATAGTCAGCTG
AAAGAGCTGCAGAGCCAGCATACCCATTGTGCACAGGACCTGGCAATGAAAGATGAGCTGCTGTGCCAA
CTGACCCAGAGCAATGAAGAACAGGCAGCACAGTGGCAGAAAGAAGAGATGGCCCTGAAACACATGCAG
GCAGAACTGCAACAGCAGCAAGCAGTTCTGGCCAAAGAAGTTCGCGATCTGAAAGAGACACTGGAATTT
GCAGATCAAGAAAATCAGGTTGCACATCTGGAACTGGGTCAGGTTGAATGTCAACTGAAAACCACCCTG
GAAGTGCTGCGCGAACGTAGCCTGCAGTGTGAAAATCTGAAAGATACCGTGGAAAATCTGACCGCCAAA
CTGGCAAGCACCATTGCAGATAATCAAGAACAAGATCTGGAAAAAACCCGTCAGTATAGCCAGAAACTG
GGACTGCTGACCGAGCAGCTGCAGTCTCTGACCCTGTTTCTGCAGACAAAACTGAAAGAAAAAACCGAG
CAAGAAACACTGCTGCTGTCAACCGCATGTCCGCCTACCCAAGAACATCCGCTGCCGAATGATCGTACC
TTTCTGGGTTCAATTCTGACAGCCGTTGCCGATGAAGAACCGGAAAGCACACCGGTTCCGCTGCTGGGT
AGTGATAAAAGCGCATTTACCCGTGTTGCAAGCATGGTTAGTCTGCAGCCTGCCGAAACACCGGGTATG
GAAGAGTCACTGGCCGAAATGAGCATTATGACCACCGAACTGCAGTCACTGTGTTCTCTGCTGCAAGAA
TCAAAAGAAGAAGCAATTCGTACACTGCAGCGCAAAATTTGTGAACTGCAAGCGCGTCTGCAGGCACAA
GAGGAACAGCATCAAGAAGTGCAGAAAGCAAAAGAAGCCGATATTGAGAAACTGAATCAGGCGCTGTGT
CTGCGCTATAAAAACGAAAAAGAACTGCAAGAAGTGATCCAGCAGCAGAACGAAAAAATCCTGGAACAA
ATTGACAAAAGCGGTGAACTGATTTCACTGCGCGAAGAAGTTACCCATCTGACCCGTAGTCTGCGTCGT
GCCGAGACTGAAACCAAAGTTCTGCAAGAGGCCCTGGCAGGTCAGCTGGATAGCAATTGTCAGCCGATG
GCAACCAATTGGATTCAAGAAAAAGTTTGGCTGAGTCAAGAGGTGGATAAACTGCGCGTTATGTTTCTG
GAAATGAAAAATGAGAAAGAAAAACTGATGATCAAATTTCAGAGCCACCGCAATATCCTGGAAGAGAAC
CTGCGTCGTAGCGATAAAGAACTGGAAAAACTGGATGATATTGTGCAGCACATCTATAAAACCCTGCTG
AGTATTCCGGAAGTTGTTCGTGGTTGTAAAGAACTGCAGGGACTGCTGGAATTTCTGAGC 
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6.4.2 SKAP 
6.4.2.1 Wild type gene 
ATGGCGGCTCCCGAAGCCCCGCCCCTGGACAGAGTTTTCCGTACAACATGGCTGTCTACAGAGTGCGAT
TCCCACCCACTTCCGCCTAGCTACCGGAAGTTTCTATTTGAAACCCAGGCGGCCGACTTAGCCGGTGGC
ACGACAGTTGCTGCAGGGAATCTTTTAAACGAGAGCGAGAAGGACTGCGGGCAGGACCGGCGGGCTCCT
GGGGTTCAGCCGTGCCGCCTCGTTACGATGACCAGTGTGGTTAAGACAGTGTATAGCCTGCAGCCCCCC
TCTGCGCTGAGCGGCGGCCAGCCGGCAGACACACAAACTCGGGCCACTTCTAAGAGTCTCTTACCTGTT
AGGTCCAAAGAAGTCGATGTTTCCAAACAGCTTCATTCAGGAGGTCCAGAGAATGATGTTACAAAAATC
ACCAAACTGAGACGAGAGAATGGGCAAATGAAAGCTACTGACACTGCCACCAGAAGGAATGTCAGAAAA
GGCTACAAACCACTGAGTAAGCAAAAATCAGAGGAAGAGCTCAAGGACAAGAACCAGCTGTTAGAAGCC
GTCAACAAGCAGTTGCACCAGAAGTTGACTGAAACTCAGGGAGAGCTGAAGGACCTGACCCAGAAGGTA
GAGCTGCTGGAGAAGTTTCGGGACAACTGTTTGGCAATTTTGGAGAGCAAGGGCCTTGATCCAGCTTTA
GGCAGTGAGACCCTGGCATCACGACAAGAATCCACTACTGATCACATGGACTCTATGTTGCTGTTAGAA
ACTTTGCAAGAGGAGCTGAAGCTTTTTAACGAAACAGCCAAAAAGCAGATGGAGGAGTTACAGGCCTTA
AAGGTAAAGCTGGAGATGAAAGAGGAAAGAGTCCGATTCCTAGAACAGCAAACCTTATGTAACAATCAA
GTAAATGATTTAACAACAGCCCTTAAGGAAATGGAGCAGCTATTAGAAATG 
 
6.4.2.2 Codon-optimized gene 
ATGGCAGCACCGGAAGCACCGCCTCTGGATCGTGTTTTTCGTACCACCTGGCTGAGCACCGAATGTGAT
AGCCATCCGCTGCCTCCGAGCTATCGTAAATTTCTGTTTGAAACCCAGGCAGCAGATCTGGCAGGCGGT
ACAACCGTTGCAGCAGGTAATCTGCTGAATGAAAGCGAAAAAGATTGTGGTCAGGATCGTCGTGCACCG
GGTGTTCAGCCGTGTCGTCTGGTTACCATGACCAGCGTTGTTAAAACCGTTTATAGCCTGCAGCCACCG
AGCGCACTGAGCGGTGGTCAGCCTGCAGATACCCAGACCCGTGCAACCAGCAAAAGCCTGCTGCCGGTT
CGTAGCAAAGAAGTTGACGTTAGCAAACAGCTGCATAGTGGTGGTCCGGAAAATGATGTTACCAAAATT
ACCAAACTGCGTCGCGAAAATGGTCAGATGAAAGCAACCGATACCGCAACCCGTCGTAATGTTCGTAAA
GGTTATAAACCGCTGTCGAAACAGAAAAGCGAAGAGGAACTGAAAGATAAAAATCAGCTGCTGGAAGCC
GTTAATAAACAACTGCATCAGAAACTGACCGAAACACAGGGTGAGCTGAAAGATCTGACCCAGAAAGTT
GAACTGCTGGAAAAATTTCGTGATAACTGTCTGGCAATCCTGGAAAGCAAAGGTCTGGACCCTGCACTG
GGTAGCGAAACCCTGGCAAGCCGTCAAGAAAGCACCACCGATCACATGGATAGCATGCTGCTGCTGGAA
ACCCTGCAAGAAGAACTGAAACTGTTTAATGAAACCGCCAAAAAACAAATGGAAGAACTGCAGGCACTG
AAAGTGAAACTGGAAATGAAAGAAGAACGCGTCCGTTTTCTGGAACAGCAGACCCTGTGTAATAATCAG
GTTAATGATCTGACCACAGCCCTGAAAGAAATGGAACAGCTGCTGGAAATG 
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